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Current bone repair materials can be too stiff compared to native bone and with 
insufficient strength for load bearing applications often with brittle fracture behaviour. In 
addition they can have unacceptably high polymerization shrinkage and decline in 
strength with time. This thesis describes the development of chemical cure, silica 
reinforced dimethacrylate composites and discusses their viability as alternatives for 
bone repair. The intended applications of these composites include hip fracture screw 
augmentation and vertebroplasty 
Characterization and comparison of cement materials was central to this thesis. The 
handling of the materials was assessed qualitatively via repeated delivery and mixing 
whilst the rate and degree of cure was determined from Fourier Transform Infrared 
(FTIR) spectroscopy. This cure data was used with composition to calculate and 
compare the volumetric shrinkage of materials. Biaxial testing gave the fracture 
behaviour, flexural strength and Young’s modulus of cements. 
The properties of several existing bone cement materials (including composite cements 
Cortoss and Comp06 and PMMA cements Palacos R and Simplex P) were compared 
using the techniques above.  
Subsequently a variety of (di)methacrylate monomers, silica fillers and silica and 
polymer fibres were screened, and monomer and filler systems selected for further 
testing.  
The levels of each component in the selected systems were varied systematically and 
the effects on trends in mechanical properties were quantified. The interaction between 
level of initiator and the chosen monomer system was investigated and the 
polymerization reaction described in terms of kinetic theory.  
It was found that PPG DMA, combined with UDMA and HEMA monomers, and silane 
treated silica glass particles and fibres could produce materials that cured more 
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extensivley than existing bone cements (69 – 97 % methacrylate conversion compared 
to 86 % and 64 % for Palacos and Cortoss respectively). A PPG DMA composite 
achieved a flexural strength of 93 MPa that was maintained even after  
20 weeks storage in hydrated conditions, unlike Cortoss declined in strength by 40 % 
following hydrated storage. Maintainance of good mechanical properties is essential for 
load bearing applications. This PPG DMA composite had a stiffness of 2.2 GPa, whilst 
PMMA cements and Cortoss had Young’s moduli 1.6 and 3.4 GPa respectively. 
Moreover these materials were found to perform well in-vivo in a lapine femoral 
condyle model. 
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1 Introduction and Literature Review 
In the following sections different bone cement materials and applications will be 
introduced as motivation for this project. The composition and shortfalls of selected 
cement materials will be described and a review of the literature surrounding research 
into their development will be presented. Through this introduction the scope and aims 
of this project will be defined.   
1.1 Bone Cement: Definition and History 
Definition 
Bone cements are a class of synthetic materials that are implanted into the body to 
repair damaged bone. In this thesis, a bone cement is defined as a paste-like material 
that is implanted whilst soft, to repair bone tissue in a range of applications, which then 
cures within the body. Bone cements can either remain within the body for many years 
(non-degradable) or be broken down by biological processes and replaced by new 
bone growth (degradable). Bone cements should not be confused with bone grafts; in 
which bone tissue (either from the patient or another human or animal source) is used 
to repair bone defects. Bioactive glasses are also not considered bone cement 
materials. Non-degradable bone cement materials will be the focus in this thesis, 
neither bioactive glass nor bone grafts will be covered.  
History 
One of the first reported instances of using a non-biological material to repair bone was 
by Dressman in 1892, using plaster of Paris (1). Poly(methyl methacrylate) (PMMA) 
has been used historically as an acrylic ‘glass’ being used extensively in World War II 
in windshields of aircraft and submarines. Following this Charnley noticed that PMMA 
was biologically inert as servicemen wounded with PMMA shrapnel did not show any 
adverse biological response to the material. He encouraged the use of methyl 
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methacrylate resins in orthopaedic surgery from the 1940’s onwards (2,3). Since this 
time PMMA has been established as a major medical material with a huge number of 
applications including, but not limited to, bone repair, contact lenses, denture and 
impression materials in dentistry. Although the prevalence of PMMA in orthopaedics 
and dentistry is clear different types of bone cement have emerged. 
1.2 Applications and Materials 
There are a variety of cement materials available for various applications. In this 
section a selection of these applications and materials will be summarized. This is by 
no means an exhaustive list but is intended to highlight the most prevalent indications 
of common bone cement materials. The incidence of each usage will also be 
discussed. 
Calcium phosphate based cements and PMMA resin cements have both been used to 
reconstruct bones in craniofacial and other skeletal defect surgeries (1,4). 
In cases where sections of bone are missing, such as following bone tumour excision 
or the bone trauma/defects mentioned above, acrylic bone void filler materials have 
been used (2,5). These materials can be loaded with antibiotic drugs in the case of 
infection (3). 
Total Joint arthroplasties commonly use PMMA cements to anchor joint prostheses (2–
4). 
More recently, Osteoporotic vertebral fractures have been stabilized with (PMMA) 
cements (2–4). 
The numbers affected by bone cancer or requiring bone reconstruction following 
osteomyelitis or trauma and the relative risks of developing osteoporosis are varied. It 
is estimated that over 3000 people will be diagnosed with bone cancer in the US in 
2013 (6). The number of people hospitalized by osteomyelitis was over 51 000  from 
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1993 - 2000. Whilst the estimated numbers requiring bone reconstruction following 
trauma were around 500 000 annually in the US in 2005 (7). Around 1 in 5 / 1 in 2 
(Men/Women) over 50 years in age in England and Wales will develop an osteoporotic 
fracture (8). Although these statistics are a mixture between absolute numbers and 
relative risks, and are therefore not directly comparable, it is clear that osteoporotic 
fractures are the most prevalent of these conditions. Furthermore, the increasing 
elderly population (8) means that vertebral fracture numbers and the incidence of hip 
and knee implant requirements are escalating.   
1.3 Project Motivation 
When looking at the numbers of patients affected in each treatment case it was clear 
that osteoporotic fractures are the most prevalent. As such, bone cement development 
for applications involving the treatment of osteoporotic fractures was chosen as the 
main motivation for this project. 
1.4 Current Bone Cement Treatments for Osteoporotic Fractures 
In the previous sections, the main indications of bone cement were summarized and 
osteoporotic fracture applications were defined as the motivation for this project. This 
section will introduce the current bone cement treatment strategies for two of the most 
common osteoporotic fractures in more detail. Furthermore some treatment options, 
which are not currently common practice, are suggested as improvements on current 
methods. Finally the requirements of successful bone cement materials in each of 
these applications will be discussed. 
1.4.1 Vertebral Fractures 
Vertebroplasty is the name given to the procedure in which vertebral fractures are 
stabilised by percutaneous injection of bone cement. This method was first introduced 
in 1987 using PMMA cement (9). More recently composite bone cements have been 
introduced (5,9–11). 
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The following key properties for a successful vertebroplasty cement material were 
defined by Heini and Berlemann (9):  
• Injectable 
• Easy to handle  
• Radiopaque 
• Sufficient viscosity to prevent leakage prior to cure 
• Constant viscosity before cure, curing time sufficient to allow implantation. 
• Sufficient strength/stiffness to restore mechanical properties of vertebrae (both 
compressive and bending strengths must be sufficient to carry the loads applied 
to the material and at the bone/cement interface in the implanted site) (12).  
Some of the problems with vertebroplasty cements are discussed in section 1.5. 
1.4.2 Femoral Neck Fractures 
Traditionally, femoral fractures are fixed by replacing the femur head with a prosthesis, 
which must be held in place with surgical cement in a total joint replacement (TJR). 
Screws and plates are used to treat femoral neck fractures in healthy bone, but do not 
work well with osteoporotic bone. Screw augmentation with bone cement can 
overcome this. 
Canulated screws on their own only attach to the bone at the ends.  As the bone is 
weak the screw cannot get any purchase and the surrounding bone is often damaged. 
Systems involving screws, and augmented with bone cement come some way to 
increasing the contact area between implant and bone and improving the stability of 
the fracture (13,14). 
When the femoral head is replaced with a prosthesis, bone cement is used as a grout 
to anchor the prosthesis into place and transfer loading between prosthesis and bone 
(3). The bone cement increases the contact area between the prosthesis and bone 
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tissue, by mechanical interlocking, making it more suitable for osteoporotic patients 
with low quality bone. 
Requirements for cements for screw augmentation and TJR are as follows: 
• Sufficient strength and stiffness to carry applied loads (15) without damaging 
weak host bone. 
• Viscosity /composition that enables good mechanical interlock with bone 
• Radiopaque 
• Easy to handle and implant. 
• Curing rates that facilitate implantation. 
In addition to the above, there are British standard (ISO 5833 - 2002) and ASTM 
standard (ASTM F 451-08) specifications for acrylic bone cements. In these standards 
the following requirements are stipulated: 
ISO 5833 
Bone cements should be supplied in sterile packaging. Setting time should be between 
6.5 – 15 minutes for syringe deliverable cements and 3 – 15 minutes for hand mixed 
materials with a maximum curing temperature of 90 °C. The compressive strength 
should be over 70 MPa, with bending strength over  
50 MPa and stiffness over 1.8 GPa. Cement viscosity should be such that intrusion is 
more than 2 mm. Stability such that following storage at 23 °C for one hour, viscosity 
should not increase by more than 10 %.  
ASTM 
The material when removed from its package should be sterile. Setting time should be 
5 – 15 minutes with a maximum temperature rise of  
90 °C. Compressive strength should be more than 70 MPa. After heating for 48 hours 
at 60 °C, the viscosity of the liquid should not increase by more than 10%. 
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The test methods for determining the above are specified in each standard. 
1.5 Currents Cements: Description and Disadvantages 




• Cure: curing times and rates; and degree of conversion 
• Shrinkage and heat generation 
• Mechanical properties: strength, stiffness, fracture behaviour and fatigue 
response. 
As described previously bone cements are paste-like materials that set within the body. 
As part of this research project is concerned with characterization of the setting 
chemistry of cement materials, firstly, this section will describe the setting mechanism 
of two classes of bone cement (PMMA cements and composite cements) currently 
used for treatment of osteoporotic fractures along with dental composites. Following 
this these materials will be described according to the above categories with some of 
their disadvantages followed by a summary of their key components. After this some of 
the key modifications made to PMMA and composite materials will then be addressed. 
Bone cements are paste-like materials composed of a liquid phase and a solid powder 
phase. A composite is generally defined as a material that has physically distinct 
phases that differ in either material or form like concrete or carbon fibre composites. As 
will be seen in the following sections the two main groups of bone cements described 
(poly(methyl methacrylate) and composite cements), strictly speaking are both 
composites; in that they both consist of a liquid phase, solid reinforcing phase and 
often a radiopacifying phase. For the purposes of this thesis poly(methyl methacrylate) 
cements are not termed ‘composites’ because the main constituents (liquid and 
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reinforcing phase) are different forms of organic material, whereas so called 
‘composite’ cements consist of phases of different form and material; the liquid phase 
is organic and the reinforcing phase is inorganic. 
1.5.1 Free Radical Polymerization 
The bone cements introduced below are a mixture of liquid and powder phases in 
proportions that result in a paste. The liquid phase is monomer molecules that contain 
one (or more) methacrylate groups that contain a carbon to carbon double bond (C=C). 
Chemical initiators are included; these are small compounds that form free radicals 
with a short half life. Initiator radicals can be stabilized either chemically or with 
exposure to light of the correct frequency (16). The mechanism by which these 
materials harden and cure is free radical addition polymerization during which free 
radicals generated by the initiator system attack the liquid monomer C=C double bond, 
breaking it open to create a monomer free radical that can bond to other monomer free 
radicals creating a polymer chain.  
Reaction Mechanisms 
An inhibited dimethacrylate polymerization mechanism can be represented by (17) 
    Initiation 
    
  Propagation 
  Inhibition 
    
  Crosslinking 
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   Termination 
For monomethacrylates (like PMMA) crosslinking does not apply. As can be seen from 
the above mechanisms, initiation is either when an initiator free radical (I) or a 
monomer free radical (M) interacts with a monomer molecule, creating a monomer 
free radical that can either go on to create more radicals or join a polymerzation chain. 
This chain formation is called propagation. Often bone cements include an inhibitor to 
prevent polymerization during storage. In the inhibition step free radicals are 
neutralized and prevented from causing further polymerization. For termination, the 
above assumes a general case where chain radicals are consumed in pairs to produce 
dead polymer. kd, kp, kz, kc, and kt are rate constants for initiation, propagation, 
inhibition, crosslinking and termination. During propagation, diffusion becomes difficult 
due to the decreased mobility of the growing polymer chains, and termination (diffusion 
controlled) reactions are prevented; the rate of polymerization increases rapidly 
(autoacceleration). These simplified mechanisms assume that monomers in bone 
cements all have similar polymerization rates and can copolymerize. A simplified 
schematic of free radical polymerization can be found in Figure 1-1. 
Mn• +Mn• kt! →! P
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Figure 1-1 Free radical polymerisation reaction schematic. Initiator free radical (I) attacts double bonds in 
methacrylate group to create monomer free radical – which can in turn create more monomer free radicals 
and polymerize to form a polymer chain. In the case of PMMA cements R is CH3. For dimethacrylates, two 
methacrylate functional groups are present and crosslinking is possible. 
1.5.2 PMMA Cements 
Composition  
PMMA cements contain methyl methacrylate (MMA) monomer liquid (Figure 1-2) and 
pre-polymerized PMMA powder (2). There are many poly(methyl methacrylate) 
cements available with a range of compositions and additives. Typical PMMA cements 
contain liquid methyl methacrylate monomer (MMA) with pre-polymerised beads of 
poly(methyl methacrylate) as filler with a radiopacifier of barium sulphate or zirconium 
dioxide (18). PMMA cements have a chemical initiator system usually incorporating; 
Benzoyl Peroxide (BP) initiator and Dimethyl-para-toluidine (DMPT) accelerator. The 
benzoyl peroxide radicals are stabilised by the DMPT accelerator; following mixing, the 
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composite is formed via chemically induced free radical polymerization of the monomer 
liquid forming an interpenetrating network with the dissolved polymer.  
 
Figure 1-2 Molecular structure of methyl methacrylate monomer. 
The inclusion of barium sulphate as a radiopacifier has been reported to encourage 
bone resorbtion (18,19) whilst the toxicity of the accelerator DMPT and initiator BP 
have also caused concern (18,20). Bone resorption can lead to cement loosening (21). 
PMMA cements often contain antibacterial agents to prevent deep infection following 
TJR. There have been some concerns raised that inclusion of antibacterial agents, 
particularly aqueous based, can detrimentally affect curing and mechanical properties. 
It has been found, however, that when incorporated at the correct level by the 
manufacturer that there are no adverse effects (22). 
Handling 
PMMA cements are supplied to the surgeon as a powder and a liquid that must be 
mixed in the operating room prior to use. 
Hand mixing of powder and liquid components has been identified as producing PMMA 
cements with poorer mechanical properties than mechanically/vacuum mixed cements 
(23) and could be responsible for a reduction in sterility (24). It has also been reported 
that the scatter of strength results for hand mixed cements is larger than for 
mechanically mixed materials (15,25) whilst differences in skill and technique of 
cement preparer has been shown to result in cements of varying porosity (26). 
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(23,27,28). There are concerns also about the exposure of the mixing technician to 
methyl methacrylate during hand mixing; repeated exposure can lead to contact 
dermatitis and sensitisation (29,30).  
If too much pressure is used during vertebroplasty, or the cement is too liquid when 
injected, it can leak before it cures (31). A study by Nieuwenhuijse found that around 
75 % of vertebroplasties investigated, exhibited some leakage (32). Whilst uncured, 
cement leakage into blood can cause pulmonary embolism and cardiac perforation. 
Once cured leaked cement can damage surrounding vertebrae and put pressure on 
the spinal cord (33).  
After mixing, PMMA cements can gradually change in viscosity as the polymer beads 
swell with monomer (2). Initially viscosity can be low and if the cement is placed too 
soon it may mix with blood.  Conversely, if the viscosity becomes too high before 
placement, bone penetration and micromechanical bonding may be jeopardized (2). 
Cure 
As mentioned above, PMMA cements cure via free radical polymerization of Methyl 
methacrylate monomer, initiated by BP and DMPT. Conversion ratio is the ratio of 
reacted monomers to the initial level of monomers. The level of BP and DMPT has 
been reported to have a power law effect on the setting time of PMMA cement (34).  
The levels of initiators used can significantly affect the degree of conversion and hence 
the amount of residual monomer (35). With PMMA cements, induction time, before the 
onset of cure, is long; typically several minutes (3). Furthermore, final conversion is 
never 100% (30). It has been reported that monomers can leach out of PMMA cement 
during the induction time and after cure when less than 100% conversion is achieved 
(36,37). This can cause problems similar to uncured cement leakage mentioned above. 
Oxygen inhibits free radical cure. As mentioned above, porosity can reduce mechanical 
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properties, oxygen trapped in pores can also reduce the level of conversion of PMMA 
cements (38).  
The manufacturers advise that the cure of PMMA materials can be delayed by pre-
chilling the components (39,40). The temperature of the materials will affect the 
kinetics of the polymerization reaction and may affect the level of conversion. 
Shrinkage and Heat Generation 
There is a volume decrease and heat generation associated with each polymer bond 
created during composite cement cure. This can cause a rise in temperature of the 
tissues surrounding the site where the cement material is implanted and tissue 
necrosis. This necrosis in combination with polymerization shrinkage can result in a 
loose cement implant.   Loads cannot then be passed effectively between the cement 
and the tissue (21). 
MMA is of low molecular weight (MW).  This means PMMA cements are subject to high 
shrinkage (2,41,42) and heat generation (41). Polymerization shrinkage has been 
measured to be 6 - 7 vol.% for PMMA cements and may result in residual stresses that 
can cause cracking in cement in TJR procedures and can shorten lifespan of the 
implant (43,44). Furthermore polymerization shrinkage could damage trabecular bone 
before loading (45) and be detrimental to the bone-cement interface stability. This 
could be especially important when implanted in weak osteoporotic bone. Furthermore 
damage to the bone-cement interface has been postulated as a cause of cement 
loosening in TJR (21). 
Measurement of polymerization shrinkage has been performed via a density bottle 
method (46) and computer controlled mercury dilatometer method (47). 
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Mechanical Properties 
PMMA cements are far from satisfactory in terms of mechanical properties; the 
modulus of PMMA is up to an order of magnitude higher than cancellous bone 
(3,15,48) meaning that cement deflection on loading will be very different from 
surrounding bone. This could cause damage to weak, low density bone. 
PMMA cements are weaker in tension and shear than in compression and exhibit 
strain rate dependent properties (viscoelasticity) (15).  For this reason it is important to 
know the strain rate and test method used when strength and stiffness values are 
quoted in the literature. PMMA cements have poor resistance to fatigue and low 
fracture toughness which can limit their use in applications where cyclical loading 
bearing is present (15,49). 
1.5.3 Composite Cements 
A class of cement materials inspired by dental composite materials addresses many of 
the problems associated with PMMA cements, that are outlined above. Although 
composite materials do solve some of the problems with PMMA cements, some still 
remain. 
Composition 
Dental composites comprise Dimethacrylate monomers (such as Bisphenol A Glycidyl 
Methacrylate (BisGMA), Urethane Dimethacrylate (UDMA) and Triethylene Glycol 
Dimethacrylate (TEGDMA)) together with inorganic fillers usually supplied as a 
premixed paste that is cured by light activated free radical polymerization (50). Light 
cure, however, is unsuitable for bone cement applications due to the large volume of 
material and inaccessibility of the implant sites. 
Cortoss and Comp06 are pre-mixed, dual paste chemically curing alternatives to 
PMMA cements that are now commonly used in vertebroplasty. These composite bone 
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cements are more similar to dental composites than PMMA cements as they contain a 
mixture of dimethacrylate monomers and silica fillers more commonly found in dental 
composites. In addition Cortoss contains the calcium containing phase combeite, whilst 
Comp06 contains Hydroxyapatite. 
Bisphenol A is a clear plastic that is commonly used to make drinks bottles and food 
packaging (51) is present as an impurity in some resins such as BisGMA (52). 
Hormone mimicking properties have been reported for bisphenol A (53) and have lead 
to some safety concerns with BisGMA use (52).  
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Handling 
Dual paste composites such as Cortoss and Comp06 are supplied in double barrelled 
syringes with automatic mixing tips.  This reduces mixing time / variability, surgeon / 
material contact and potentially patient infection risk. Furthermore, dental composite 
filler particles, and the filler in composite bone cements, are silica based (54).  Unlike 
the PMMA beads, these do not swell with time.  The viscosity of dental composite 
pastes, and Cortoss, therefore remains stable until methacrylate conversion. Silane 
coating filler particles decreases the viscosity and improves the handling of Dental 
composites (55). Cortoss and Comp06 both contain silane coated filler for this reason. 
Cure 
Dimethacrylate conversion levels in Cortoss, and other dental composites, have been 
reported to be ~ 50 - 60% (56–59). In principle this is sufficient to bond all monomers 
into a polymer structure.  BisGMA, however, has been reported to exhibit low monomer 
conversion (60).  This could be a problem as some monomer molecules may be free to 
diffuse into body fluids. A study investigating the effect on conversion of relative 
amounts of the monomers found in Cortoss (BisGMA, BisEMA and TEGDMA) found 
that higher levels of BisGMA reduced conversion, whilst TEGDMA increased cure (61). 
Shrinkage 
Low conversion in combination with high dimethacrylate molecular weight leads to low 
composite shrinkage (~2 vol.% for dental composites (62)).  This compares with ~7 
vol.% for PMMA cements (63).  As heat generation and shrinkage are proportional; 
both are related to the number of polymerized methacrylate groups (41).  Composites 
will give less than half the heat generation of PMMA cements.  Water sorption in more 
hydrophilic dental composites can balance out polymerization shrinkage (64) .  This 
could also be the case with composite cements. The large volume of material used, 
compared to dental applications however, would mean hydration will take considerably 
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longer than curing time and so any damage to bone caused by shrinkage will be done 
before it can be counteracted by hydration swelling. 
Mechanical Properties 
Although flexural strength of composites can be much higher than that of PMMA 
(65,66) Cortoss has been shown to exhibit lower or comparable strength to PMMA 
cements (10). A particular problem with Cortoss is the very brittle nature of the 
material. This brittle behaviour is associated with poor fatigue resistance. Furthermore, 
a potential problem with BisGMA containing composites, such as Cortoss, used in 
cancellous bone would be high modulus and brittle fracture (10,58).   
1.5.4 Summary of Components and Uses 
Although Composite cements are used as an alternative to PMMA cements for some 
indications, sales figures from Stryker, manufacturers of Simplex P PMMA cement, 
report 23 million doses1 of cement have been sold over 45 years since the material 
was released. Orthovita, manufacturers of Cortoss composite bone cement, reported 
more modest sales of 7400 units in the three years following its release on the market 
(67). From this it is clear that whilst composites are viable alternatives to PMMA 
cements, PMMA is still very much the mainstay of the orthopaedic arthroplasty and 
vertebroplasty market. Unfortunately there is no available clinical data comparing the 
longevity of implanted PMMA and Composite cements. The table below summarises 
the materials and uses described in the previous sections to enable the reader to 
compare PMMA and composite bone cements and dental composites.  
  
                                                1	  From	  advertisment	  in	  the	  Journal	  of	  Bone	  and	  Joint	  Surgery,	  Volume	  90-­‐A,	  number	  2,	  February	  2008.	  2	  Operations were conducted by Vehid Salih, Ensanya AbouNeel and Peter Revell with full 
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Incomplete cure  
Mechanical 
properties poorly 





























Vertebroplasty particularly in 
osteoporotic patients 















Table 1-1 Summary of material composition, properties and uses. 
1.5.5 Modifications to bone cements 
As we have seen in the previous section, there are problems associated with both 
PMMA and Composite bone cements. In this section, the literature surrounding the 
modifications that have been made to these materials to address their shortfalls will be 
reviewed.  
Composition 
Cortoss and Comp06 already contain calcium-containing phases. Inclusion of Calcium 
phosphate materials, into dental composites, that participate in secondary reactions 
(64) or release re-mineralising ions (50) have been shown to improve biocompatibility. 
The release of remineralizing ions could be useful for the localized treatment of 
osteoporosis. 
Although the usage of antibacterial components in PMMA cements is relatively 
common, they are still quite a new addition to dental composites. It has been shown 
that antibacterial agents can be added without affecting mechanical properties (68). 
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Handling 
Pre-mixed and injectable PMMA cements have been developed by Hazenwinkel et al. 
(34,35,69,70). In these cements the pre-polymerised PMMA filler is pre-dissolved in the 
monomer phase and so there is no swelling period. These materials were found to 
have curing and mechanical properties comparable with commercially available PMMA 
cements. 
Cure 
Monomer choice has been shown to be an important consideration in conversion levels 
of composite cements. Long chain, flexible monomers have been shown to achieve 
higher conversion compared to stiff molecules with the ability to hydrogen bond 
(71,72). Inclusion of a low molecular weigh monomethacrylate HEMA and the 
antibacterial agent chlorhexidine has even been shown to increase levels of conversion 
of a dental composite (73). A range of structurally sophisticated monomers have been 
introduced into dental composite materials with mixed results regarding effects on cure 
and mechanical properties due to varying solubility and reactivity of these monomers 
(50). Sideridou reduced the glass transition temperature of an initial monomer mixture 
in a light curing composite and found that this resulted in a higher degree of conversion 
(74). 
In the above section, the level of BP was reported to affect the cure of PMMA cements. 
The rate of polymerization is also dependent on the monomer system used (75). 
Changing the relative concentrations of monomers (TEGDMA: BisGMA: UDMA) as 
well as initiators will affect the degree of conversion and time of cure. 
The powder to liquid ratio (PLR) of commercial hand mixed PMMA cements is usually 
kept at a constant 2:1 volume ratio. A study by Lewis investigated changing the PLR of 
an injectable PMMA cement and found that increasing the PLR increased the rate of 
polymerization due to an increased amount of BP initiator (76). 
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Shrinkage 
Whilst long chain flexible monomers can improve the degree of conversion, they do not 
adversely affect polymerization shrinkage (77). Although increasing the degree of 
conversion should increase shrinkage, the density of double bonds in high molecular 
weight monomers is lower and so shrinkage will not be increased relative to smaller 
molecules. 
Residual stresses due to polymerization shrinkage have been discussed above as a 
potential problem for bone cements. It has been shown that curing composites at 
temperatures over the glass transition temperature (Tg) can result in stress relaxation 
(78). Choosing a system with a low Tg could remove the problems associated with 
residual stresses. 
Mechanical Properties 
As mentioned in the previous section, surface treatment of filler particles can greatly 
improve the mechanical properties (and handling) of composite materials. The 
inclusion of silane treated in-organic fillers into PMMA cements has been shown to 
improve mechanical properties in a similar way to when used in composite bone 
cements (79). A study into aspect ratio of filler reinforcement has shown that high 
aspect ratio fillers can also improve mechanical properties but may increase the 
viscosity (49). Size of fillers is also important; including nano-particles and increased 
amounts of ZrO2 radiopacifier increased the mechanical properties of an injectable 
PMMA bone cement (70). 
The addition of fibres to PMMA, dental and bone composites has been investigated.  
Fibre incorporation into composites can increase strength but the effects of chemistry, 
concentration and aspect ratio are critical (56,62,80,81). Acrylic resins have been 
reinforced with fibres made from a range of different materials at varying length scales 
including nano-scale carbon tubes and micro-scale quartz, polyvinyl alcohol, Kevlar, 
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calcium phosphate, ceramics like zirconia or silicate glasses (49,56,57,62,80–83). 
Glass fibres have been preferred for use in dental materials because of their 
translucency, ease of silane surface treatment and improved flexural strength and 
fatigue resistance (84).  
Monomer choice is also of central importance to tuning of mechanical properties. As 
discussed in the previous section, dimethacrylate monomers could have lower residual 
monomer, cross linking monomers have been shown to work well with surface treated 
glass fibres to improve mechanical properties (85). Puska showed that crosslinking 
monomers had the ability to bond with silane treated filler better than linear MMA (86). 
Monomers containing amine groups were added to PMMA cements by May-Pat to 
increase water sorption and cell attachment and it was found that compressive and 
bending strength was decreased, but fracture toughness was improved (87). 
PMMA cements have been reinforced with βTCP coated in poly(ethylene) glycol 
resulting in cement with good long term strength – this would be an improvement over 
Cortoss, which exhibits a strength decline. 
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1.6 Hypotheses 
From the literature conducted above, it is believed that the type of monomer system 
will affect the handling of the material and will change how effectively the initiator 
system works, changing the rate and total time taken for the material to polymerize. 
Calcium phosphate particles can encourage a long term bond between the material 
and surrounding bone.  
In an unpolymerized state, the monomers can be toxic, their size and type will affect 
how easily they can dissolve water and travel into the body. If initiator chemicals are 
present in high dosage after polymerization is complete they too can leach out of the 
material and can cause damage to surrounding tissues and cells.  
A good level of conversion will mean more links within the polymer network and so a 
higher strength. 
The heat generated, the percentage decrease in volume due to polymerization 
shrinkage and the initial and long term toxicity of the product are largely governed by 
the size and type of the monomers used.  As explained earlier, smaller monomers will 
mean more heat and shrinkage, whilst a high PLR will mean less monomer in a given 
amount of cement therefore less heat generation. 
The polymerized material will absorb water and this can compensate for the 
polymerization shrinkage. 
Good dispersion and bond between the monomer and filler phases will mean a high 
strength. Using adhesive monomers can allow bonding between the polymer and 
calcium phosphates found in the material as well as surrounding bone. Also, coating 
the filler particles with monomer molecules allows a good dispersion of the glass 
particles in the monomer, and consequently the polymer network. 
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The secondary calcium phosphate/water reaction and the interpenetrating network that 
this creates is another mechanism by which the strength is increased. 
Fibres can increase mechanical properties if they are well dispersed and have good 
interfacial bond strength with the polymer phase. 
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1.7 Project Scope and Aims and Objectives 
In the previous section, the modifications that have been made to bone cement 
materials to improve their performance were summarized. In light of this, this section 
will summarize the aims of the project. The areas of development in this project 
(project scope) will be described.  
The project aim is to develop bone cement materials that could be used to augment 
screws in osteoporotic hip fractures and to stabilize vertebral fractures.  
From computer modelling and surgeon consultation performed by the sponsoring 
company Ozics, and information from the above literature review a set of target 
properties has been drawn up. 
Target Properties: 
1 The cement must be compatible with delivery via a syringe and mixing tip to avoid 
surgeon mixing complications. 
2 The level of heat and shrinkage of the product should be comparable or less than 
that of Cortoss in order to be competitive. 
3 The formulation curing time should be 1 – 3 minutes to allow manipulation of the 
implantation site by the surgeon after injection although the material should be fast 
setting enough to prevent leakage or excessive monomer leaching. 
4 The level of monomer conversion should be more than in current products to 
reduce possible toxicity. 
5 The product must be strong enough to transfer the loading between bone and 
screw in hip, or carry required loads in vertebra. It must also have relatively low 
stiffness to be compatible with bone movement upon loading and prevent 
associated bone damage (Ozics deemed that a flexural strength of 50 – 70 MPa is 
required and that stiffness should be comparable to PMMA cements). 
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6 Additionally, the cement should not be brittle. Instead it should deform when 
overloaded to cause pain that will be a signal to the patient that something is 
wrong rather than the first sign of overloading being catastrophic brittle failure. 
Project Objectives: 
1 To determine the properties and characteristics of current popular PMMA and 
composite bone cement materials and a dental composite (chapter 3). 
2 To screen possible components for inclusion in cement materials that could fulfil 
the above target properties (chapter 4). 
3 To select candidate components and conduct systematic investigation into their 
effects on cement properties (chapter 5). 
4 To select a monomer and filler system and characterize the in-vitro and in-vivo 
performance of this prototype formulation (chapter 6) and to investigate the effects 
of changing the initiator system on shelf life and curing of this material (chapter 7). 
5 To determine to what extent the in-vitro and in-vivo response of the selected 
materials fulfil the target properties and to suggest future research directions and 
further work (chapter 8) to enable the production of a competitive bone cement 
product.  
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2 Materials and Methods 
This section summarizes all the materials and the protocols used throughout the 
project. At the start of each chapter a summary of the materials and methods used is 
given.  
2.1 Materials 









Silane treated silica 
glass, 
Combeite 
Pre-mixed paste in double 






Silane treated barium 
silica glass 
Hydroxyapatite 
Pre-mixed paste in double 
barreled syringe (chemical cure 
following mixing) 
Palacos R Heraeus MMA 
PMMA 
Zirconium dioxide 
Monomer liquid and powder 
supplied separately mixed before 
delivery (chemical cure following 
mixing) 





Monomer liquid and powder 
supplied separately mixed before 
delivery (chemical cure following 
mixing) 




Premixed syringe - light cure 
Table 2-1 Details of commercial materials investigated in this project. Description and component 
information from manufacturer. 
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2.1.2 Monomers 
Abbreviation Name Supplier Product code MW 
PETA Pentaerythritol tetraacrylate Polysciences 01547-100 352 
UDMA Urethane dimethacrylate Esstech X850 0000 470 
PPGDMA 
Poly (propylene glycol)425 
dimethacrylate 








Esstech X943 7446 228 
PPGMMA 
Poly(propylene glycol) 300 
monomethacrylate 
Polysciences 15934-250 370 
HEMA  Hydroxyethyl methacrylate Esstech X968 7044 130 
Table 2-2 Details of Monomers that were used throughout this project. Molecular weight information  
from manufacturer. 
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2.1.3 Fillers 
Shape Silanated Abbreviation 
Name / manufacturer’s 
code 
Size (µm) Supplier 
Particle 














IF-2019 barium  










borosilicate glass fibre 
15x300 MO-SCI 
Table 2-3 Details of filler materials used throughout this project. Information from manufacturer. 
  
Kirsty Main  PhD Thesis 
 56 
2.1.4 Initiators, Activators and Inhibitors 
  Abbreviation Name Supplier Product code MW 








Fluka 34750 220 
Table 2-4 Details of initiator, activator and inhibitor chemicals used throughout this project.  
Details from manufacturer.  
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2.2 Methods 
A summary of the methods employed in each section can be found at the start of each 
chapter. 
2.2.1 Apparatus Required for Material Preparation 
To prevent contact dermatitis associated with monomers, latex gloves were worn for all 
sample preparation. Hands were washed and gloves changed whenever they came 
into contact with monomers and after all preparation.  A laboratory coat was worn to 
prevent clothing contamination. 
Metal spatulas and glass pipettes were used to handle the fillers and viscous 
monomers, and diluent monomers respectively.  
All weighing was done using a Pioneer analytical balance (Ohaus, UK).  
Amber glass bottles were used to contain the monomers and additives during mixing. 
Paste mixing was performed by hand using a metal spatula and a rubber mixing-pad 
(3M ESPE) (Figure 2-2). 
Commercial materials and prepared composite pastes were mixed via double barrelled 
syringes with 2 x 5 cm3 (Figure 2-3) or 2 x 10cm3 barrels in conjunction with a delivery 
gun and screw mixing tips (Sulzer Mixpac, Switzerland, and Orthovita, USA, 
respectively). 
Room condition: temp 23 °C, light on or off as desired, depending on daylight. 
Refrigeration: Fridges maintained between 1 – 5 °C with no light. 
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2.2.2 Commercial Materials Sample Preparation 
Commercial materials were prepared for use as described in the following sections.  
2.2.2.1 Cortoss and Comp06 Composites 
Double barrelled syringes containing Cortoss or Comp06 materials were removed from 
the fridge 30 minutes prior to use to allow the material to warm up to ambient 
temperature.  
2.2.2.2 PMMA Cements 
Equal quantities of the powder and liquid phases of Simplex P PMMA (Stryker) and 
Palacos R bone cements were mixed on rubber dental mixing pads according to 
manufacturer’s instructions. 
2.2.2.3 Z250 
Disc specimens of Z250 were sandwiched between sheets of acetate and cured with a 
blue light-curing unit (L.E. Demetron I, Kerr, USA), for which the power output was 
1000 mWcm2. Specimens were exposed to the light source for 60s on each side. 
2.2.3 Composite Sample Preparation 
2.2.3.1 Monomer Preparation 
Monomer mixture (prior to addition of initiators) 
First, the desired monomers were mixed together with inhibitor without any 
initiator/activator. Monomers were weighed into an amber bottle (total amount between 
8 and 10 g, mass percentages of components weighed to an accuracy of 0.001g). The 
order of weighing was from component of smallest amount to largest amount. BHT was 
pre-dissolved in the diluent monomer of choice at a higher concentration (20x 
concentrated) to minimise weighing errors. 
The amber bottle was capped and the monomer mixture mixed for 15 minutes using a 
magnetic stirring bar at room temperature at speed setting 2/3. This gave a ‘stock 
monomer mix’ that could be stored at 5 °C for up to two months with no effect on the 
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curing kinetics of the end product. The stirrer bar was removed before storage to 
prevent any breakdown of the plastic bar by the monomers. 
Addition of initiators to monomer mixes 
The monomer mixes were at ambient temperature before being combined with 
initiator/activator and so were either used straight after being prepared or removed 
from the fridge 30 minutes prior to use. A small amount of the desired monomer mix 
was weighed into two amber bottles (2-5 g depending on number of specimens to be 
made). 
The desired quantity of initiators/activators were added to the monomer; BP into one 
bottle and DMPT into the other. 
Monomers and initiators were mixed for 30 minutes using magnetic stirring bar at 
speed 2/3 to ensure complete dissolution of the initiator / activator. Once the 
monomers were combined with initiator or activator they were mixed with fillers and 
used on that day to prevent any variability in cure due to monomer instability.  
2.2.3.2 Filler Preparation 
All fillers were stored at room temperature in airtight containers to ensure that they 
were kept dry. Care was taken not to introduce moisture into the bulk of the filler 
materials by decanting small amounts of filler sufficient for two or three day’s work at a 
time. 
2.2.3.3 Paste Mixing and Syringe Filling 
Depending on the powder to liquid ratio required, an amount of monomer mix 
(containing initiator) was weighed onto a mixing pad. The required mass of filler(s) was 
(were) added.  
Roughly half the filler was combined with the monomer to make a thin paste. Once a 
homogenous consistency was achieved, the remaining filler was incorporated. Care 
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was taken to mix in such a way as to avoid excessive introduction of air to the mixture. 
The paste was worked with the spatula to remove any visible air bubbles or filler 
aggregates. 
These steps were repeated for the activator containing monomer mix. 
Each paste was added to one side of a double barrelled syringe; again care was taken 
to avoid air bubbles. Stoppers were inserted into each barrel and the syringe was left to 
stand with the tip pointing upwards to allow the pastes to settle against the stoppers 
and for air bubbles to escape. 
A lid was fastened onto the syringe after a plunger was used to push the pastes to the 
tip and level the stoppers (Figure 2-4). 
 
Figure 2-2 Filler powder and monomer mix on rubber mixing pad prior to mixing. 
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Figure 2-3 Double barrelled syringe and screw mixing tip. 
 
Figure 2-4 Initiator and Activator pastes are combined by being extruded through screw mixing tips via a 
delivery gun. 
2.2.4 Wet Point 
The wet point is defined as the minimum mass of monomer added to a filler powder to 
achieve a cohesive mass, and is given as a percentage of monomer in the resulting 
paste. 3g of the filler to be tested was weighed onto a rubber mixing pad, small (0.01g) 
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amounts of monomer were added incrementally to the filler until a barely cohesive 
paste was achieved. The weight percentage of monomer in the paste was calculated. 
2.2.5 Factorial Analysis 
Factorial analysis is the main method of analysis that has been used to investigate the 
materials used. It is a method that allows the effect of more than one variable to be 
investigated simultaneously.  
It is assumed that the reaction process can be expressed in the form of a kinetic 
expression such as a power law (Equation 2-1). This kinetic expression can be shown 
to be equivalent to a factorial expression (Equation 2-2) (88). Experimental results, D, 
can be used to determine the effect of each variable on the parameter measured. In 
effect the rate constants in the kinetic expression are determined from solving factorial 
equations. In this way it is possible to demonstrate how much the variables under 
investigation affect properties of interest. Ho and Young (88) performed a two level 
factorial analysis (simultaneous investigation of two variables; in this report three 
variables are investigated at one time.  For a complete factorial experiment, 8 
specimens are then required. The size of a1, a2 and a3 show the size of the effect of 
each of the three variables (Equation 2-3). Effect of variable 'i' is quantified by ai; this 
can be calculated from the ratio of the geometric mean of n specimens (Dn) with 
variable i at its high and low value respectively. Factorial analysis also enables 
quantification of interaction effects between the variables.  Strong interaction effects, 
however, complicate understanding of the effects of variables and prevent fitting of 
simple kinetic expressions. The size of these interactions is given by a12, a13, a23 and 
a123. An intermediate formulation (with intermediate values of each variable) is often 
tested. If there are no interactions the intermediate formulation will be similar to the 
average result of the other eight formulations. 
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D = kV1b1V2b2V3b3⇒ ln(D) = ln(k)+ b1 ln(V1)+ b2 ln(V2 )+ b3 ln(V3)   Equation 2-1  
ln(D) = ln(D) ± a1 ± a2 ± a3 ± a12 ± a13 ± a23 ± a123     Equation 2-2  
2ai = ln
Π Dn( )vari HIGHn








'        Equation 2-3  
2.2.6 Fourier Transform Infrared Spectroscopy 
Fourier transform infrared spectroscopy (FTIR) can be used to measure the degree of 
conversion of methacrylates (71,73,88,89). Differential scanning calorimetry (DSC) and 
Fourier transform Raman spectroscopy (Raman) can also be used (64,78,90–92). 
These are the most common techniques for finding the degree of conversion.  
This section will give some of the reasons why FTIR has been used in this project to 
record the polymerization reaction and degree of conversion and address some of the 
technique’s limitations compared to Raman and DSC.  
With FTIR, there is the opportunity to use a real time monitoring method, that allows 
not only the degree of conversion to be found but also the rate at which the 
polymerization reaction progresses. The method of FTIR used in this project is based 
on that of Young et al. (89) in which the curing of methacrylate systems is monitored in 
real time producing a curing profile. This is the main reason for choosing FTIR 
measurement over Raman spectroscopy.  
FTIR and Raman spectroscopy are complementary.  Peaks that are active in Raman 
are often weak in FTIR.  Peaks selected for polymerization reaction monitoring are 
central to the success of the technique. The C=C peak (at 1638 cm-1 in FTIR), for 
example, is stronger in Raman than in FTIR. If this peak is used, the FTIR technique 
can have poor sensitivity to residual monomer levels when conversion is high (88). For 
this reason, other methacrylate peaks have been used as discussed later in section 
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2.2.5.2. There can be large variation in FTIR measurements of conversion when using 
different peaks. It is therefore difficult to compare results with literature when different 
peaks have been used (71). 
With DSC measurements, there is a delay between sample mixing and the start of 
reaction monitoring due to having to seal the DSC container and place in the 
instrument. There is less delay between sample mixing and reaction monitoring when 
using real-time FTIR as, after mixing, the material can be placed on the FTIR crystal in 
seconds.  As a result, very sensitive and accurate measurement of the induction period 
of materials, especially injectable composites, is possible.  
The attenuated total reflectance (ATR) FTIR method used in this project measures the 
reaction near the surface of the material in contact with the diamond – it cannot easily 
measure conversion of double bonds in the bulk of materials (93). DSC is better suited 
to measuring the bulk material reaction as it measures enthalpy changes of an entire 
volume of material. 
2.2.6.1 FTIR Background 
The FTIR method was selected as the technique for measuring the polymerization rate 
and degree of conversion. This section is intended to be a brief explanation of the 
underlying principles of the technique.  
ATR FTIR spectroscopy is a method of vibrational spectroscopy in which the vibrations 
of molecular bonds after absorbance of incident infrared radiation give information 
about molecular structure.  
Absorbed Infrared radiation causes the bonds between atoms in molecules to vibrate 
at their resonant frequencies. Different bonds have various strengths/lengths and 
absorb different wavelengths of radiation. The resonant frequencies correspond to 
discrete vibrational energy levels (Figure 2-7).  
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Absorption of infrared radiation causes changes in the electron distribution (dipole 
moment) of the bond and hence transitions between energy levels (94). The resonant 
frequencies/vibrational energy levels depend on the size of the atoms and the electron 
density of the bond. The dipole moment of polar bonds can be more strongly deformed 
than non-polar bonds and so FTIR can more easily show the asymmetric vibrations of 
polar groups. For this reason water molecules can be easily detected with FTIR. 
FTIR Instrumentation 
The purpose of an FTIR instrument is to determine the wavelengths of infrared 
radiation that are absorbed by a particular material and hence infer the type of bonds 
that exist between the atoms of the molecule. The intensity of light absorbed at a 
particular wavelength can be determined by finding the ratio of incident radiation to 
radiation that has been absorbed/ transmitted (Beer Lambert law). 
In FTIR spectroscopy, an IR source is projected, through a sample, onto a detector. An 
FTIR instrument, therefore, consists of a polychromatic IR radiation source; a sampling 
method to determine the ratio of intensity of incident to transmitted/absorbed radiation; 
and an instrument to determine the wavelengths of the incident and 
transmitted/absorbed radiation. 
The sampling method employed in this project to find the intensity of radiation 
interacting with the sample is attenuated total reflectance (ATR). In this method the 
material being investigated is placed on a crystal of material with high refractive index 
(diamond). Radiation from the source has a real component that is totally internally 
reflected and an imaginary component (at 90° to the real part) that probes the surface 
of the sample in contact with the crystal (0.5 – 5 µm). At frequencies around where 
radiation is absorbed, the imaginary component is attenuated, and at other frequencies 
it is not.  
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A Michelson interferometer forms part of an FTIR instrument and is used to determine 
which wavelengths have been absorbed by the material. The interferometer is used 
conjunction with the Fourier transform to determine the wavelengths of absorbed light 
from the intensity of the polychromatic radiation after it has interacted with the sample. 
Figure 2-5 shows the experimental set up of a Michelson interferometer. Light from the 
sample is split by a beam splitter, which sends half the signal to a moving mirror and 
half to a fixed mirror. The reflected radiation from the fixed mirror and moving mirror 
arrive at the detector with a path difference depending on the position of the moving 
mirror. The interference of the two beams at the detector gives an interferogram of 
intensity as a function of time. Due to the position of the moving mirror the two beams 
will only constructively interfere at one point giving an interferogram with a centre burst 
that quickly dies away at other times. A computer uses the Fourier transform and the 
Beer Lambert law to convert this interferogram into a plot of Absorbance as a function 
of wavelength. In an FTIR instrument, all the wavelengths of the source reach the 
detector simultaneously; a full spectrum can be found in seconds. This makes FTIR 
spectroscopy suitable for real-time monitoring of polymerization.  
FTIR spectra (Figure 2-6) can give qualitative and quantitative information about a 
material. Whilst the position of the peaks in the spectrum gives information about the 
chemical groups present, the relative heights of peaks in a spectrum of absorbance vs. 
wavenumber give quantitative information about the relative amounts of each bond 
type. This is particularly useful when monitoring polymerization reactions in real time as 
the relative heights of the peaks corresponding to the methacrylate group infer how 
many of these groups have polymerized as the reaction progresses. 
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Figure 2-5 Schematic of a Michelson Interferometer. Light from source is split between moving and fixed 
mirrors, arriving at the detector with a path difference dependent on the position of the moving mirror. 
FTIR Resolution 
The spatial resolution of the FTIR spectrometer is limited by the size of the crystal. 
Each spectrum found is the average chemical structure over the whole area of the 
crystal. In the case of composite cements, the spectrum found will be an average of 
both the polymer and filler phases. 
The wavelength resolution, which is different from the spatial resolution, is defined as 
the closest division in between discrete wavenumbers that can be detected. To detect 
two discrete wavenumbers (two distinct lines in the frequency domain), the beam from 
the sample must be scanned in the time domain for one complete period (from one 
maximum to the next on the interferogram). The wavelength resolution of an FTIR, 
therefore, is determined by the distance over which the moving mirror can travel. The 
resolution is in fact proportional to the reciprocal of the distance the mirror can move. In 
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2.2.6.2 Cure Profile and Degree of Conversion 
Material FTIR spectra, at 25 ºC, were obtained using a series 2000 FTIR spectrometer 
(Perkin-Elmer, UK) with a temperature controlled golden gate diamond ATR 
attachment (Specac, UK) and Timebase software.  1 mm thick, 10 mm diameter brass 
rings, placed around the ATR diamond (maintained at 25 °C), were filled directly with 
the material to be investigated either from a double barrel syringe (composites) or after 
1 minute of mixing (PMMA cements) (n = 4).  The top surface of the mixed paste was 
covered with acetate to prevent surface oxygen inhibiting the polymerization process.  
Spectra of the lower surface of the specimen were recorded with a resolution of 4 cm-1, 
every 4 s for 20 minutes from 700 cm-1 to 2000 cm-1. Difference spectra were obtained 
to ensure methacrylate polymerization was the only process causing spectral changes 
(89). FTIR spectra of each component were obtained and compared with literature to 
aid peak assignment.  
Percentage monomer conversion was estimated using Equation 2-4. 
Conversion(%) = 100 h0 − ht( )h0
     Equation 2-4 
   
Where h0 and ht were taken as peak absorbance at 1320 cm-1 above the background 
level at 1335 cm-1 initially and after a time t  (Figure 2-6) (73). Final peak height and 
conversion (C) were calculated by linear extrapolation of data versus inverse time to 
zero.  
If a single reaction is occurring, fractional reaction extent (ξ) can be calculated using 
Equation 2-5 below (95). 
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       Equation 2-5 
Where A0, At and Af are absorbance above the baseline initially, at time t, and finally, at 
any wavenumber with significant variation. In this project, the absorbance at 1320 cm-1 
was used. A0, At and Af were the height of the peak at 1320 cm-1 relative to the base at 
1335 cm-1.  The time to 50% reaction (t0.5) was taken as the time at which the reaction 
extent was 50% of its final level. Reaction extent was plotted against time divided by 
t0.5 to address if methacrylate conversion profiles could be described by a single curve 
(95).  
2.2.6.3 Shrinkage and Heat Generation  
Shrinkage and heat generation are both proportional to degree of conversion (96).  
One mole of polymerizing C=C bonds typically generates 57 kJ of heat (41) and gives 
volumetric shrinkage of 23 cm3 (97). The total heat generation and shrinkage due to 
the composite curing process can therefore be estimated using Equation 2-6 and 
Equation 2-7.   
       Equation 2-6 
      
       Equation 2-7 
N is the number of moles of reacted bonds per unit volume in each of the nine cement 
formulations.  This can be estimated using Equation 2-8. 











      
Equation 2-8
 
Where [M] is the total monomer mass fraction and C the final fractional monomer 
conversion calculated from FTIR. Σ indicates a sum over all the monomers in the liquid 
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and mass fraction of monomer i respectively. Assuming the formulation behaves 
“ideally”, and is non-porous, density (ρcomp gcm-3) can be estimated using a simple rule 
of mixtures (Equation 2-9). 
     Equation 2-9  
ρmonomer and ρfiller are the densities of the monomer mixture and filler. PMMA cement 
monomer and filler densities were taken as 0.94 and 1.24 gcm-3 respectively, giving an 
assumed PMMA cement density of 1.08. This assumes that there are no air bubbles in 
the mixture. The porosity of PMMA bone cements made according to manufacturer’s 
instructions (via hand mixing) has been found to range between 1.08 - 1.2 % (15,23) 
and so this assumption was taken to be a reasonable one. 
  
Figure 2-6 FTIR spectra of a curing PFC with time. Inset shows change in absorbance used to determine 
cure profile. The 1320 cm-1 peak used to measure peak height (relative to base at 1335cm-1)corresponds 
to C-H bond in the polymerizing methacrylate group.  
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2.2.7 Raman Spectroscopy 
As already stated the quantum vibrational energy levels in molecules can be used to 
infer the molecular structure of a substance. Raman spectroscopy is another 
vibrational spectroscopy method used to determine the quantum energy levels present 
within a material and hence to determine the molecule bonds present. 
In FTIR, the atoms were excited to a higher vibrational energy by certain frequencies of 
radiation. In Raman spectroscopy, high-energy radiation interacts with the electron 
cloud of the bonds within a molecule. Photons excite the molecules to virtual energy 
levels at higher energy than any of their vibrational resonance modes (Figure 2-7). 
When the molecular bonds relax, they release energy, again in the form of photons. 
Most of the time the molecules relax to their preferred energy level (for the given 
temperature) and the photons emitted have the same energy (and hence same 
frequency) as the photons that were absorbed. These photons are said to be 
‘elastically’ scattered (Rayleigh scattering). Some of the time, however, the molecule 
relaxes to a higher or lower vibrational energy level, the energy of the photons is not 
conserved, and so the emitted photons have a different frequency from the incident 
radiation. These are inelastically, or Raman, scattered photons. Raman scattering can 
be defined as Stokes or Anti-Stokes scattering (Figure 2-7).  
Similar to FTIR spectroscopy, Raman spectra provide both qualitative and quantitative 
information. The Raman spectrum of a material is a plot of intensity of the scattered 
radiation as a function of the frequency (Raman) shift. The position of the peaks gives 
information about the chemical bonding of the molecule whilst the peak intensity is 
related to the concentration of the bond type. With respect to methacrylate composite 
materials Raman spectroscopy can be used to give the molecular make-up of a 
material and also level of methacrylate conversion following the curing reaction as the 
number of C=C methacrylate bonds decrease.  
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Figure 2-7 Schematic representation of a diatomic molecule. Dashed line represents potential energy, 
discrete vibrational energy levels are shown. Arrows representative of elastic and inelastic scattering. 
High-energy laser light excites atoms to a virtual energy level. Emitted photons with a higher/lower energy 
than the incident photons are inelastically scattered and defined as Stokes/Anti-Stokes scattered 
respectively. 
Raman Instrumentation 
A Fourier Transform Raman (Raman) microscope consists of an optical confocal 
microscope, a laser excitation source (633 nm), and a detector. The sample is first 
illuminated with visible light, which is focussed on a chosen area. The visible light 
source is then switched off and the laser source is used to excite the area in focus. 
Raman scattered photons are then passed through a pin hole aperture to a Michelson 
interferometer from which the Raman shifted regions are inferred. Rayleigh scattered 
radiation is prevented from reaching the detector by selective filters. The data from the 
interferometer give a plot of Raman shift vs. intensity (given as a count of photons). 
The optical microscope can be used to focus on a large area, the laser beam can then 
be moved incrementally giving a spectrum at each increment and generating a map of 
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The laser beam focuses only on the surface of the material and so the spectra 
represent only the surface chemistry of the material. The area to be mapped must be 
flat so that the laser can remain focused as it scans and clear spectra can be found. 
Raman Resolution 
In Raman spectroscopy, once again it is the distance travelled by the moving mirror in 
the Michelson Interferometer that determines the wavelength resolving power of the 
instrument. 
The spatial resolution of the Raman microscope is limited by the optics of the 
microscope; the slit size and the ‘pin hole’ aperture size. In most cases this will be 
around 5 µm, and so features smaller than 1 µm (for example small particles of filler) 
will not be shown as distinct in a Raman map. In this project, the increment for each 
spectrum in the mapped areas was 2 µm.  
A Lab Ram spectrometer instrument (Horiba Jobin Yvon, France) was used to 
generate all Raman spectra in this project. 
2.2.7.1 Raman Mapping 
Biaxial test specimens that had been hydrated for 24 hours prior to biaxial testing were 
secured on glass slides with adhesive putty and a suitable flat area of 40 µm2 of the 
fracture surfaces was illuminated with visible light under 50x magnification. A 633 nm 
He-Ne laser excited the chosen surface. Raman spectra were generated over the 
wavenumber range 100-3000 cm-1 by averaging two spectra of 20 s acquisition. 
Wavenumber resolution was maintained at 2 cm-1 whilst the confocal hole of 300 µm 
gave a spatial resolution of around 5 µm as previously mentioned. Spectra were 
recorded at 4 µm2 increments over the chosen area. The background was subtracted 
from all spectra and the area under each was normalized over the wavenumber range.  
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The component spectra were determined by selecting spectra from either 
representative areas of the composite or maps of the filler powder or monomer liquid 
before mixing. Peaks corresponding to particular molecular groups were identified by 
comparing the component spectra to literature. Each component spectrum was then 
assigned a colour. Maps were generated by analyzing and colouring each 2 µm area 
depending on how closely it resembled each of the component spectra.  
2.2.8 Biaxial Flexural Testing 
In this project biaxial flexural testing has been used to characterize the mechanical 
properties of formulations. Composite materials are quasi-brittle (as discussed in the 
Introduction, chapter 1) therefore the compressive strength of composite materials will 
be higher than the tensile strength. When subject to bending, the bottom edge of a test 
specimen is in tension. The failure of the specimen is governed therefore by the tensile 
strength of the material. The tensile strength of a material is defined as the maximum 
tensile stress in the material at first failure. This is taken to be the critical ‘strength’ of 
resin composite materials throughout this project. 
There are, however, different experimental setups for determining flexural strength that 
can lead to variation in the results achieved. This section will explain some of the 
background of flexural testing, some of the advantages and limitations of biaxial testing 
compared to other flexural testing methods, and the reasons for selecting the biaxial 
flexural test protocol that is employed in this thesis. 
2.2.8.1 Biaxial Flexural Testing Background 
There are many flexural test methods for characterizing maximum tensile stress in a 
material at failure (and hence the flexural strength of that material). Beam flexural 
testing (4-point bend) is specified in ISO 5833 for determining the flexural strength of 
acrylic resin cements. 3 and 4-point bending have been used to determine flexural 
properties of cement materials (56,57,61,81,84,86,87,98). Biaxial flexural testing has 
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been used extensively in the determination of mechanical properties of dental materials 
and bone cements (10,62,64,99–101). The comparison of testing methods has been 
the subject of research also (99,100,102–105). 
In uniaxial testing (such as 3-point and 4-point bending tests) there is a simple stress 
state (the beam must be long enough to allow this) where the stress varies linearly 
throughout the thickness of the material with maximum tensile stress on the bottom 
edge and the stress is uniaxial. In 3-point bend, the maximum stress occurs at one 
point and in 4-point bend there is a region of uniform tensile stress between the loading 
points. In biaxial testing the stress state is more complex, and the maximum stress is 
concentrated on a small volume on the underside of the specimen. The volume over 
which the maximum stress acts is larger in 4-point than in 3-point bending and both are 
larger than for biaxial testing. A larger volume subject to maximum stress will mean a 
more flaws sampled which could result in a more scatter of results (104,106) making  
3 and 4-point bending less reproducible than biaxial testing.  
Flexural beam testing often requires larger specimens requiring more material at more 
expense. Rectangular beam specimens can also be difficult to manufacture, increasing 
the possibility of flaws. One major disadvantage of beam bending flexural tests is the 
possibility of spurious edge failures due to the likelihood of manufacturing producing 
flaws at the edges of beam specimens where the maximum shear stress is 
experienced. Biaxial specimens do not suffer from edge failures in the same way; the 
disc specimens are easier to make and can be smaller – these are two major 
advantages of biaxial testing. 
In the literature, one of the arguments for using biaxial testing is that for dental 
materials, biaxial flexure is more representative of occlusal stress state (103). 
Obviously this project is investigating materials for bone repair. It is envisaged that the 
bone repair materials will be used in osteoporotic vertebroplasty and femoral neck 
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screw augmentation. In vertebroplasty the material is mainly be in compression, whilst 
in screw augmentation the material stress state is more similar to beam bending. As 
such this argument is not as applicable in this project.  
A range of biaxial test method geometries exist; ball-on-ring, ball-on-three-ball, piston-
on-ring are a few of these (100). In this project the ball-on-ring biaxial test method is 
used – care must be taken to ensure the specimens are flat as this method is not as 
suitable for warped specimens as the similar ‘ball-on-three-ball’ method. 
There are a number of assumptions behind the equation for biaxial strength; the 
specimen is assumed to be ‘thin’, that is, the specimen is assumed to be thin enough 
that it is in a state of plane stress with no through thickness stresses developing. This 
simplifies the maths considerably and allows an analytical solution for the strength to 
be found. Generally a ‘thin’ assumption requires the ratio of the radius to the thickness 
to exceed 20. This aspect ratio is only four, in this project, so the values of strength 
found will be an overestimate of the true strength (107). For this reason the values of 
strength obtained from this method are useful for comparison between different 
formulations tested in this way with this specimen geometry but cannot be compared 
with values of flexural strength obtained from different specimen geometry or different 
test methods like 3-point bend tests. 
Although the biaxial method is not perfect in terms of geometry, the benefits of 
increased reliability and reproducibility, ease of specimen manufacture, ability to use 
moulds that are cheap and disposable (e.g. circlips at < 5p each) and small specimen 
size, are thought to be sufficient justification for using biaxial testing over 3-point or 4-
point bending. 
2.2.8.2 Poisson’s Ratio 
When a material is subjected to bending stresses (as in Biaxial testing), the material 
will expand and contract out of the plane of loading. Poisson’s ratio is a measure of the 
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in-plane deformation relative to out of plane deformation. The applied load and the 
measured deflection are used to calculate the strength and the Young’s modulus of the 
material as described in the following sections. Any Poisson’s extension or contraction, 
therefore, has to be taken into account and the Poisson’s ratio included in equations. 
Polymeric materials exhibit what is known as viscoelastic behaviour (108). They have 
properties that are time dependent (109); their stiffness is dependent on the strain rate 
(or over what time period the loading is applied). As the stiffness varies with time so 
does the Poisson’s ratio. 
Many sources quote Poisson’s ratios, for dental composites consisting of polymer and 
silica phases, ranging from 0.225 - 0.24 (100,102,103,110). In these papers, the test 
method for determining Poisson’s ratio is not mentioned. A dynamic test method (using 
an ultrasonic test method) can be used, in which ultrasound is used to excite materials 
at high frequency. This has been reported to result in higher values for material 
stiffness than static tests and hence lower values of Poisson’s ratio (111). It is clear 
that strain rate is central to the value of Poisson’s ratio measured. In a study by Chung 
the following findings are summarized: In a compressive test with a low strain strain 
rate of 0.2 mm/min, a low Young's modulus and therefore a high Poisson's ratio (0.4 - 
0.44) was found. In a tensile test with a higher strain rate of 0.5 mm/min, a higher 
Young's Modulus and so a lower Poisson's ratio (0.3 - 0.39) was found. In dynamic 
testing using ultrasound and hence very high strain rates a higher still Young's 
modulus, and so lower still Poisson's ratio (0.23 – 0.27) was found (112). Resin-glass 
composite materials behave differently at different strain rates; the behaviour of the 
material at ultrasonic frequencies is not the same as at lower strain rates. In the biaxial 
test method used in this project, the crosshead speed is 1 mm/min and so strain rates 
are relatively low. It is feasible therefore to use a value for Poisson's ratio more similar 
to that determined by low strain rate testing. For this reason a Poisson’s ratio of 0.3 
has been used throughout.  
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2.2.8.3 Disc Specimen Preparation for Biaxial Testing 
Eight brass rings were placed onto two sheets of acetate on a glass block.  
Composite Materials (Including Commercial Composite Cements)  
A screw mixing tip was fitted to the double barrelled syringe. Using the delivery gun 
with an even pressure, enough paste to just fill each of the rings (four at a time) was 
extruded through the mixing tip (Figure 2-4).  One disc requires around 0.2 - 0.3 g of 
paste to fill it (depending on the Powder to Liquid ratio, PLR). The filled rings were 
covered immediately with another sheet of acetate and topped with another glass 
block. The weight of the glass block was sufficient to expel excess material from the 
rings, but occasionally light manual pressure was also required (for example if a high 
PLR was used). 
PMMA Materials  
A metal spatula was used to pack the PMMA materials and smooth the surface level 
with the height of the ring mould. The rings were covered immediately with another 
sheet of acetate and topped with a glass block. Light manual pressure was applied to 
expel excess material. 
Specimens of all materials were left in the acetate and rings under glass block 
pressure at least overnight, and for up to 24 hours, to fully cure. The acetate and brass 
ring moulds were then removed (Figure 2-8).  
After de-moulding, the surface and edge of each disc was checked to make sure it was 
flat and smooth.  
2.2.8.4 Hydration 
Discs that were to be tested in their hydrated state were added, individually, to sterilin 
tubes containing 20 ml distilled/deionized water and stored at 37 °C for 24 hours, or 
longer, prior to testing. 
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2.2.8.5 Flexural Testing 
Central deflections during the testing should not exceed half of the thickness in order 
for maximum stress and modulus equations to be valid (107). Eight discs were tested 
to determine biaxial mechanical properties. 
The biaxial flexural strength (BFS), elastic modulus and fracture behaviour of the 
composite formulations was found using a ‘ball-on-ring’ biaxial testing method.  In this 
method, a hydrated disk specimen was placed on a knife edge ring support (radius 
4mm) and then loaded by a spherical tip in an Instron 4505 Universal Testing Machine 
(Instron, USA) (Figure 2-9). The load and central deflection of the disk were recorded 
and plotted on a load vs. deflection graph (Figure 2-10) from which the maximum load 
at fracture and the pre-fracture slope were determined to find the biaxial flexural 
strength and elastic modulus respectively. 
Strength 
BFS, can be determined via Equation 2-10: 




















,    Equation 2-10  
Where BFS is biaxial flexural strength (MPa), Lmax is maximum load (N), a is support 
radius (mm) and t is average thickness of specimen (mm). 
Modulus 
The elastic modulus of a disk specimen was found from the slope of the load deflection 
plot from a biaxial test for a range of different support situations by Higgs et al. 
(Equation 2-11) (113) The deflection of the centre of the disk specimen during testing is 
related to the applied load by Equation 2-12. βc is a variable related to the number of 
equally spaced supports and is determined by solving Equation 2-13. Assuming a ring 
support is equivalent to an infinite number of equally spaced supports; as m tends to 
infinity and βc tends to a value of 0.5024. Substituting this βc value into Equation 2-12 
and differentiating with respect to ω gives an expression for the rate of change of load 
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with deflection, in terms of the Young’s modulus, E, which is equivalent to the gradient 





0.5024a2        Equation 2-11  




Et3        Equation 2-12  
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    Equation 2-13  
 
 
Figure 2-8 Biaxial disc specimen after being removed from bass ring mould, before edges have been 
smoothed by removing excess material. 
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Figure 2-9 Schematic of biaxial test. Disc specimen is placed on a ‘knife edge’ circular support. The load 
cell tip (ball bearing) is lowered onto the specimen at 1 mm/min and the corresponding load vs. 
displacement is recorded. A maximum of central deflection of 0.5t (0.5 mm) is permited. 
 
Figure 2-10 This is the load vs. central deflection plot generated by the computer connected to the load 
cell. The flat region (ω < 0.075 mm) is before the load cell makes contact with the disc specimen. The 
slope of the plot for 0.075 < ω < 0.24 mm depends on the stiffness of the material. At 0.24 mm the 
specimen fractures.  The load at this point determines the BFS of the material. 
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2.2.9 Bound Analysis 
It is possible to predict the envelope within which the modulus of a composite will lie 
based on the moduli of the components and the structure of the composite. The 
simplest models for predicting composite bounds are the Voight and Reuss models. A 
Voight composite is one in which the phases are in parallel and as such are deformed 
by the same amount (iso-strain), the applied stress is shared between phase one and 
phase two proportionally according to their relative stiffnesses. The uniform strain 
condition leads to a linear equation for the composite stiffness (114)  
EVoight = En fn
n
∑        Equation 2-14 
 
In a Reuss composite the phases are in series, and hence under the same stress, the 




∑         Equation 2-15 
Voight and Reuss composites are described as the upper and lower rule of mixtures 
bounds for composites. Generally Voight and Reuss models provide the envelope 
within which the actual composite modulus will be found. 
 
The composite formulations in this study are examples of particulate reinforced 
composite materials. The Hashin Shtrikman lower bound model (115) can be used to 
predict the modulus of a particulate composite consisting of stiff particles in a 
continuous compliant phase (Equation 2-16). Conversely the Upper bound predicts the 
stiffness of a composite of compliant particles in a stiff continuous phase (Equation 2-
17). The Hashin-Shtrikman bounds are derived from a concentric spheres model in 
which it is assumed that particles are spherical and do not interact with one another 
(116). 
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        Equation 2-16 
 
        Equation 2-17 
Where E is young’s modulus or stiffness, K is bulk modulus (Equation 2-18) and G is 
shear modulus (Equation 2-19) (all GPa). 
KL/U = Km/ f +
f f /m
1
K f /m −Km/ f
+
3 fm/ f
3Km/ f + 4Gm/ f
     Equation 2-18 
GL/U =Gm/ f +
f f /m
1
Gf /m −Gm/ f
+
6 Km/ f + 2Gm/ f( ) fm/ f
5Gm/ f 3Km/ f + 4Gm/ f( )
   Equation 2-19 
 
Where f is the volume fraction of a phase. In the Voight-Reuss models, the subscripts 
‘1’ and ‘2’ refer to the individual phases. In the Hashin-Shtrikman model the subscripts 
‘m’ and ‘f’ refer to the polymer and filler phases respectively, whilst ‘L’ and ‘U’ denote 
upper and lower bounds. The Young’s moduli of UDMA and PPGDMA unfilled polymer 
resins were taken to be 2 GPa (114) and 0.03 GPa  (117) respectively. The modulus of 
the glass filler was taken to be 72 GPa (118). 
The stiffnesses of the PFCs were predicted using the Voight-Reuss and Hashin-
Shtrikman models. In the Voight-Reuss case the PFCs were treated as three phase 
composites; phases one and two being the UDMA and PPGDMA respectively, and 
phase three the glass. HEMA was assumed to have negligible effect on the mechanical 
properties because of its very small volume fraction. 
The Hashin-Shtrikman model here is for a two phase composite. The organic phase of 
the PFC materials was a co-polymer of PPGDMA, UDMA and HEMA. Again the effects 
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UDMA and PPGDMA that fulfilled an iso-stress condition due to polymer crosslinking; 
both polymers were assumed to be subject to the same stress and share deformation 
according to their relative stiffnesses as in a Reuss composite. The Reuss-stiffness of 
the polymer phase was found and this was used as Em in the Hashin-Shtrikman bound 
analysis. The filler phase was modeled as a spherical particulate filler in the Hashin-
Shtrikman analysis. 
2.2.10 Scanning Electron Microscopy and Energy Dispersive X-ray Analysis 
All scanning electron microscopy (SEM) images were captured using JSM-5410LV 
Scanning Microscope (Jeol, USA) and INCA software. Energy dispersive x-ray (EDX) 
analysis was performed using an Inca X-Sight 6650 detector (Oxford Instruments, UK).  
Biaxial specimens were left in their sterilin tubes, with the lid placed on loosely, to 
thoroughly air dry for at least 7days prior to imaging with SEM or EDX elemental 
analysis. 
2.2.10.1 Imaging 
Biaxial Specimens Fracture Surfaces 
Biaxial specimens that were to be imaged were mounted onto stubs with fast setting 
epoxy adhesive with the fracture surface positioned parallel to the stub base. 
Filler Materials and PMMA Powders 
A thin layer of filler material was mounted onto stubs using adhesive carbon tabs. The 
mounted specimens were then sputter coated (gold and palladium coating). The 
accelerating voltage for the scanning electron beam was set at 10 kV. 
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2.2.10.2 EDX Elemental Analysis 
Specimens were mounted as described above in section 2.2.10.1. 
Adhesive conductive carbon tape was used to connect mounted specimens of Cortoss, 
Comp06, and Z250 to their stubs.  These specimens and the filler particles were then 
elementally analyzed without any further coating. The PMMA cements were carbon 
coated and elementally analyzed. The accelerating voltage for the scanning electron 
beam was set at 25 kV  
2.2.11 Accelerated Ageing 
Essentially the Arrhenius equation gives a relationship between the rate of the reaction 
in question and temperature (Equation 2-20). It was assumed that the spontaneous 
polymerization of composite bone cement formulations will have an Arrhenius type 
temperature dependence. 
       Equation 2-20  
Where k is a rate constant, A is the frequency factor (the total number of free radicals 
generated per second, not all will result in propagation of the polymer chain 
(polymerization)), Ea is Activation energy, R is the universal gas constant and T is 
temperature in Kelvin. 
The formulations consist of two pastes containing Benzoyl Peroxide (BP) and 
Dimethyl-para-toluidiene (DMPT) respectively. The rate of spontaneous polymerization 
of each of these pastes (the shelf life) of the formulation can be related to their storage 
temperature. In the case of the BP paste the rate of spontaneous polymerization will be 
controlled by the rate of decomposition of BP. Varying levels of BP/inhibitor and 
inhibitor will alter the level of spontaneous polymerization at various temperatures and 
hence follow a different Arrhenius relationship (different frequency factor and possibly 
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The decomposition of the BP or the monomer into free radicals was assumed to be the 
rate limiting step in the spontaneous polymerization. It was therefore assumed that the 
rate constant would be directly proportional to the reciprocal of the time taken to 
polymerize (Equation 2-21). Time to polymerization was defined as the time at which at 
least one milimetre of polymerized material was seen around the edge of the 
specimen. 
         Equation 2-21  
Where ts is polymerization time. 
Formulations (uncured) were placed in incubators (maintained at 60 °C, 45 °C, and 37 
°C) and monitored every 30 minutes during office hours over two days. When a 
material showed signs of beginning to cure, it was monitored every ten minutes until 
the time of set was reached and recorded. The time of set (ts) was defined as the time 
taken for 1 mm of cured material to be observed at the edge of the specimen. Three 
specimens of each formulation were placed in the incubators at 6 hour intervals. In this 
way it was hoped that if the time of set fell overnight then it could be observed in one of 
the other specimens placed at a later start time. The natural logarithm of the cure times 
was plotted against the reciprocal of the corresponding incubator temperature. The 
Arrhenius equation is given below (Equation 2-22). The Arrhenius coefficients were 
found from a linear fit of the data plotted according to Equation 2-23. 
       Equation 2-22  
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       Equation 2-23  
From the established Arrhenius relationships for varying levels of BP, Inhibitor and 
DMPT it is possible to predict the time at which spontaneous polymerization will occur 
for a given storage temperature and hence what the shelf life of the formulation will be 
at different temperatures. 
The natural log of the reciprocal of the polymerization time can be plotted against the 
inverse of the temperature in degrees Kelvin for each temperature. This gives three 
points from which a line of best fit can be found. The gradient of this line gives the 
activation energy (Ea) and the y-axis intercept gives the Frequency factor (A) for the 
system. 
2.2.12 In-vivo 
In many respects the lower femoral implantation procedure is an excellent model for 
the response of trabecular bone to an implant material. The trabecular bone region of 
the lower femur is similar in structure to that found within human vertebrae.  
Holes were made in the lateral cortex of distal femoral condyles (both right and left 
sides) of male New Zealand rabbits2. The animals, weighed between 2.3 kg and 2.5 kg. 
A hole of 2 mm diameter was drilled to a depth of 3 mm; this hole was then reamed to 
a diameter of 4 mm. The bleeding was stemmed with a swab before the materials were 
implanted. 
The allocation of materials to holes was random and the composition of all materials 
can be found in Table 2-5. There were four replicates of each material and time of 
implant (n=4). 8 implant sites were filled with low viscosity composite cement and 8 
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with commercially available high viscosity PMMA cement, Palacos R (Heraeus PLC, 
UK).  
2.2.12.1 Sterile Cement Manufacture 
All cement manufacture/portioning was undertaken in a fume hood sterilized with 70% 
ethanol.  
Palacos R 
Portions (0.4 g) of Palacos powder were weighed into sterile jars (sterilized with U.V. 
radiation for 20 mins). These jars remained sealed at room temperature until opening 
in the operating theatre where the powder was combined with 200 µl of room 
temperature Palacos liquid. When the cement had reached the ‘dough’ consistency 
recommended by the manufacturer it was implanted by hand into the implant site. 
Composite material 
The filler was sterilized by UV light for 20 minutes prior to mixing. The monomer was 
not sterilized as it was hypothesized that it was sufficiently toxic to prevent bacterial 
growth. The components of the composite cement were combined in the sterile fume 
hood and then added to a sterile double barrelled syringe (sterilized by immersion in  
70 % ethanol for one hour and then air dried in sterile fume hood for  
12 hours). The composite cement was prepared on the day prior to implantation and 
stored at 4 °C until use. The composite cement was injected into the implant site from 
the double -barrelled syringe using a mixing gun via a sterile mixing tip (sterilized by 
immersion in 70 % ethanol for one hour and then air dried in sterile fume hood for 12 
hours). 
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2.2.12.2 Post Implantation Care and Euthanasia of Animals 
The animals were allowed to move freely in individual cages during the implant time. At 
one or four weeks the animals were euthanized by barbiturate injection.  
2.2.12.3 Specimen Removal 
The distal end of the femur was removed and fixed in a 5 % formalin solution. Notes 
were made on the explanted sites detailing whether the material was visible and how 
well the wound had healed relative to other sites. Any abnormalities or infections were 
noted. 
2.2.12.4 X-Ray Microtomography Analysis 
X-ray microtomography (micro CT) images of the fixed samples were found using the 
following instrument settings: 50 kV, 800 mA, (power of 40 W) with an exposure time of  
5 s through 0.75 mm aluminium. The minimum transmission was 4.3 %. The samples 
were rotated around the axis of the femur, with images being taken every degree for 
360° of rotation. The images were averages over 4 frames per rotation step. These 
images were reconstructed to give cross sectional images through the thickness of the 
sample in either the coronal, sagittal, or transverse planes. Micro CT images were 
used to determine the radiopacity of the implanted materials relative to the surrounding 
bone. The tissue/material interface was also examined for evidence of bone contact 
and material interdigitation and distribution. This will give insights into the 
biocompatibility/effect of curing exotherm, and the effect of cement viscosity.  
After micro CT images were obtained, the samples were embedded in Technovit resin 
and prepared as cut and ground sections (20 µm thick) using an Exakt system 
(Heraeus PLC, UK). Sections containing the implant site were made as transverse 
sections and stained with Toluidine blue methods and Goldner’s Trichrome stains. In 
addition, samples of spleen, heart and lung tissue were taken at the time of explant 
and analyzed for any abnormalities. Samples (approx. 5 x 5 x 5 mm) were taken from 
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each of the organs at the time of death. Routine techniques for sampling were used 
(e.g. left ventricle of heart, lower lobe of lung, cross section in middle of spleen, cross 
section of kidney including pelvis, left lobe of liver). Microscopy screening, by 
experienced histopathologist, checked the features of each organ for normality and 
evidence of pathological changes3. 
2.2.12.5 Histological Analysis 
The histological sections were examined to determine the biological response to the 
implant materials (including cellular evidence of inflammatory response and fibrous 
tissue formation), bone contact and material interdigitation and distribution. 
Name Liquid Powder Powder: Liquid (by weight) 




from chapter 6) 
PPGDMA, UDMA, 
HEMA (10:9:1) 
Silica glass powder (G4S), 
Silica glass fibres (FGS) 
(3:1) 
3:1 
Table 2-5 Materials used in in vivo work. 
                                                3	  All	  histological	  work	  was	  undertaken	  by	  Tom	  McInnes	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3 Commercial Comparisons  
3.1 Abstract 
The aim of this chapter was to characterize commercially available PMMA and 
composite bone cements in order to provide benchmark properties for a successful 
bone repair material. 
Raman mapping and SEM and EDX analysis together provided detailed information on 
the chemistry and microstructure of the materials investigated. The reaction extent vs. 
normalized time, from FTIR analysis, was plotted for each material and the conversion, 
induction time and time to 50% reaction were found. Finally biaxial testing was used to 
find the flexural strength and stiffness along with the fracture behaviour. The curing 
profiles, levels of conversion, shrinkage and mechanical and fracture properties were 
found and compared to the chemistry and phase composition of each material to 
suggest what materials would be useful in a bone repair material. In conclusion, high 
molecular weight bifunctional monomers that can chemically bond to fillers will increase 
the curing and strength of the materials, however the powder to liquid ratio must be 
balanced to maintain a sufficiently low modulus. 
3.2 Introduction 
In the introduction (chapter 1) the different types of bone repair material were 
introduced. In this chapter, two PMMA and two composite bone cements will be 
investigated along with one dental composite material.  
3.3 Aims and Objectives 
This chapter aims to characterize and compare the chemical composition, 
microstructure, curing and mechanical properties of commercially available bone 
cements and a dental composite. Characterizing each material will provide benchmark 
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properties for development of new bone cement materials. Comparison with literature 
will highlight areas in which improvements can be made. 
The Raman spectra of each material and available component spectra will be found 
and spectral peaks associated with the characteristic chemical groups for each 
material. 
The microstructure of cured materials will be investigated and compared to the 
advertised composition of each material. It is hoped that a novel microstructure 
characterization method, using Raman mapping, can be established and used with 
SEM and EDX, to give information about the chemistry of materials at the macroscopic 
scale including: 
• Size, chemistry, surface structure and dispersion of filler particles 
• Chemistry of polymer phase 
• Interaction between polymer and filler phases e.g. bonding between polymer 
and filler. 
The shape of curing profile and level of cure are to be established, and the inhibition 
time (ti) and time to 50% cure (t0.5) are to be quantified using FTIR.  
Polymerization shrinkage will be calculated from degree of conversion and actual or 
estimated material composition. Comparison of shrinkage values obtained via 
calculation, and values from literature, will allow the shrinkage calculation method to be 
validated.  
In terms of mechanical properties, the biaxial flexural strength and Young’s modulus, 
as well as the fracture behaviour, for each material will be determined.  
Possible links between the microstructure, curing and mechanical properties will be 
discussed, including possible failure mechanisms, and candidate materials will be 
proposed for incorporation in new bone repair materials. 
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3.4 Hypotheses 
It is envisaged that spectra obtained by Raman mapping will be sufficiently variable 
across an area to enable determination of size, shape and dispersion of the inorganic 
and polymer filler components within the polymer matrix phases. Chemical variations 
determined on the micron scale obtained by combining Raman spectral maps and 
SEM images might provide greater insight into how different phases interact.  
It is hypothesized that there will be a link between the level of cure and the mechanical 
strength of the materials as is reported in the introduction (chapter 1) of this thesis. It is 
thought that degree of conversion of composite materials should be lower than for 
PMMA materials as the former are dimethacrylate and will have fewer unbound 
monomer chains at lower levels of conversion. The calculated shrinkage of dental 
composite materials is reported in literature to be lower than for composite bone 
cements and PMMA cements.  It is thought that the calculation method for 
polymerization shrinkage should give results that reflect this. 
Literature suggests that dental composite and composite bone cement materials with 
high filler contents and long chain dimethacrylate monomers will have higher flexural 
strengths and Young’s moduli than PMMA cements. Whilst most of the values of 
strength in literature are found via 3-point bending experiments, this thesis employs 
biaxial testing for the reasons outlined in the material and methods chapter. It is 
thought that the biaxial testing will give strength results consistently higher than those 
found from 3-point bend tests. It is not known how the Young’s modulus results will 
compare to those found from 3-point bend tests. 
Areas in which currently available bone cements fall short of biological requirements 
have been discussed in the introduction of this chapter. Comparison of the chemistry, 
composition and curing and mechanical properties of these five commercial materials 
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could highlight which components are responsible for certain material attributes and 
therefore determine possible avenues of development for a new bone cement material. 
3.5 Materials and Methods 
In this chapter, the following four commercial bone cements and one dental composite 
were investigated and compared: 
Simplex™ P Stryker®, UK 
PMMA Bone cements 
Palacos R® Heraeus, UK 
Cortoss™ Orthovita, USA 
Composite Bone cements 
Comp06™ Ozics, Switzerland 
Filtek™ Z250  
3M™ ESPE ™, UK 
Ireland 
Dental Composite 
Table 3-1 Commercial materials to be investigated with manufacturer and description. 
The composition of each material was ascertained from collating information from the 
manufacturer’s information and literature. The fracture surfaces of each material were 
examined with SEM and Raman spectroscopy was used to make spectral maps of 
these surfaces. 
The curing profiles and degree of conversion were determined via FTIR (n=4) using 
changes in intensity of those spectral peaks identified as being involved in free radical 
polymerization (see chapter 2; Materials and Methods). Polymerization shrinkage was 
calculated from degree of conversion and formulation composition. The flexural 
strength and stiffness of the commercial materials was found by biaxial testing of disc 
specimens (n=8). The fracture behaviour was also observed during biaxial testing.  
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3.6 Results 
3.6.1 Material Composition, Chemistry and Microstructure  
3.6.1.1 Product Descriptions 
Simplex P and Palacos R 
Simplex P and Palacos R are chemically curing PMMA bone cements that are supplied 
as separately packaged powder and liquid components that are mixed in the OR prior 
to implantation. The powder contains polymer beads, radiopacifier and BP. The liquid 
component contains MMA monomer, DMPT and inhibitor. On mixing the polymer 
beads swell and dissolve in the monomer and the initiator system initiates free radical 
polymerization. 
Cortoss and Comp06 
Cortoss and Comp06 are two paste, chemically curing, composite bone cement 
systems. The monomers and fillers are pre-mixed and supplied in a double barrelled 
syringe. These pastes have low enough viscosity to be easily syringeable and so are 
deemed to have excellent handling properties compared to the PMMA cements above. 
One paste contains BP and the other DMPT.  On mixing through a screw mixing tip, 
these components initiate free radical polymerization. 
Z250 
Z250 is a restorative dental composite material. It is supplied as a single packable pre-
mixed paste containing monomer and filler phases as well as photoinitiators. The paste 
can be polymerized by exposure to intense blue light. 
The composition of the commercial materials from manufacturer’s information or 
literature is summarized in Table 3-2. The quantities of the components are given 
where this information was available. 










Simplex P MMA 
MMA-Styrene copolymer, PMMA, 
BaSO4 
1.7 -  2.3 wt.% BP, 
2.5 vol.% DMPT, 





PMMA-methacrylic acid copolymer 
ZrO2 
 chlorophyll 
0.75 % BP**, 
1.0 wt.% DMPT, 


















Barium boroaluminosilicate glass 
 fumed silica fillers,  
Hydroxyapatite powder  
(3-methylacryloxy-propyltrimethoxy silane) 
2.0 wt.% BP  
2.5 wt.% DMPT 









amine*, CQ†, BHT* 30 
Table 3-2 Summary of properties of commercial products. All information from manufacturers usage 
instructions unless otherwise stated. +(2) §Communication with Ozics *type and quantity information is 
unavailable, **(40) †(119)††(10) ~(59) 
3.6.1.2 SEM Images and Raman Mapping 
Simplex P 
A SEM image of simplex powder is provided in Figure 3-1 below. Raman analysis 
compared with Simplex manufacturers information and known Raman spectra of 
PMMA (120), polystyrene (121) and barium sulphate (122,123) from literature 
confirmed that the round beads (up to 30 µm in size) are MMA-Styrene copolymer. The 
smaller beadlets (around 1 µm in size) contain both PMMA and barium sulphate – 
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although it was not possible to distinguish between these in EDX analysis of the filler 
alone. 
 
Figure 3-1 SEM image of Simplex P filler powder. Large smooth particles are MMA-styrene co-polymer, 
smaller flaked particles are either PMMA / barium sulphate. 
Figure 3-2 is an SEM image of the fracture surface of a Simplex P biaxial specimen in 
which pores ranging from 15 – 100 µm are observed. A high magnification SEM image 
of an area of the fracture surface (Figure 3-3), shows polymer network interspersed 
with small beadlets and a 25 µm region of polymer containing no beadlets – this 
indicates either that the pre-polymerized MMA-styrene beads has not dissolved in the 
MMA liquid prior to polymerization or that this is a region in which the small flaked 
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Figure 3-2 SEM image of a fracture surface of a Simplex P biaxial specimen. Can clearly see pores 
(smooth holes) in material up to 100µms in size. Boxed area shown in Figure 3-3. 
 
Figure 3-3 Boxed area from figure 2 here shown at higher magnification. Region with no flaked particles 
thought to be either undissolved MMA-Styrene co-polymer bead or a region where flaked beadlets have 
been pulled out of matrix during fracture. 
The spectra of the phases of Simplex P used to construct the Raman map are shown 
in Figure 3-4. The MMA-styrene co-polymer spectrum is characterized by peaks at 
606, 1002 and 1457 cm-1 due to the styrene aromatic ring (121). Peaks at 812 cm-1 and 
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MMA spectrum has a peak at 1731 cm-1 as would be expected, corresponding to 
methacrylate C=O. The 1620 cm-1 peak corresponds to the C=C of the methacrylate 
group. Subtracting a PMMA spectrum from the combined PMMA-barium sulphate 
spectrum isolated the barium sulphate spectrum, as it was not possible to find areas of 
pure BaSO4 with the Raman technique. The barium sulphate spectrum was confirmed 
by comparison with a spectrum found by Degen and Newman (122). 
 
Figure 3-4 Raman spectra of components of Simplex P. RED: MMA-Styrene copolymer, GREEN MMA 
liquid, BLUE: barium sulphate. 
In the Raman map of Simplex P (Figure 3-5) the blue map represents areas with a 
barium sulphate spectrum. The green map indicates areas in which a MMA liquid 
spectrum was detected. The red map indicates regions that have a spectrum 
corresponding to the MMA-styrene polymer beads. These three coloured maps when 
overlaid give the fourth map in the series in Figure 3-5. In the overlaid map, pink 
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represents regions in which MMA-styrene co-polymer and barium sulphate spectra are 
co-incident, whilst yellow denotes areas of C=C presence in the polymer phase.  
 
Figure 3-5 Raman maps of a region of the fracture surface of a Simplex P biaxial specimen. The blue map, 
1, indicates regions where the spectrum for barium sulphate is present. The Green map, 2, indicates areas 
where the MMA monomer spectrum is detected. The red map, 3, shows where the spectrum of the MMA-
styrene co-polymer was detected. Map 4 is the other three component maps superimposed. 
Palacos R 
The SEM image of the Palacos powder prior to mixing with the monomer liquid (Figure 
3-6) shows polymer beads (PMMA-methacrylic acid) that are 15 – 30 µm in diameter 
and mainly smooth, and bubbly particle agglomerates. The bubbly particle 
agglomerates were found to contain Zirconium by EDX and so are thought to be 
radiopacifier ZrO2.  
Figure 3-7 shows a large scale SEM image of the fracture surface of Palacos, it has 
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polymer network interspersed with ZrO2 particle agglomerates. The polymer network 
looks to have pulled away from the ZrO2 particles during fracture. The polymer is 
smooth and there are no areas resembling the polymer beads from the powder. 
 
Figure 3-6 SEM image of Palacos filler powder. Large smooth particles are PMMA-methacrylic acid, 
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Figure 3-7 SEM image of fracture surface of Palacos Biaxial specimen showing the entire thickness of the 
sample. One large pore is visible in this area. 
 
Figure 3-8 SEM image of Palacos fracture surface at higher magnification. ZrO2 particles have space 
around them where polymer has pulled away during fracture (arrows). Polymer appears smooth – no 
visible polymer particles still in tact. 
  
Pore 
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The spectra for each component used to make the Raman map of Palacos and the 
peak wavenumbers are in Figure 3-9. The Polymer phase is characterized by the  
816 cm-1 peak corresponding to C-O-C chemical group, with the  
1736 cm-1 peak due to C=O stretching (120,124). The methyl methacrylate monomer 
phase again is differentiated from the polymer by it’s prominent C=C peak. The ZrO2 




Figure 3-9 Raman spectra of components of Palacos R. RED: PMMA bead from filler, GREEN MMA liquid, 
BLUE: Zirconium Dioxide. 
The Raman map of Palacos is shown in Figure 3-10. The red areas are where the 
polymer bead spectrum was detected. The green areas indicate regions where the 
spectrum is most similar to MMA liquid. The blue areas indicate the ZrO2 particle 
agglomerates with a size of around 25 µm. All three phases are distinct and separate 
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as was thought from the EDX analysis. As with the Simplex P map, the green region 
denotes unpolymerized monomer. 
 
Figure 3-10 The overlaid Raman map of a region of the fracture surface of a Palacos biaxial specimen. 
Blue indicates regions where the spectrum for Zirconium Dioxide is present. Green indicates areas where 
the MMA monomer spectrum is detected. Red shows where the spectrum of the PMMA polymer beads 
was detected. The three phases in Palacos are distinct and so only the overlaid map is displayed. 
Cortoss 
Figure 3-11 and Figure 3-12 show the fracture surface of Cortoss. The higher 
magnification SEM image (Figure 3-12) indicates that the fracture surface of Cortoss 
consists of large angular particles (20x5 µm) interspersed in a mixture of smaller rough 
particles and polymer. The fracture surface shows some large angular particles 
protruding with other angular shaped ‘holes’ (of the same size as the large angular 
particles). Other round holes were present (50 µm) although are not shown in Figure 
3-12 – these are air bubbles from the mixing and sample injection processes. 
Using EDX it was found that both the large angular particles and the small rough 
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calcium, silicon and oxygen so may be combeite (Na2Ca2Si3O9) although Si: Ca = 2.5 
was higher than expected.  This could be a consequence of surrounding particles with 
high Si content.  The smaller particles contain oxygen, barium, calcium and silicon (Si: 
Ca = 5) and so likely to be a barium containing glass.  
 
Figure 3-11 SEM image of cross section of Cortoss biaxial fracture surface.  
 
Figure 3-12 SEM image of the fracture surface of Cortoss. Large angular particles were interspersed in, 
what looks like, a mixture of Polymer and smaller rough particles. Holes the same shape and size as the 
large angular particles also evident. 
The spectra used to construct the Raman map of the Cortoss fracture surface are 
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and 1400 cm-1. The polymer phase is characterized by a peak at 1612 cm-1, which 
represents the aromatic carbon ring in both the BisGMA and BisEMA; the C-O-C group 
in these monomers is also responsible for the 1115 cm-1 peak. There is also a double 
peak at 1400 cm-1 and 1455 cm-1, which represents the aliphatic C-H vibrations for 
TEGDMA, BisGMA and BisEMA. There is a slight 1640 cm-1 peak which represents 
C=C in unpolymerized methacrylate groups. The third phase was assumed to 
correspond to Combeite. It is characterized by a single strong broad peak at 984 cm-1. 
Although the Raman spectrum of combeite could not be confirmed by comparison with 
literature. 
 
Figure 3-13 Raman spectra of components of Cortoss. RED: glass filler, GREEN BisGMA, BisEMA 
TEGDMA polymer, BLUE: Combeite phase. 
Polymer spectra from the Raman map (Figure 3-14) were comparable at all points 
indicating no phase separation of the different monomers at the micron scale. Raman 
mapping indicates that there are distinct glass particles of the order of 5 µm but in 
addition areas consistent with flocs of submicron glass particles. Larger regions with 
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combeite spectrum were detected particularly in the top left corner of the Raman map.  
The size was consistent with the larger particles seen in EDX and tentatively assigned 
as combeite. The glass, polymer and combeite are generally well separated 
 
Figure 3-14 Raman maps of a region of the fracture surface of a Cortoss biaxial specimen. This map 
superimposes where the spectra of each phase is detected. The green corresponds to polymer, the red to 
glass and the blue to combeite-type areas respectively. The phases are mainly separate apart from some 
association between the glass and combeite in the top left hand corner indicated by a pink colour. The size 
of the glass particles can be estimated. The top left corner shows some pink (coincident glass and 
combeite spectra) this is thought to be due to small glass particles on top of a larger combeite particle. 
Comp06 
The Glass phase of Comp06 was available and could be imaged separately (Figure 
3-15). This glass has a range of particle sizes with large angular crystals around 15 µm 
in size and smaller flocs of crystals from 0.5 – 5 µm in size. EDX analysis of this glass 
powder showed that it contains Al, Si, S and Ba (oxygen excluded) (molar ratios 
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Figure 3-15 SEM image of glass phase of Comp06. Particle size ranges from 0.5-15 µm. 
Round holes (20 µm) that are present in the SEM image of the fracture surface of 
Comp06 (Figure 3-16) are assumed to be air bubbles from the mixing and sample 
injection processes. The high magnification SEM fracture surface image of Comp06 
(Figure 3-17) shows some large angular particles protruding with other angular shaped 
‘pull out holes’ (similar to Cortoss). Using EDX, these large particles were found to 
contain aluminium, silicon and a small amount of barium consistent with the glass. The 
hydroxyapatite phase (formula Ca10(PO4)6(OH)2 ) was difficult to detect by EDX.   
 
Figure 3-16 SEM image of cross section of Comp06 biaxial fracture specimen. Air bubbles shown with 
arrows. 
Air Bubbles 
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Figure 3-17 SEM image of fracture surface of Comp06 biaxial specimen. ‘Pull-out’ hole visible and 
labelled.  
The spectra of each of the phases used to construct a Raman map of Comp06 is given 
in Figure 3-18. The polymer phase contains BisGMA and BisEMA similar to Cortoss 
and so is characterized once again by the aromatic peak at 1609 cm-1. There is also a 
1410 cm-1 polymer peak which represents the aliphatic C-H vibrations and slight 1640 
cm-1 peak which represents C=C in unpolymerized methacrylate groups. The calcium 
phosphate phase is characterized by a strong peak at 960 cm-1 (P-O symmetrical 
stretching in PO4) (126). This is comparable with the Raman spectra for 
hydroxyapatite. The glass phase is characterized by a strong double peak near 1400 
cm-1. 
Hole 
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Figure 3-18 Raman spectra of phases used to construct Raman map of Comp06. a) Glass spectrum 
shown in Red plot. b) Polymer spectrum shown in green plot. c) Hydroxyapatite phase shown in blue. 
Figure 3-19 shows the Raman map of the fracture surface of Comp06 with red 
representing glass, green representing polymer, and blue representing hydroxyapatite. 
Monomer spectra were comparable at all points indicating no phase separation of the 
different monomers at the micron scale. In the relatively small area examined primarily 
only smaller (3-5 µm) glass and hydroxyapatite particles were observed. The glass and 
Calcium Phosphate phases are separate with no association of the two in the region 
examined. 
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Figure 3-19 Raman map of fracture surface of Comp06. Red regions correspond to glass spectrum. Green 
areas are polymer. Blue areas denote Hydroxyapatite. 
 
Z250 
The grain structure of the Z250 (Figure 3-20, high magnification in Figure 3-21) is very 
different from the PMMA cements and the composite bone cements. It is difficult to 
distinguish on the SEM image between the reinforcement glass filler and the polymer 
network. The glass particles are not distinct and the size cannot be determined from 
either of the SEM images. EDX of the fracture surface confirmed that the filler phase 
contained only Si, O and Zr with no calcium.  The fracture surface is uneven but it is 
not clear whether the cracks that lead to failure have propagated through the filler 
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Figure 3-20 SEM image of cross section of biaxial fracture specimen of Z250. Very low porosity. 
 
Figure 3-21 High magnification SEM image of fracture surface of Z250. Filler particles and monomer are 
indistinguishable at this scale. 
The spectra of each of the phases is given Figure 3-22. The polymer phase is 
characterized by a peak at 1607 cm-1, which represents the aromatic carbon ring in 
both the BisGMA and BisEMA.  There are also peaks at 1400 – 1450 cm-1 in the 
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polymer spectrum representing the aliphatic C-H vibrations and slight 1638 cm-1 peak 
which represents C=C in unpolymerized methacrylate groups.  
 
Figure 3-22 Raman spectra of phases used to construct Raman map of Z250. a) Glass spectrum shown in 
Red plot. b) Polymer spectrum shown in green plot. 
The Raman map of the fracture surface (Figure 3-23) shows regions with the polymer 
spectrum in green and regions of glass in red. The regions of red indicate that the size 
of the filler in Z250 is around 2 – 4 µm. The particles appear, on the whole, well 
dispersed but with some regions of flocculation of smaller particles (submicron).  
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Figure 3-23 Raman map of Z250. Glass particles are around 2 µm in size and shown in red. Polymer 
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3.6.2 Conversion, Cure times and Shrinkage 
Table 3-3 gives the cure times and conversion of all materials. Palacos has a shorter 
inhibition time and faster cure than Simplex with a higher level of conversion. 
Conversely Cortoss bone cement has the shortest inhibition time before the start of 
polymerization.  All materials have much higher double bond conversion than Z250 
whilst Palacos and Simplex P cements have higher conversion than Cortoss and 
Comp06. Comp06 has a similar conversion level to Cortoss whilst having a longer 




tinh (s) t0.5 (s) Shrinkage (vol.%) 
Simplex P 76 ± 1 276 ± 29 406 ± 28 6.2 ± 0.1 
Palacos R 86 ± 2 170 ± 16 281 ± 19 6.9 ± 0.2 
Cortoss 64 ± 4 130 ± 29 232 ± 21 3.8 ± 0.1 
Comp06 64 ± 0 171 ± 17 416 ± 15 3.7 ± 0.1 
Z250 49 ± 1 light cure 1.8 ± 0.1 
Table 3-3 Cure times, levels of conversion and calculated shrinkage values for all materials. 
Figure 3-24 gives the normalized cure profiles of all the materials. All the materials 
have a similar shape to these plots, however, they are not totally overlapping. 
The sharpness of the plots varies between the materials. Z250 has the steepest profile 
with the start and end of polymerization being the most abrupt – this is as expected as 
it is the only light curing material.  
The shape of the PMMA cement profiles is overlapping in the range 0.5 < t/t0.5 < 1.  At 
earlier times, however, the Palacos displays a region in which the level of monomer 
appears to increase (corresponding to a negative value for reaction extent). This 
behaviour is consistent with swelling and dissolution of the polymer beads; as the 
beads swell/dissolve the material makes better contact with the crystal and so the level 
of monomer looks to increase slightly before polymerization begins. The Simplex P 
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does not exhibit swelling or dissolution behaviour. After t/t0.5 > 1, the Palacos and 
Simplex profiles no longer overlap, the Palacos has more complete conversion.  
The Cortoss and Comp06 profiles overlap until t/t0.5 > 1.5.  After this time, the rate of 
polymerization of the Cortoss is faster than the Comp06 leading to a slightly more 
angular shape. The rate of polymerization of Cortoss and Comp06 is slower (with a 
more gradual curve) in the latter stages of polymerization compared to the PMMA 
cements and Z250. 
 
Figure 3-24 Cure profiles of PMMA, Z2504, Cortoss, Comp06.  
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3.6.3 Strength, Modulus and Fracture Behaviour 
Palacos and Simplex P have mean strengths of a 145 MPa and 126 MPa respectively 
(Figure 3-25).  These strengths are not statistically different. The elastic moduli of 
Palacos and Simplex P cements are both 1.6 GPa (Figure 3-26). Z250 has a much 
higher BFS and modulus than both the PMMA cements (Figure 3-25 and Figure 3-26). 
Cortoss and Comp06 have comparable BFS to both PMMA cements but have higher 
modulus. Both the BFS and E of Cortoss and Comp06 are lower than for Z250 (Figure 
3-25 and Figure 3-26).  
 
Figure 3-25 Strength of PMMA, Z250, Cortoss, and Comp06 BFS of composite bone cements and PMMA 
cements are similar. Z250 has a significantly higher BFS than all other materials. 
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Figure 3-26 Moduli of PMMA, Z250, Cortoss, and Comp06. Moduli of PMMA cements are lower than 
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Figure 3-27 shows the load/deflection plots for all the materials. The PMMA cements 
have a ‘ductile’ type of behaviour compared to the Z250, Cortoss and Comp06 which 
all exhibit brittle fracture. The number of ‘break points’ in the graph is indicative of how 
many pieces the sample fractured into; one or two indicates a break into 3 pieces, 
whilst 3 indicates a break into quarters. 
 
Figure 3-27 Typical load / deflection graphs for each material during biaxial testing. PMMA cements have a 
quasi-ductile fracture shape whilst the composites display a quasi-brittle fracture pattern with no ductile 
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3.7 Discussion 
3.7.1 Microstructure and Chemistry from SEM, EDX and Raman 
The MMA-styrene copolymer spectrum has many of the same groups as PMMA. In the 
‘red’ Raman map of Simplex P (Figure 3-5), it is therefore difficult to distinguish the 
poly (MMA-Styrene) beads from the PMMA flaked beadlets. The dark regions in the 
blue map, however, could better show where un-dissolved poly(MMA-styrene) beads 
are. Another way to locate areas of poly(MMA-styrene) would be to isolate the styrene 
spectra and use this to represent the co-polymer phase. In the overlaid map, points at 
which a barium sulphate spectrum and a poly(MMA-styrene) spectrum were detected 
were coincident and appeared pink. It is thought that these regions are due to the 
PMMA beadlets; it is possible, therefore, that barium sulphate coats the flaked PMMA 
beadlets. A mixture of components in the flaked beadlets would explain why barium 
was detected in them by EDX analysis. This could, however, simply be because the 
barium sulphate particles are small and the resolution of the Raman and EDX is not 
good enough to distinguish between them and PMMA.  Bright green/yellow spots show 
where incomplete polymerization has occurred – C=C double bonds. These regions 
occur mainly around the outside of the undissolved poly(MMA-Styrene) beads. MMA 
has a similar spectrum to PMMA and so the entire map appears slightly green.  
The Raman map of Palacos Figure 3-10 shows that the radiopacifier and polymer 
phases are distinct; the spectra representing each phase described the structure of the 
material well. This is because the ZrO2 particles in Palacos were large enough for the 
resolution of the Raman map to accurately detect them. 
The Raman maps of Simplex P and Palacos R have approximately 165 µm2 and  
90 µm2 unreacted methacrylate in a 1600 µm2 area; Raman therefore predicts 10 % 
and 6 % residual monomer respectively. FTIR cure analysis estimate 24 % and 14 % 
residual monomer for Simplex P and Palacos R respectively. Raman mapping is 
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therefore not considered an effective tool for estimating the degree of conversion. 
Usually when Raman is used to calculate the degree of conversion, the average 
spectrum over a mapped area is compared before and after cure (64). This method is 
obviously only useful for dual pastes or light cure composites. 
Silicate glass spectra in literature mainly identify a peak at around 1000 cm-1, however, 
this peak could not be detected in glass contained in Comp06; only a double peak at 
1350 cm-1 and 1400 cm-1 was detected in Raman analysis of the glass alone. For this 
reason, areas with spectra similar to this in the other composite materials (Cortoss and 
Z250) were assumed to be glass despite not matching glass spectra from literature.  
The EDX method was unable to detect phosphorous in Comp06 and therefore the 
presence of hydroxyapatite could not be confirmed using EDX. Heavy elements, such 
as barium used as a radiopacifier, scatter x-rays more than lighter ones; it is thought 
that these heavy elements swamp the x-ray detector preventing the detection of 
phosphorous in all but very few areas. From the Raman analysis, the volume fraction 
of silica glass relative to hydroxyapatite in the composite was high; silicon from 
adjacent glass molecules was thought to be masking the detection of hydroxyapatite 
also. The hydroxyapatite phase was, however, detected by Raman spectroscopy of the 
Comp06 fracture surface. In the Raman map of Cortoss and Comp06 the areas of 
combeite and hydroxyapatite were of similar size and so it is thought that these two 
composites contain similar amounts of these compounds, however, this would need to 
be confirmed by mapping of more areas. In EDX analysis, small rough particles were 
identified in Comp06 that contained aluminium: silicon: sulphur: barium in molar ratios 
of approximately 1: 6: 0.3: 1. The mass of sulphur detected was very low and so it was 
assumed that it was contamination on the sample from handling. X-Ray fluorescence 
(XRF) analysis found that the glass in comp06 contained the elements Al: Si: Ba in the 
molar ratio 1:8:1. EDX examines only the surface (top few microns) of a sample, 
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whereas in XRF5, the sample is ground, the bulk properties can be better determined 
(127). It is thought that the different penetration depths of each technique could 
account for differences in results. 
The microstructure and texture of Cortoss can be seen to be coarser than for comp06 
and Z250 from the SEM images (Figure 3-12, Figure 3-17 and Figure 3-21). In 
Comp06 the microstructure (via SEM and Raman mapping) had a finer texture than 
Cortoss. Flocculation would be expected with submicron particles due to surface 
energy penalties associated with the large surface area of small particles encouraging 
agglomeration. 
3.7.2 Cure Profiles, Conversion and Shrinkage 
Palacos has a shorter inhibition time than Simplex P despite having a swelling period 
associated with polymer dissolution in the liquid monomer. It is thought that the 
dissolution of Palacos polymer prior to cure, seen in the cure profile and suggested by 
SEM and Raman mapping, allows a faster subsequent curing reaction than Simplex P. 
In Simplex P the MMA-styrene copolymer particles appear not to dissolve in the MMA 
monomer.  This is consistent with the curing profile showing no ‘swelling’ region. The 
regions with no barium are where the MMA-styrene copolymer beads are – suggesting 
that they may not have dissolved. It is thought that the solubility of pure PMMA in 
Palacos has higher solubility than the poly(MMA-Styrene) in Simplex P. 
The PMMA cements have a higher degree of conversion than the composite bone 
cements and Z250, however, from Table 1 it can be seen that the composite bone 
cements and Z250 contain cross linking monomers whereas the PMMA cements 
contain only mono-methacrylates and so the conversion is not a clear indicator of 
which material has lower residual monomer. More discussion of this can be found in 
chapter 5. 
                                                5	  XRF analysis performed by Dr Wendy Xia.	  
Kirsty Main  PhD Thesis 
 123 
Polymerization shrinkage was calculated from degree of conversion and material 
composition. As discussed in the materials and methods chapter (chapter 2), 
polymerization shrinkage and heat generation are proportional to the monomer volume 
fraction and average molecular weight per methacrylate group. Cortoss contains 41 
vol.% filler.   Simplex P monomer fraction is 38 vol.%.  Using rule of mixtures to find 
material density will slightly overestimate shrinkage, as it does not take into account 
any volume due to voids.   
The low molecular weight of the Simplex P monomer is therefore the primary reason 
for its higher shrinkage. Simplex P has been measured to have polymerization 
shrinkage of between 5 and 7 % (2,42) and Kuehn theorized that PMMA cements will 
shrink by 7 % on curing (41). These values are comparable than the 6.9 % calculated 
in the present study despite assuming no voids. In the quoted studies, large volumes of 
material could have increased polymerization temperatures, enabling higher 
conversion6 and hence shrinkage. Therefore, despite non-zero porosity, shrinkage 
measured is similar to calculated value. Z250 was calculated to have a 1.8 % decrease 
in volume following polymerization.  This figure compares well with reported values for 
dental composites (around 2 % (62)).  This is in part due to the high molecular weight 
monomers and high filler content that these materials consist of, and partly due to the 
low conversion of the bifunctional monomers (55 – 75 % conversion, (128)). Cortoss 
contains similar monomers to Z250 but exhibits around 65 % conversion and so the 
shrinkage of this material was calculated to be higher than dental materials.  
The exact amounts of the monomers in Cortoss, Comp06 and Z250 were not divulged 
by the manufacturer, the shrinkage results were calculated assuming equal quantities 
of each monomer, and so it does not make sense to compare the literature values to 
calculated values to validate the calculation method. The values of shrinkage from 
literature correspond well to those values calculated for the PMMA cements in which 
                                                6	  Discussion of polymerization temperature and subsequent conversion in Chapter 5.	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the composition is known. For this reason the calculation method is thought to be a 
reasonable way to predict polymerization shrinkage. 
The SEM image of Palacos (Figure 3-8) shows gaps between polymer and ZrO2. There 
is no chemical bonding between the radiopacifier particles and the polymer material. It 
is thought that the gaps between the ZrO2 and the polymer could have been enlarged 
due to polymerization shrinkage of the polymer phase. There are similar levels of 
shrinkage predicted in Simplex but smaller gaps appear around the PMMA-barium 
phase because the size of the beadlets is smaller than that of the ZrO2 particles in 
Palacos. There is no evidence of shrinkage in the composite materials. 
3.7.3 Strength, Modulus and Fracture Behaviour 
 Biaxial flexural strength (BFS) and Young’s modulus (E) of both Simplex P and 
Cortoss have been found by Boyd et al (10). Cortoss was found to have BFS of around 
100 MPa with a modulus of 1.7 GPa, whilst Simplex P was found to have BFS of 150 
MPa and Modulus of around 1.1 GPa. Boyd et al. used the ball-on-three-ball 
arrangement for biaxial testing. It is thought that the different values obtained from this 
study are due to the different test method employed. As discussed in the introduction 
and materials and methods chapters (chapter 1 and chapter 2) the strength results 
obtained from the same test methods and materials in different laboratories give widely 
varying results. Further, different test methods (for example 3-point bend vs. biaxial 
methods, and different biaxial methods) can result in different values for strength and 
modulus and so it is thought that there is little point in comparing BFS and modulus 
results from literature to those in this project. Rather the strength and modulus values 
serve as a comparison between other materials in this study.  
Palacos contains only monofunctional MMA and has low stiffness relative to strength.  
This may be because the polymer beads dissolve in the monomer prior to cure and 
there are fewer voids at the filler/polymer interface compared to polymer/glass 
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composites. Also unpolymerized monomer acts as plasticizer in both the PMMA 
cements, reducing the modulus. 
In amorphous polymers such as PMMA, strength is increased by raising molecular 
weight and chain entanglements.  With PMMA a long period of dissolution prior to cure 
may reduce interfacial weakness at the bead / monomer interface.  Preventing 
flocculation of the radiopacifying components (e.g. barium sulphate) could also improve 
strength. In composites, silane treatment enables a chemical bond between filler and 
polymer. 
The fracture surface of Z250 has a fine but rough texture. Karacaer et al. reported a 
rough texture of reinforcement post fracture as indicative of a good interfacial bond 
(129). The high strength of Z250 and rough texture are therefore indicative of a good 
interfacial bond between the filler and polymer phases. 
The grain size of the materials is also indicative of the strength in the composite 
materials. The smaller filler size in Z250 corresponds to the highest strength although 
as discussed this is assuming a similar level of bond strength between filler and 
polymer in the different materials.  
The modulus of the material is linked the modulus and volume fraction each of the 
phases (114). The PMMA cements have low modulus polymer filler and so have low 
modulus overall. The composite cements have more flexible long chain monomers and 
lower filler volume fraction than Z250 and hence a lower modulus. 
Fewer air bubbles were seen in Cortoss and Comp06 than the PMMA cements. The 
most air bubbles were seen in simplex P and the least in Z250. It is thought that this is 
due to the mixing techniques, with the premixed composite materials exhibiting lower 
porosity. Hand mixing of PMMA cements is thought to be a major source of porosity 
and variability in porosity. The level of porosity has been shown to correlate with the 
modulus (28) and this is demonstrated in this project; the lowest modulus materials 
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being the PMMA cements with highest porosity, and the highest stiffness pairing with 
the lowest porosity is Z250. Intermediate porosity and stiffness were exhibited by 
Cortoss and Comp06. 
The texture of the fracture surface in the SEM images of Simplex and Palacos (Figure 
3-3 and Figure 3-8) would indicate that the polymer network stretched and failed in 
tension. This is consistent with the ductile shape of the load/displacement curve. There 
are some holes in Figure 3-8 which are evidence that the ZrO2 particles have ‘pulled 
out’ rather than fracturing indicating that the interface is weak between these two 
phases reducing strength as discussed above. 
The fracture behaviour of the composite materials is quasi-brittle, with no plastic 
deformation. The Cortoss and Comp06 fracture surfaces (Figure 3-12 and Figure 3-17) 
show some large angular particles protruding with other angular shaped ‘holes’ (of the 
same size as the large angular particles). This behaviour is suggests that the interface 
between the polymer phase and this angular phase is weaker than the strength of the 
particles; the particles ‘pull out’ rather than breaking, debonding such as this can 
encourage crack initiation as reported by Basaran et al. (79). Brittle cracking around 
the filler reinforcement is consistent with the brittle fracture shape of the load/deflection 
plot for these materials. 
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3.8 Conclusions 
SEM and Raman mapping proved to be useful in characterizing the microstructure and 
chemistry of the commercial PMMA and composite bone cements and the light curing 
dental composite. EDX gave variable results and was not sensitive to small amounts of 
compounds containing low atomic mass elements (like hydroxyapatite in Comp06).  
Polymerization shrinkage was calculated from level of conversion and material 
composition. This method for predicting polymerization shrinkage gave similar values 
to other shrinkage measurement methods, but did not take into account porosity. 
The microstructure of the materials along with the curing and mechanical 
characterization implied the failure mechanisms of the materials. The introduction 
chapter suggested that current PMMA bone cements had levels of residual monomer 
and polymerization shrinkage that were too high. Conversely, composite bone cements 
were too stiff and without sufficient strength for load bearing applications. Curing 
results suggest that the high molecular weight, and flexible dimethacrylate monomer 
BisEMA used in Cortoss and Comp06 results in higher conversion than less flexible 
monomers used in Z250. This monomer choice and a high filler content resulted in 
lower shrinkage than the lower molecular weight monomethacrylates used in the 
PMMA cements. From the Biaxial test data and SEM images it is clear that the bond 
between the polymer and filler and the grain size of the materials is central to the 
strength whilst a low modulus can be achieved by using high volume fractions of low 
modulus components. The PMMA cements had ductile fracture whereas the composite 
materials were inherently brittle. High molecular weight flexible dimethacrylate 
monomers should be used in conjunction with high filler content to give materials with 
high conversion with low shrinkage. Fillers that bond to the polymer phase will help 
increase strength. The level of filler will need to be optimized to maintain low shrinkage 
and low modulus. 
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4 Component Screening 
4.1 Abstract 
The aim of this chapter was to select monomers and fillers that, when incorporated in a 
composite, show the potential to improve on the properties of current commercial 
PMMA and composite bone cement materials. 
The effect of various fillers and monomers on the handling, cure, calculated shrinkage 
and mechanical properties of their composites were investigated and compared. 
It was found that the filler G4S, which is currently used in Comp06, made composites 
with the lowest viscosity enabling the highest filler content, which resulted in high 
strength and could result in lower polymerization shrinkage.  
PPGDMA also resulted in composites with good handling properties and high 
conversion. High molecular weight and crosslinking ability meant composites with 
lower shrinkage and comparable strength and modulus to Cortoss and Comp06 were 
possible. 
Glass fibres prevented brittle fracture when incorporated in composites at high weight 
percentages, but did compromise handling. 
In conclusion, composites made with silane treated glass G4S and glass fibres FGS and 
PPGDMA combined with UDMA and HEMA have the potential to outperform current 
bone cement materials and a systematic study of the effects on composite properties 
of these components should be conducted. 
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4.2 Introduction 
In the previous chapter, composite bone cements, Cortoss and Comp06, were found to 
have excellent handling properties. It is thought that a successful alternative composite 
material should also be deliverable via a syringe and mixing tip. 
The shrinkage of PMMA materials was found to be high with composite materials 
having lower values. High molecular weight monomers and high filler contents are 
responsible for lowering shrinkage. 
PMMA materials did not achieve 100 % conversion and so will have residual monomer. 
The conversion of BisGMA composites was found to the around 65 % and this 
combined with the health concerns surrounding BisGMA (discussed in the introduction, 
chapter 1) mean that UDMA is thought to be a better base monomer for composite 
bone cements. In addition, UDMA composites have been shown to have superior 
mechanical properties to BisGMA composites (130). TEGDMA is the most common 
diluent monomer used in bone and dental composites, although poly(propylene glycol) 
methacrylates have been reported by some as having enabling high conversions and 
crosslinking due to molecular flexibility (131–133). In the studies by Abou Neel and 
Zhao, PPGDMA is copolymerized with polylactide to produce a degradable polymer. In 
this project PPGDMA is used as a pure polymer and is not degradable. 
The merits of silane treated glass fillers were discussed in the introduction (chapter 1) 
and the previous chapter (chapter 3).  Silane treatment is thought to be essential for a 
good bond between filler and polymer in a composite material thereby enabling high 
strength. 
Also reported in the Introduction (chapter 1) were the wide ranging effects of fibre 
incorporation on composite mechanical properties. Silane treated glass fibres do have 
the potential to increase the strength of composites and improve the fatigue resistance 
by modifying the fracture behaviour. 
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4.3 Aims and Objectives 
The aim of this chapter is to select monomer and filler systems, from the candidate 
materials, that have the potential to solve some of the problems of PMMA and 
composite bone cements identified in the previous chapters. 
The selection will be based on the handling, curing characteristics, calculated 
shrinkage and mechanical properties of composites made with each of the candidate 
components. The success of each composition will be determined by comparison with 
other candidate composites and commercial materials. 
The effect of surface treatment and size and shape of filler particle on the handling and 
mechanical composite properties was to be determined along with the effect of filler 
composition on composite radiopacity. The effect of the monomer system on the 
composite handling, curing and mechanical properties was investigated. 
4.4 Hypotheses 
In terms of filler incorporation, based on the information gleaned from the literature 
review (chapter 1) and the results of the previous chapter, it is thought that silane 
coated glasses will lower composite viscosity enabling high filler content and result in 
higher BFS/Modulus. 
It is thought that fillers containing barium will make more radiopaque composites than 
those containing low atomic weight elements. 
It is envisaged that incorporation of silane treated fibres will change fracture patterns 
and could increase composite strength. 
The hypothesized function of the monomers investigated in this chapter is described in 
Table 4-1.   
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Table 4-1 Summary of function of various diluent and bulk monomers. Molecular weight of monomers 
listed along with a summary of intended function. 
In addition, PPGMMA and PPGDMA were thought to be more hydrophobic than Poly 
(ethylene glycol) methacrylate (PEGMMA) or Poly (ethylene glycol) dimethacrylate 
(PEGDMA) preventing excessive water sorption therefore increasing strength. 
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4.5 Materials and Methods 
A selection of monomer and filler materials (candidate materials), selected based on 
the performance of commercial materials tested in chapter 3 and experimental 
formulations reported in literature, were investigated via SEM and EDX and then 
incorporated into composite formulations. These formulations were characterized in 
terms of composition, handling, cure (times and level of conversion), shrinkage and 
mechanical properties.  
Firstly, five particulate glass fillers (G1, G1S, G2S, G3S and G4S), a glass fibre filler (FGS), 
and an aramid fibre filler (FA), were imaged and their particle size estimated via SEM. 
Their elemental composition was found with EDX. The experimental particle size and 
composition were compared to information from the manufacturer.  
Handling vs mechanical properties 
The wet point of each glass was found. As explained in chapter 2 (materials and 
methods) the wet point is the amount of monomer that must be added to filler to make 
a cohesive mass, and is given as a percentage of monomer in the resulting paste. 
Composites were made from each of the particulate glasses, G1, G1S, G2S, G3S and 
G4S, (composition as in table 4-2) were then biaxially tested. The first task was to 
ascertain whether the wet point correlated to particle size, handling or 
strength/modulus and then determine the effect of silane treatment on composite 
properties.  
Radiopacity 
Composites containing silanated glasses, G1S, G2S, G3S and G4S, were used to fill  
2 mm holes drilled in rabbit tibbial bone and their radiopacity compared using microCT.  
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Effect of fibre incorporation 
The effect of fibre incorporation on handling and mechanical properties was tested by 
comparing composites made with G1S glass and either 10 wt.% or 50 wt.% FGS fibres 
(table 4-2). 
Effect of HEMA 
The effect of incorporating the diluent monomer HEMA was investigated by finding the 
handling, curing characteristics (normalized cure profile and curing times) and biaxially 
testing composites containing HEMA against those without (table 4-2). All composites 
PLR 4:1 with G4S glass filler. 
Variation of diluent monomers 
The effect of various diluent monomers (PETA, PPGMMA, PPGDMA, DDMA, 
TEGDMA) on the handling, cure, calculated shrinkage and mechanical properties of 
composites (table 4-2) was assessed. 
Polymerization shrinkage was calculated from degree of conversion and material 
composition.  
Full details of all methods can be found in Materials and Methods (chapter 2). 
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Table 4-2 Chapter 4 composite compositions. Throughout this thesis, monomer quantities are given as 
percentages of total monomer. Filler content is either given as PLR or weight percentage of total 
composite mass. For example a composite quoted as having 75 wt.% UDMA, will have a monomer system 
that contains 75 wt.% UDMA. Unless otherwise stated all composites in this chapter contain 0.5 wt.% BP / 
DMPT with 70ppm BHT where these quantities are percentage of total monomer mass. Fibre quantities 
are given as percentage of filler mass. 
Handling vs mechanical properties and radiopacity 
Monomer (wt.%) PLR Fillers 
75 % UDMA  
25 % TEGDMA  
5 % HEMA 
3:1 (G1, G1S, G2S) 
4:1 (G3S and G4S) 
containing one of G1, G1S, G2S, G3S or G4S 
Fibre incorporation 
Monomer (wt.%) PLR Fibres  
(wt.% of filler) 
Fillers 
65 % UDMA 
22.5 % TEGDMA  
12.5 % HEMA  
3:1 10 % 
or 50 % 
G1S and FGS 
Effect of HEMA 
Monomer (wt.%) PLR Fillers 
64 % UDMA  
21 % TEGDMA 
14 % HEMA 
OR 
64 % UDMA  
35 % TEGDMA 
4:1 G4S 
Variation of diluent monomers 
Monomers (wt.%) PLR Filler 
30 % diluent monomer 
65 % UDMA  
5 % HEMA  
 
4:1 G4S 
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4.6 Results 
4.6.1 Filler Screening 
4.6.1.1 Characterization of Fillers 
Five glass filler particles and two fibre fillers were investigated via SEM and EDX. The 
elemental composition from manufacturer’s information and from EDX is displayed in 
Table 4-3. The elemental composition was determined by taking EDX spectra at a 
minimum of three different sites. If the spectra obtained at the three sites were 
substantially different then more spectra were obtained until the most common 
elements could be determined. There are some elements that were not detected and 
some discrepancy as to the relative amounts of the compounds present in the fillers 
was observed. For example, phosphorous was not detected in glasses G1 or G1S whilst 
boron was absent from EDX analysis of G2S G3S and G4S. Nitrogen was not detected in 
the aramid fibres. Calcium, aluminium and magnesium were detected in the glass 
fibres (FGS) in addition to silicon and oxygen, as expected, but once again boron was 
not detected. Sodium was found in the EDX spectra of G3S in addition to those 
elements expected.  This indicates some of the limitations in using EDX for elemental 
analysis. 
The particle sizes quoted by the manufacturers were either given as a d50 size or as a 
size range. The quoted particle sizes can be compared to the SEM images of the filler 
materials (Figure 4-1 and Figure 4-2); it was found that the sizes were in good 
agreement. Some of the glass fibres are longer than the 300 µm quoted by the 
manufacturer but they were observed to make up less than 10 % of total. The aspect 
ratio of the aramid fibres can be seen to be similar to the glass fibres for the majority of 
fibres but some in the SEM image are approaching 1 mm in length these were 
observed to make up between 1 – 2 % of total.  
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Name 




Manufacturer Composition Elemental composition (molar ratio) 
G1 3.7* 
SiO2, SrO, Al2O3, F, ZnO, P2O5, 
Na2O 
18F, 3Sr, 7Si, 6Al, Zn, 2Na  
G1S 2* 
SiO2, SrO, Al2O3, F, ZnO, P2O5, 
Na2O 
16F, 3Sr, 8Si, 6Al, Zn, 2Na 
G2S 2* SiO2, BaO, B2O3, Al2O3 9Si, Ba, 2Al 
G3S 10 – 40  SiO2, B2O3, Al2O3 24Si, 2Na, 1Al 
G4S 12 – 40  SiO2, BaO, B2O3, Al2O3 6Si, Ba, Al 




SiO2, B2O3 7Si, 2Ca, 2Al, Mg 
Table 4-3: Seven types of glass particle, subscript ‘s’ denotes silane treatment. *d50 size quoted, 
otherwise particle size range given. Manufacturer composition given in order of largest first. 
 
Figure 4-1 SEM images of glass particles.  




G4S 50	  μm	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Figure 4-2 SEM images of aramid (FA) and glass (FGS) fibres. 
4.6.1.2 Comparison of Particulate Fillers 
The wet point of the available particulate fillers was determined (Figure 4-3). In the 
case of the non-silane treated glass, this cohesive mass was very stiff and packable. 
For the silane treated glasses, at the wet point, the paste was also stiff and packable 
but only a small amount more monomer was necessary to turn the material into a 
flowable paste. Glass G4S had a lower percentage of monomer at the wet point than all 
the other glasses. Both G3S and G4S were flowable/syringeable with 80 wt.% filler (PLR 
4:1) and so biaxial specimens were made with this level of filler. Glasses G1S and G2S 
were only syringeable at slightly lower filler contents (75 wt.% - 78 wt.%) and so biaxial 
specimens were made with 75 wt.% filler. 
 
FA	  Aramid FGS	  Silane	  coated	   glass 
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Figure 4-3: Wet Point of glass filler materials. Values are percentage of filler in a filler/monomer paste. 
Monomer mixture is 70 wt.% UDMA; 25 wt.% TEGDMA; 5 wt.% HEMA. n=2, error bars are range of 
results.  
Figure 4-4 and Figure 4-5 show that the strengths and stiffnesses of the silanated glass 
composites were significantly higher than the strength and stiffness of the non-silane 
treated glass composites. The formulation containing G4S had the highest strength and 
was significantly stronger than the G2S composite. The strength of the non-silane 
treated glass composite was poor, and so glass G1 was discounted from further testing.  
The stiffnesses of the silane treated glass composites were all significantly higher than 






















Kirsty Main  PhD Thesis 
 139 
 
Figure 4-4 Biaxial Flexural Strength of composites made with unsilanated glass and silane treated glasses. 
Silane treated glasses have significantly higher strength, n=8, error bars are 95% confidence interval. 
 
Figure 4-5 Elastic moduli of composites made with unsilanated glass and silane treated glasses. The 
composites made with silane treated glasses are significantly stiffer than the unsilanted glass composite. 
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The radiopacity of silanated glass composites can be seen in Figure 4-6. The same 
composition as in biaxial testing was used. The visibility of all the glasses is good apart 
from G3S whichG3S, which is not as radiopaque as the others as expected from the 
glass compositions.  
 
  
Figure 4-6 MicroCT images demonstrating radiopacity of Silane treated glass composites relative to Rabbit 
tibial bone.  
4.6.1.3 Fibre Incorporation 
Table 4-4 shows the filler and fibre content of the fibre composites that were biaxially 
tested. Substitution of some of the particulate filler with fibres in all compositions 
reduced flowability, although the effect was minor in the glass fibre composites. Aramid 
fibre composites had very poor handling when combined with G1S glass and so G4S 
glass was used instead.  The compositions with higher percentages of both glass and 
aramid fibres were less cohesive than their low fibre counterparts. All compositions, 











Kirsty Main  PhD Thesis 
 141 
In addition to the poorer handling, the strength and stiffness of the aramid fibre 
composites was lower than the glass fibre composites due to the lack of chemical 
bonding between the fibre and monomer network (Table 4-4).  
The 50 wt.% glass fibre composites and the 5 wt.% aramid fibre composites exhibited 
less brittle fracture behaviour than the low percentage fibre composites (Figure 4-7). 
Composite 
Filler :Filler: Fibre  
(by mass) 
BFS (MPa) E (GPa) 
G1S + FGS 
90:10 165 ± 14 3.9 ± 0.5 
50:50 178 ± 11 4.7 ± 0.5 
G4S + FA 
99:1 134 ± 9 3.2 ± 0.4 
95:5 116 ± 9 2.9 ± 0.4 
Table 4-4 BFS of fibre composites with varying filler / fibre type and content. Altering the fibre content does 
not significantly affect the strength, although the silane treated fibre composite have significantly higher 
BFS. n=8, errors are 95% confidence interval. 
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Figure 4-7 Fracture behaviour of fibre composites. a) G1S + 50 wt.% FGS. b) G1S + 10 wt.% FGS c) G4S + 5 
wt.% FA d) G4S + 1 wt.% FA. High fibre composites (a and c) exhibit more ductile fracture behaviour. 
Maximum Load carried by aramid fibre composites is lower than for glass fibre composites as Kevlar fibres 
are not silane treated.  There is therefore poor bonding between fibres and filler/polymer phases. 
4.6.2 Monomer Screening 
4.6.2.1 Effect of HEMA 
The addition of HEMA made the composites less viscous and less ‘oily’ in appearance. 
The curing profiles of the composites with HEMA had a more abrupt end to curing than 
those without; for t > t0.5 the curve of the curing profile for the HEMA composite was 
sharper (Figure 4-8). Furthermore, HEMA delayed t0.5 significantly but had lesser effect 
on inhibition time (Table 4-5).  
The conversion of the materials containing HEMA was slightly higher than those 
without (Table 4-5).  
Addition of HEMA further increased biaxial strength and stiffness. 
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74 ± 2 19 ± 5 85 ± 8 152 ± 10 3.9 ± 0.2 
Table 4-5 Conversion, Cure times, BFS and Modulus for composites with and without HEMA. Composites 
both contain UDMA, TEGDMA and G4S filler  
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4.6.2.2 Variation of Diluent Monomers 
There were no significant differences in the handling of the composites made with the 
different diluent monomers; all composites were syringeable. 
From the normalized cure profiles (Figure 4-9) it can be seen that rate of cure in the 
latter half of the curing reaction (after t0.5) correlates with the effective molecular weight 
of the composite monomer phase for all but the PPGDMA composite. With higher 
effective molecular weight, cure is faster after t0.5.  
 
Figure 4-9 Normalized cure profiles for composites containing different diluent monomers. Materials in 
legend listed in the order of fastest cure after t0.5. 
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Table 4-6 summarizes the conversion and cure times in which TEGDMA has been 
replaced with different diluent monomers. PPGMMA had the highest level of 
conversion, followed by PPGDMA, TEGDMA and PETA, whilst DDMA composites did 
not cure satisfactorily, and so no cure times were determined nor biaxial testing 














PPGMMA 80 ± 1 211 ± 18 0.42 ± 0.01 270 3.6 ± 0.1 
 TEGDMA 70 ± 1 164 ± 7 0.40 ± 0.02 193 4.5 ± 0.1 
PPGDMA 76 ± 1 198 ± 12 0.35 ± 0.02 243 3.6 ± 0.1 
DDMA 16 ± 2 Poor Cure - no biaxial testing, no measurement of cure times. 
PETA 65 ± 4 175 ± 12 0.41 ± 0.04 212 3.5 ± 0.2 
Table 4-6 Summary of level of conversion for each composite containing a different diluent monomer 
alongside 65% UDMA and 5% HEMA. Effective molecular weight is average molecular weight per 
methacrylate group in composite monomer system. n=4, errors are standard deviation. 
The strengths (Figure 4-10) and stiffnesses (Figure 4-11) of the materials made with 
varying diluent monomers do not correlate with either the effective molecular weight or 
conversion of the monomer phase. The material made with PPGMMA has the lowest 
BFS with the material with TEGDMA having the highest. The PPGMMA composite also 
has the lowest stiffness with the TEGDMA and PETA composites having the highest 
Young’s modulus. 
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Figure 4-10 BFS of materials containing different diluent monomers. . n=8, error bars are 95% CI. 
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4.7 Discussion 
4.7.1 Filler Screening 
As was seen in chapter 3, EDX analysis is not sensitive to lower mass elements. In 
particular EDX spectra failed to identify the presence of phosphorous and boron in the 
glass fillers and nitrogen in the aramid fibres. As discussed previously, in the case of 
glass materials, it is thought that this is due to the EDX detector becoming swamped by 
heavier elements such as barium and strontium. Oxygen was detected despite being 
present at the same levels as nitrogen. 
The wet points of the glasses correlated with the mechanical properties of their 
composites.  The lower the amount of monomer required to make a cohesive paste, 
the higher the BFS and stiffness of the composite. Silane treatment lowered the 
viscosity of the composites significantly at monomer contents just past the wet point. 
Composites made with glasses G3S and G4S were syringeable at higher filler content 
than those formulaltions containing G1S and G2S – they therefore enable lower 
shrinkage composites. The strengths of the silane treated glass composites (Figure 
4-4) were comparable to Z250 (224MPa) and were significantly higher than both the 
PMMA cements (152MPa for Palacos, 131MPa for Simplex P) and Cortoss and 
Comp06 (120MPa and 146MPa respectively). The silane treated glass composites 
(Figure 4-5) were significantly stiffer than the PMMA cements (1.6GPa for Palacos and 
Simplex P), and similar in modulus to Comp06, Cortoss and Z250 (3.1GPa, 3.4GPa 
and 4.1GPa respectively). A high strength with a low stiffness is desirable in bone 
repair applications. All materials failed in a brittle manner. Glass G4S is the same glass 
that is used in the commercial composite Comp06. The UDMA, TEGDMA, HEMA 
monomer system together with silanated glass facilitates higher PLR whilst maintaining 
syringeability compared to BisGMA composites such as Cortoss and Comp06. 
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There was a strong correlation between modulus and strength in the glasses tested.  
The ratio of BFS to modulus for each glass was G1: 2.9 %, G1S: 4.5 %, G2S: 5 %, G3S: 
4.9 %, G4S: 5.1 %. The value of 2.9 %, for the non-silane treated glass, is particularly 
low. This could be due to higher air incorporation / porosity, compared to the silane 
glasses, reducing the modulus. Porosity is expected to reduce both strength and 
modulus (as discussed in the introduction) but it would seem to have more effect on 
the stiffness. 
4.7.1.1 Fibre Incorporation 
The aramid fibres are less dense than the glass fibres (ρaramid = 1.44 ρglass = 3) and are 
not silane treated.  This made it impossible to add as high a weight percentage of 
aramid fibres as glass fibres. The lack of fibre silane treatment is one of the reasons for 
poorer handling of the aramid fibre composites compared to the glass fibre composite.  
Following first failure of the composite, there was a pseudo-plastic region in the load 
deflection graphs of all of the high fibre composites in which there was fibre bridging of 
the cracks. In the case of the 5 wt.% aramid fibre composite, this fibre bridging was not 
as sustained as for the glass fibre composites. It is thought that this is due  to a lack of 
chemical bonding between the fibre and polymer or filler phases as the aramid fibres 
were not silane treated. 
4.7.2 Monomer Screening 
4.7.2.1 Effect of HEMA 
HEMA is more hydrophilic than TEG DMA and so it was thought that the water sorption 
of a HEMA containing composite could be higher than one where HEMA is replaced by 
TEGDMA. In addition to this, conversion was increased by adding HEMA. Higher 
conversion will result in higher polymerization shrinkage but if the water sorption is 
higher the polymerization shrinkage could be more effectively compensated for. The 
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conversion level of the HEMA composite was significantly higher than the BisGMA 
containing commercial composites Cortoss and Comp06.  
HEMA does not cross link; it is thought that the end of cure is more abrupt because the 
HEMA containing composite does not cross link to the same extent as the non-HEMA 
composite, although this does not adversely affect the strength. 
4.7.2.2 Variation of Diluent Monomers 
The late polymerization rate was shown to be faster for higher molecular weight 
monomers for all but the PPGDMA composite. Conversion after 50% is thought to be 
mainly due to crosslinking; the reaction kinetics and polymerisation mechanisms are 
discussed in more depth in chapter 5. The higher molecular weight molecules, if they 
are not flexible, will not be able to crosslink as easily as low molecular weight or flexible 
chains and hence the crosslinking phase could be short – there is a more involved 
discussion of the polymerization reaction kinetics in the next chapter (chapter 5).  
The shrinkage of the diluent monomer composites was similar to those calculated for 
Cortoss and Comp06 in the previous chapter. The different diluent monomers all have 
different hydrophobicity and so will encourage different amounts of swelling due to 
water sorption. This is something that should be investigated along with empirical 
measurements of shrinkage. 
Despite the composite made with PPGMMA having the highest conversion, it had the 
lowest BFS and Modulus. This is because the monomethacrylate could not cross link 
resulting in lower strength and modulus. Monomethacrylates have also been shown to 
have poorer interaction with silane treated fillers due to lack of cross linking as was 
discussed in the introduction. This poor interfacial bond will also lower strength and 
stiffness. The composite containing PPGDMA has a reasonable strength and low 
modulus compared to the commercial bone cements (Cortoss, Comp06, PMMA) 
mentioned in the previous chapter.  It also had higher conversion and lower predicted 
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shrinkage compared to the more typical TEGDMA composite. PPGDMA has not been 
used in a commercial material before. 
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4.8 Conclusions 
Silane treated glasses enable better handling, and higher PLR. Higher PLR and 
chemical bonding between filler and polymer enables high flexural strength and 
modulus. 
Glasses containing heavy elements such as barium give better radiopacity than 
glasses that do not contain such heavy elements. 
Glass G4S was deemed to have performed the best out of all the glasses tested based 
on handling, strength and modulus values for its composites. 
Glass and Aramid fibres both changed the fracture pattern of composites, but the 
silane treated glass fibres, FGS, were thought to enable better fibre bridging without 
compromising on strength. 
A small quantity of HEMA increased the conversion and mechanical properties of 
composites and improved handling by lowering monomer viscosity. 
PPGDMA was considered the best diluent monomer based on cure rate, conversion 
(free monomer remaining) and modulus; but with a small compromise on strength. It is 
thought that PPGDMA could be a good candidate material for incorporation in 
commercially competitive bone cement materials. 
PPGDMA, G4S glass and FGS fibres will be the subject of a systematic study in the next 
chapter. 
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5 Systematic Variation of Key Components 
5.1 Abstract 
The aim of this chapter was to investigate the effects of systematically varying the 
levels of PPGDMA, filler G4S and FGS fibres on composite properties. 
A novel dimethacrylate monomer, PPGDMA, was used with UDMA, HEMA and silica 
glass particles and fibres to create a set of PPGDMA fibre composite (PFC) dual paste 
chemically curing materials that were compatible with delivery via a double barrelled 
syringe and mixing tip.  
The degree of conversion and curing kinetics of the PFCs, Cortoss and Simplex P 
were found using FTIR whilst the mechanical properties (including flexural strength and 
Young’s modulus) were obtained via biaxial flexural testing. The curing kinetics were 
investigated and an equation derived to describe the curing profiles of the PFCs / bone 
cements in terms of their time to half reaction and inhibition time. The curing profile 
equations were compared to kinetic theory for free radical polymerization and used to 
infer possible reaction mechanisms for the PPGDMA system. The curing profiles and 
equations and mechanical properties of the PFCs and Cortoss and Simplex P bone 
cements were compared. It was found that PFC materials had more complete 
conversion, and faster cure than Cortoss and Simplex P meaning possibly lower 
residual monomer and less chance of monomer leakage during implantation. The 
flexural strength of some of the PFC materials was comparable to Cortoss and Simplex 
P but with reduced modulus, more accurately matching the properties of trabecular 
bone and being less likely to damage weak osteoporotic bone. Incorporating fibres into 
the PFC materials prevented brittle fracture seen in Cortoss and mimicking the fracture 
behaviour of Simplex P. It is thought that a material with intermediate levels of 
PPGDMA, G4S glass filler and FGS fibres could be a viable alternative to existing bone 
cements.  
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5.2 Introduction 
In the introduction to this thesis (chapter 1) some of the shortcomings of current bone 
cement materials were highlighted. Namely the poor cure and high shrinkage of PMMA 
cements, and high stiffness and brittle fracture of composite materials. 
In the previous chapter a monomer (UDMA, PPGDMA and HEMA) and filler system 
(silane coupled barium silica glass, G4S, and silica glass fibres, FGS), that were shown 
to have the potential to combat these shortcomings, were selected for further testing.   
The systematic study of these selected components is the subject of this chapter. 
5.3 Aims and Objectives  
The aim of this chapter is to systematically vary the levels of selected monomers, and 
fillers to ascertain their effect on the cure, conversion, and mechanical properties of 
dual paste, chemical cure bone cement formulations. Establishing effects of 
components over a practical range will enable the relative quantities of monomers and 
fillers to be balanced to produce a material that may have the potential to combat the 
inadequacies of current bone repair materials. 
5.4 Hypotheses 
As discussed in the previous chapter and the introduction to this chapter, PPGDMA is 
a long chain flexible monomer. It is intended that the range of PPGDMA investigated in 
this chapter, will produce composite formulations with reduced stiffness yet a high 
degree of methacrylate conversion and good flexural strength compared to BisGMA 
containing composites. 
Further, it is thought that altering the level of PPGDMA will result in curing times and 
rates that vary significantly, providing insight into the possible reaction mechanisms for 
this monomer system. 
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PPGDMA is low viscosity. It is hoped that this will allow a high level of silane coupled 
filler to be incorporated and enable good interaction between filler and monomer 
phases resulting in materials that are compatible with syringe and mixing tip delivery 
and have high flexural strength. Finally, addition of silane coupled glass fibres is hoped 
to produce materials with a non-brittle fracture pattern with their inclusion having no 
detrimental effect on flexural strength. 
5.5 Materials and Methods 
First, a three variable factorial design experiment was performed to investigate the 
effects of level of PPGDMA monomer, IF2019 glass filler and GL0271F fibres on the 
cure rate, conversion level, BFS and Young’s modulus. In this chapter formulations are 
referred to as PPGDMA Fibre Composites (PFCs). 
Poly(propylene) Glycol 425 Dimethacrylate (PPGDMA) was combined with UDMA in 
weight ratio 3:1, 1:1 or 1:3. UDMA and PPGDMA contained approximately 150 and 100 
ppm monomethyl ether hydroquinone (MEHQ) inhibitor respectively.  In addition, 
UDMA and PPGDMA were supplemented with 70 and 170 ppm butylated hydroxy 
toluene (BHT). 7 wt.% HEMA was then added.  0.5 wt.% benzoyl peroxide (BP) or 0.5 
wt.% dimethyl paratoluidine (DMPT) were included to make initiator, or activator, 
liquids respectively. 
1, 5 or 25 wt.% silane coupled silica glass fibres (FGS) were mixed with silane coupled 
radiopaque silica glass filler (G4S).  The resultant powders (60, 75 or 80 wt.%) were 
hand mixed with the liquids to make separate initiator, and activator, pastes as per the 
method of paste manufacture detailed in chapter 2. 
Nine different formulations were investigated with three variables (PPGDMA, powder 
(P) or Fibre (F) content) using a two level factorial design (detailed in chapter 2) with 
one intermediate formulation (Table 5-1).   
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5.6 Results  
5.6.1 Physical, Chemical and Mechanical Properties of PFC Formulations. 
5.6.1.1 Mixing and Handling 
For all PFCs, initial viscosity was sufficiently low to enable use of the commercial 
syringe and automatic mixing tips. It took between 2 and 4 seconds for the pastes to 
flow through the mixing tips.  The pressure on the gun required was higher for 
formulations with greater powder content and lower PPGDMA due to their greater 
viscosity.  Whilst the syringe was in continuous use the paste did not set in the tip.   
Material, however, left within the tip set between one and seven minutes. 
It is most useful to compare the handling and mixing characteristics of the PFC 
materials to the commercial materials Cortoss and Comp06, that were introduced in 
Chapter 3, because these materials are dual paste, chemical cure, composite bone 
cements containing similar components and delivered in the same way as the PFCs. 
The bore of the PFCs mixing tips were the same as were used for Comp06 and smaller 
than those used for Cortoss. The pressure required to extrude PFC 7 and 8 was similar 
to that required for Cortoss and Comp06 and was lower than for PFC 3 and 4. The 
viscosity of the PFCs containing high filler content and low level of PPGDMA (PFC 3 
and 4) were similar to Cortoss paste, whilst the Comp06 paste was more fluid and 
similar to PFC 7 and 8. 
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5.6.2 FTIR Data 
5.6.2.1 Final Conversion and Curing Profiles 


























1 69 ±3 114 ±15 4.8 ±0.2 
PFC2 25 71 ±1 98 ±4 4.9 ±0.1 
PFC3 
80 
1 70 ±1 214 ±44 3.0 ±0.0 
PFC4 25 73 ±1 233 ±15 3.2 ±0.1 




1 96 ±3 284 ±12 5.9 ±0.1 
PFC6 25 97 ±5 240 ±15 6.0 ±0.3 
PFC7 
80 
1 95 ±4 401 ±79 3.7 ±0.2 
PFC8 25 92 ±4 337 ±17 3.6 ±0.1 
Table 5-1 Formulation compositions: Methacrylates  (PPGDMA, UDMA and HEMA), powder and 
fibre contents are given as weight percentages of total monomer, composite or powder 
respectively. FTIR analysis performed at 25 °C. Results shown: Shrinkage, t0.5, conversion, BFS 
and Modulus. Errors are 95 % confidence intervals. For Shrinkage, t0.5 and Conversion n=4.  For 
BFS and Modulus n=8. 
FTIR spectra of curing PFCs were as expected for polymerizing composite bone 
cements (Figure 5-1). Difference spectra were also all characteristic of 
methacrylate polymerization (Figure 5-2).  The largest changes in absorbance 
were observed at 1265, 1300 and 1320 cm-1 due to a change in methacrylate  
C-O stretching vibration with polymerization. Absorbance changes were also 
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noted at 1730, 1700 and 1640 cm-1 due to methacrylate C=O vibrational shifts 
and C=C loss respectively.  
 
Figure 5-1 FTIR spectra of a curing PFC 9 with time. Inset shows change in absorbance used to 
determine cure profile. The 1320 cm-1 peak used to measure peak height corresponds to C-O 
bond in the polymerizing methacrylate group. Only peaks corresponding to Methacrylate group 
are changing – indicating only one reaction (polymerization) proceeding.  
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Figure 5-2 Difference spectra of PFC 9 – showing wavenumbers where maximum changes in 
absorbance take place. 
All PFC conversion profiles demonstrated an inhibition period followed by rapid 
reaction (Figure 5-3). Extrapolated final conversions and t0.5 are provided in 
Table 5-1. By 4t0.5, reaction extent was over 80% for all samples (Figure 5-3).  
Below t/t0.5 = ti = (0.35 +/-0.04), reaction extent was negligible for all PFC. 
Conversely, in the range 0.35 < t/t0.5 < 1, a constant gradient dζ/d(t/t0.5) = 0.5/(1-
ti) = (0.77±0.03) was observed. In this range reaction extent is therefore given 
by the equation of a straight line 
    
Equation 5-1 
The reaction rate slowed for t/t0.5 >1.1.   





















[t / t0.5 − ti ]
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Figure 5-3 Reaction extent, ς, (see equation 1) versus normalized time, t/t0.5. Within experimental 
error, this plot for all formulations, overlaps with ς <50%. Beyond this point reaction extent versus 
t/t0.5 tends to 1 more rapidly if PPGDMA level is high. The legend provides formulation composition 
in order of reaction extent at t/t0.5=3.  
PPGDMA content was the only variable to affect PFC final conversion (Figure 
5-4).  It increased on average from 69 to 97% with increasing PPGDMA level 
from 23 to 70 wt.% of the monomer.  Conversion of the intermediate PFC (82 %) 
was close to the average result (Table 5-1). 
Increased PPGDMA and powder content both significantly raised PFC t0.5 
(Figure 5-4). With 60 % powder, average t0.5 was 106 and 262 s with 23 and 70 
% PPGDMA respectively.  With 80 % powder, these increased to 224 and 369 
s. The intermediate formulation t0.5 (163 s) was close to the average of those 
with 60% powder.  This is consistent with a linear increase in t0.5 with raising 
PPGDMA but an abrupt change when powder content exceeds 75 %.  














	  70%	  PPG	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ζ = 12(1-ti)
{t/t0.5- ti} 
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Figure 5-4 Quantification of effects of variables (PPGDMA, powder (P) or fibre (F) content) and 
variable interactions on final monomer conversion, time to 50 % reaction extent (t0.5) and 
shrinkage/heat generation. Error bars are 95% confidence interval (n=4). Those crossing zero 
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5.6.2.2 Shrinkage and Heat generation 
The calculated shrinkage values varied between 2.9 and 6.3 %. Heat generation 
(in kJcm-3 of cement) equals shrinkage divided by 40.4.  Factorial analysis 
indicates PFC shrinkage (and therefore also heat generation) was reduced most 
by raising powder content (Figure 5-4). Increasing PPGDMA also resulted in 
slightly higher shrinkage as effects of greater monomer conversion outweighed 
higher average monomer molecular weight. Cortoss shrinkage was calculated to 
be 3.7 % and comparable with the average value of all PFCs. Simplex P PMMA 
had the highest calculated shrinkage of 6.2 % due to the low monomer 
molecular weight. 
5.6.3 Biaxial Testing 
5.6.3.1 Strength and Modulus  
PFC biaxial flexural strength and modulus are summarized in Table 5-2. BFS 
ranged between 37 and 158 MPa with moduli varying between 0.3 to 2.9 GPa. 
 PPGDMA UDMA HEMA 




158 ±19 1.8 ±0.1 
PFC2 138 ±12 2.0 ±0.2 
PFC3 116 ±13 2.7 ±0.3 
PFC4 117 ±11 2.9 ±0.3 
PFC9 46.5 46.5 91 ±7 1.2 ±0.1 
PFC5 
70 23 
37 ±4 1.6 ±0.1 
PFC6 40 ±4 0.3 ±0.0 
PFC7 64 ±8 0.4 ±0.0 
PFC8 61 ±3 1.2 ±0.1 
Table 5-2 PFC Biaxial Flexural strength and Young’s modulus. Average over n specimens and 
errors are 95% confidence interval. (n=8). 
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The factorial analysis revealed that BFS was affected most by PPGDMA level 
(Figure 5-5).  In Figure 5-6 the BFS and Modulus values have been averaged 
over fibre content (e.g. average of PFC 1 and 2). Raising powder content 
increased strength at high PPGDMA level but had the opposite effect at low 
PPGDMA.  This gives a strong factorial interaction term (Figure 5-5).  The 
intermediate formulation (PFC 9) had strength comparable with the average 
PFC result.  
PFC stiffness was reduced most by increasing PPGDMA and also declined on 
reducing powder content (Figure 5-5). The intermediate PFC modulus (2.0 GPa) 
was comparable with the PFC average. 
Kirsty Main  PhD Thesis 
 163 
 
Figure 5-5 Factorial analysis giving effect of variables on BFS and Young’s Modulus.  PPGDMA 
has the greatest effect on both properties.  Effects of powder are complex but smaller. The effect 
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Figure 5-6 Average BFS as a function of PPGDMA percentage in monomer and total powder 
percentage (P).  This demonstrates that reducing PPGDMA monomer level increases strength.  
With high PPGDMA raising powder content increases strength.  At low PPGDMA higher powder 
reduces strength. Error bars are 95 % CI (n=16 for all 23 % PPGDMA and 70 % PPGDMA 
specimens, averaged over eight specimens at high fibre content and eight specimens at low fibre 
content as F did not significantly affect BFS results; for example the 80P/23PPG bar refers to an 
average over PFCs 3 and 4, the 60P/23PPG bar refers to an average over PFCs 1 and 2, whilst 
the 80P/70PPG bar refers to an average over PFCs 7 and 8 and the 60P/70PPG bar is an 
average of 5 and 6. For 46.5 % PPGDMA, 75 % P n=8; the 75P 46.5PPG bar is the mean value 
for PFC 9).  
 
Figure 5-7 Average modulus as a function of PPGDMA and P wt.%.  This indicates that raising the 
former but reducing the later both decrease Modulus. Error bars are 95 % CI (n=16 for all 23 % 
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and eight specimens at low fibre content as F did not significantly affect BFS results. For 46.5 % 
PPGDMA, 75 % P n=8). 
Figure 5-8 compares the measured stiffness values of the PFC materials to the 
values predicted by the Voight-Reuss and Hashin-Strikman models. The 
measured values lie in between the values predicted by the iso-stress and iso-
strain models, as is typical for all composite materials. The Hashin-Strikman 
upper bound, which predicts the stiffness of a composite consisting of compliant 
particles in a stiff matrix, overestimated the stiffness of the PFC materials as 
expected; given that the composites are glass reinforced polymers. 
 
Figure 5-8 Comparison of PFC modulus values and predicted values using Voight-Reuss and 
Hashin-Shtrikman composite models. PFC modulus values (Emeasured) lie within the Voight-Reuss 
Upper and Lower bounds as expected, and correspond closely to those modulus values predicted 
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5.6.4 Fracture Behavior 
Low fibre content samples all had brittle failure (Figure 5-9).  Raising fibre 
content had no significant effect on stress at first yield but increased deflection 
at final failure.  The increase in load observed for 23 % PPG / 80 % P in Figure 
5-9 is due to a larger sample thickness only. 
 
Figure 5-9 Example fracture patterns for formulations containing 1 % or 25 % fibres, the red line 
represeents the intermediate formulation, PFC, with 5 % fibres. At high fibre content brittle fracture 
is avoided, and the fracture behavior more comparable with Simplex P (see Figure 3-27) is 
exhibited. 
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5.7 Discussion 
The above study has compared nine systematically varying PFCs that have 
suitable rheological characteristics for use as dual pastes in double barrelled 
syringes with automatic mixing tips.  The composites are similar to those used in 
commercial bone void filler Cortoss apart from replacement of 1) BisGMA base 
monomer with more flexible, higher curing UDMA, 2) TEGDMA with a high 
molecular weight PPGDMA diluent 3) some of the silica particles with fibres and 
4) removal of Combeite phase. Property comparisons have been made with 
commercial PMMA bone cement and Cortoss composite to assess feasibility of 
using PFCs for bone repair. 
5.7.1 Mixing and Handling 
Only qualitative assessment has been made of the handling and mixing 
characteristics of PFCs. This is useful to establish how easy and practical they 
were to use in comparison to Cortoss and Comp06 materials.  
The PFC pastes are pre-mixed and do not contain polymer filler particles and so 
there was no wait for swelling and no change in viscosity required before 
implantation as when mixing PMMA cements. The easy and rapid PFC mixing 
would save the surgeon time and facilitate a fast set. The syringe units would 
need to be supplied sterile. Application via the mixing tip end directly into the 
implant site would avoid contact with other operating theatre surfaces and 
thereby reduce bacterial contamination risk. Furthermore, with syringe delivery 
multiple applications of different volumes many minutes apart are possible. Low 
levels of material left to set within the tip would seal the barrels after use 
preserving the remaining cement in a sterile, stable and unmixed state.  The 
sealed tip can subsequently be replaced with a new sterile tip as and when 
more material is required. The use of a smaller bore mixing tip than Cortoss 
could enable more precise application. In comparison, Simplex P and Palacos 
took one minute to mix by hand and 10 minutes to set at room temperature. For 
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small volumes, one minute of mixing was sufficient to allow the PMMA cements 
to achieve ‘dough’ consistency associated with polymer swelling. 
The glass particles and fibres used in the above study are silane treated.  This 
aids filler dispersion, reduces paste viscosity and enables greater filler content 
as was seen in chapter 4. The filler used also combines a range of particle sizes 
to raise theoretical maximum packing density (134). The maximum PFC filler 
content was set a couple of per cent lower than would be used to make a stiff 
paste dental composite to enable syringe use. This was 11 wt.% higher than 
Cortoss powder content. 
5.7.2 FTIR Data 
5.7.2.1 Final Conversion and Curing Profiles 
Methacrylate peak assignment has been performed by many authors 
(71,89,120,135,136). As mentioned in chapter 3, the exact location and intensity 
of the FTIR peak is dependent on the environment that the chemical group is in.  
Difference Spectra 
Difference spectra are much less variable for different compositions. FTIR 
spectra show peaks for all components including glass filler whereas in 
difference spectra, only peaks that change significantly during curing will be 
apparent. 
Young et al. (89) found difference spectra for curing RMGIC’s containing UMDA, 
TEGDMA and HEMA. Peaks due to absorbance changes for C-O, C=O, C=C, 
and C-H of the methacrylate group were identified at similar wavenumbers to 
peaks in the difference spectra for a PFC (Table 5-3).  
Absorbance changes for C-H bend, N-H deformation and C-O-C asymmetric 
stretch were also observed in RMGIC’s (89) and in the PFCs in this study (Table 
5-3).  
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Changes in absorbance during polymerization, lead to changing peaks on the 
difference spectra. At some wavelengths this is due directly to polymerization of 
the methacrylate group. For example, as the material polymerizes, the number 
of C=C bonds decreases and there is a reduction in intensity of the C=C peak at 
1637 cm-1. At other wavenumbers, however, peak changes are indirectly 
associated to polymerization. An example of this would be changes in the 
carbonyl peaks. In the PFCs there are two peaks associated with C=O as the 
carbonyl group is part of the urethane linkage in UDMA and in the methacrylate 
groups of all the monomers. The NH groups of UDMA can hydrogen bond. It is 
reported that hydrogen bonds can interact with the carbonyl of the urethane 
linkage in UDMA and lead to changes in absorbance at 1699 cm-1 whereas the 
peak for C=O of the methacrylate group at 1720 cm-1 is unaffected by hydrogen 
bonding (71). When unpolymerized, the C=O of the methacrylate group is 
conjugated with the C=C, during polymerization this conjugation is lost and so 
the intensity and position of the 1720 cm-1 C=O peak reduces (71). 
  












1733 1711 C=O stretch 1730, 1700 **1720  
















 1300 1300 





1240, 1245 ** 






Table 5-3 relative positions of FTIR peaks changing in absorbance during polymerization of PFCs 
and composites reported in literature. **(89)  
Polymerization kinetics of dental composites with the above initiators have 
previously been studied using differential scanning calorimetry (DSC) (137). The 
conversion of Cortoss has also been studied using DSC (59). The use of 
syringes combined with ATR FTIR, however, enables chemical changes to be 
monitored at much earlier times – from immediately after mixing. The degree of 
conversion from DSC for Cortoss was found to be significantly higher than the 
value found from FTIR in this study (59). In FTIR, it has been reported that there 
is the potential for microgaps to open up (due to polymerization shrinkage) 
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between the crystal and the material (138), changing the area in contact with the 
crystal which could lead to errors in measuring conversion. PFC spectra, 
however, overlap well at wavenumbers that are unchanging in the curing 
reaction and so it is uncertain whether there were any microgaps during cure. It 
is uncertain therefore, whether debonding due to shrinkage could account for 
errors in the FTIR measurement of degree of conversion and could account for 
differences in values between these two techniques. 
The reaction mechanisms for an inhibited methacrylate free radical addition 
polymerization were given in the Introduction chapter. An equation for the rate of 
initiation can be given by the assumed initation mechanism, in which the rate 
depends on the concentrations of the initator system components and the rate 
constant of initiation. The rate of initiation is then (137) 
      Equation 5-2 
Where Ri is the rate of initiation, f is the initiator efficiency (that is how many 
collisions between radicals and monomer molecules result in successful 
polymerization) and [A] and [B] are the amine and BP concentrations in the 
monomer. Similar expressions for rate of propagation (Rp), rate of inhibition (Rz) 
and rate of termination (Rt) can be derived from the propagation, inhibition and 
termination reaction equations: 
      Equation 5-3 
      Equation 5-4 
       Equation 5-5 
Where [M] is the concentration of monomer molecules and [Mn•] is the 
concentration of monomer and polymer free radicals.  
]][[2 BAfkR di =
Rp = kp[Mn•][M ]
Rz = kz[Mn•][Z ]
Rt = 2kt[Mn•]2
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Using the stationary state approximation the rate of change of monomer and 




dt = Rt + Rz − Ri = 0      
Equation 5-6 
Substituting for Rt and Rz  
   Equation 5-7 
Early Time Inhibition 
From Inhibition reaction 
      Equation 5-8 
At early times, with strong inhibition, bimolecular termination (term A, Equation 
5-7) may be neglected. Equation 5-7 and Equation 5-8 can then be combined 
and simplified to give the rate of change of inhibitor concentration (16) 
     
Equation 5-9 
Assuming initiator concentrations are sufficiently high for Ri to remain constant, 
integration of Equation 5-9 gives  
      Equation 5-10 
[Z0] is the initial inhibitor concentration.  
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kz[Z ]        
Equation 5-11 
constructing an equation for the propagation step of polymerization (Equation 5-




dt = Rp = kp[Mn




   
Equation 5-12 
















     
Equation 5-13 
Equation 5-13 is only valid when t < [Z]/Ri. 
This predicts an inhibition period given by
 
     
Equation 5-14
 
In the above PFC formulations, amine and initiator concentrations are constant. 
Furthermore, added inhibitor levels vary only slightly with composition. The 
inihibition time is directly proportional to the t0.5 time and can be found from 
multiplying the t0.5 times by 0.35 (as explained earlier in this chapter). The 
doubling of inhibition time with raising PPGDMA content may therefore be a 
consequence of f being larger for UDMA than PPGDMA (from Equation 5-14).  
Varying oxygen solubility / reaction inhibition in the different monomers, 
however, may also play a role.  The increased inhibition time with the highest 
powder content may be due to greater oxygen incorporation due to filler not 
being completely “wet” by the monomer. Alternatively, the glass surface may 
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of all these factors, although because exact initiator concentrations are not 
known, it is difficult to comment further than this. 
Simplex P contains double the concentrations of BP and DMPT and less 
inhibitor.  Greater inhibition time for Simplex P may therefore be a consequence 
of f being smaller.  Additionally, early reaction may be prevented and ti 
enhanced because BP must dissolve / diffuse, from the surface of the filler 
phase, into the monomer phase before any reaction can occur. 
Early Monomer Conversion Rate 
The steady state assumption also implies that Ri = Rt and so 
      Equation 5-15 
hence it is possible to express the concentration of monomer and polymer 
radicals in terms of Ri and kt 
       Equation 5-16 
Once most of the inhibitor has been consumed, substituting from Equation 5-16 
gives the rate of change of monomer concentration [M] (from Equation 5-3) as 
   
Equation 5-17 
Comparing Equation 5-14 and Equation 2-17 indicates that increasing Ri will 
decrease the inhibition time and increase monomer reaction rate, but to a lesser 
extent.  Decreasing the concentration of a weak inhibitor, or retarder, could 
similarly affect both properties.  A strong inhibitor, however, should only affect 
the inhibition time as it will be used up during the inhibition period.  
Immediately subsequent to the inhibition period the polymer concentration, [P], 
will be negligible.  Furthermore, the total number of polymer molecules formed is 
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much smaller than initial monomer molecules.  Moreover, larger polymer 
molecules are slower diffusing. The propagation step should therefore dominate 
over crosslinking until most of the monomer has formed into linear chains with 
pendant unreacted methacrylate groups.  From Equation 5-1 the experimental 





t0.5       
Equation 5-18
  
f is the average number of methacrylate groups per monomer and C final 
conversion.   
C and t0.5 increase on average by factors of 1.3 and 1.9 on raising PPGDMA in 
the PFC. From Equation 5-18, rate of monomer reaction therefore decreases by 
a factor of 1.5.  This would be expected from Equation 5-17 if Ri doubles on 
reducing PPGDMA as the inhibition times suggested.  This would indicate kp, kt 
and [M] may be comparable for UDMA and PPGDMA.  This is reasonable given 
their chemical and size similarities.  Raising powder content may decrease 
intermediate reaction rate because oxygen continues to inhibit the reaction after 
other inhibitors have been consumed. Equation 5-17 also predicts conversion 
rate should decline with monomer consumption.  This effect may, however, be 
counteracted by continuing consumption of inhibitors or the “gel effect” 
(otherwise known as autoacceleration in which reaction rate increases sharply 
due to large molecular size limiting diffusion and therefore termination as 
described in the introduction, Chapter 1) (139). More viscous monomers such as 
BisGMA have a more pronounced autoacceleration phase (due to the gel effect) 
and this is why the reaction rate is steeper for Cortoss than the PFCs. 
The higher concentrations of initiators and low inhibitor levels in Simplex P 
would enable rapid reaction once the BP has dissolved. Fast reaction, however, 
may lower mechanical properties due to reduction in polymer molecular weight.  
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Furthermore, it may cause greater temperature rise due to reduced time for heat 
dissipation. 
Crosslinking and Final Conversion 
After 50 % conversion, the reaction rates for PFC with low PPGDMA began to 
decline (Figure 5-3).  For PFC with high PPGDMA, reaction rate remained high 
until a reaction extent of 0.7.  Most free monomer is likely to have been 
consumed at approaching 50% conversion and further methacrylate conversion 
is subsequently due to crosslinking.  Vitrification may explain the sharper decline 
in reaction rate, after a reaction extent of 0.5, of Cortoss than the PFCs 
(comparing Figure 3-24 with Figure 5-3). As monomers are consumed Tg 
increases (74).  Polymerization generally ceases when material Tg is 20 to  
40 oC above surrounding temperature (140). Although Morgan suggests that 
polymerization ceases when material Tg is equal to temperature of system 
because of vitrification (91) Polymers with lower Tg will therefore have higher 
maximum possible degree of conversion at a given temperature of reaction (91). 
Polymers of UDMA and TEGDMA have Tg of 68 oC and 65 oC respectively 
whilst BisGMA has a Tg of 130-140 ºC (141). The maximum conversion of 
UDMA / TEG DMA composites and Cortoss is, therefore, around 70% as 
polymerization is limited by Tg of polymer system and polymerization 
temperature (74). The greater chain flexibility and lower Tg of PPGDMA  
(~ -22 oC), however, enables increased conversion (132). PMMA has a higher 
Tg (107 oC) (132) preventing conversion reaching 100% at 25oC.  
Crosslinking and / or increase in polymer molecular weight also increases Tg 
(74) but to a lesser extent than initial polymerization.  When conversion begins 
to slow, the PFCs are likely close to a glass state.  They may then continue to 
crosslink for some time with only minor further increase in Tg. If Tg does not 
increase significantly then polymerization may continue for a longer time. At this 
time both crosslinking and termination steps are likely to be slow and diffusion 
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controlled and so rate of polymerization in this phase is slow. The PMMA 
conversion ceases more abruptly than observed with the PFC. This would be 
consistent with Simplex P having no crosslinking capability.  
Incomplete conversion leaves a percentage of toxic free monomer, which might 
also reduce mechanical properties as discussed in chapter 3.  In the body, 
however, use of larger volumes of cement will lead to high temperature rises 
increasing the surrounding temperature of the cement.  Although this may cause 
tissue necrosis it will enable greater conversion.    
All the PFCs had lower calculated shrinkage than Simplex P and Palacos 
PMMA. As discussed in the materials and methods chapter (chapter 2); 
polymerization shrinkage and heat generation are proportional to the monomer 
volume fraction and average molecular weight per methacrylate group.  PFCs 
with 80 and 60 wt.% glass filler contain 42 and 66 vol.% monomer respectively, 
whilst Cortoss contains 41 vol.% filler.   Simplex P monomer fraction is 38 vol.%.  
Cortoss calculated shrinkage is comparable to PFC 7 and 8, yet achieves this 
with lower conversion carrying more risk of leaching monomers post cure. 
Dental composites typically have volumetric shrinkage of around 2% (62) which 
is comparable with the values calculated above for the high filler content PFCs.  
This is possible because the high molecular weight of the new formulation 
diluent compensates for the greater conversion with UDMA than BisGMA. 
5.7.3 Biaxial Testing 
5.7.3.1 Strength and Modulus 
In flexural strength studies the sample is under compression in the top surface 
and tension in the lower surface.  The latter generally has the most influence on 
flexural strength. With crystalline materials, maximum theoretical tensile strength 
is proportional to modulus but this is reduced by flaws that initiate crack 
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propagation (139). Crosslinking prevents crack propagation.  In composite 
materials the interface between phases is often the point of greatest weakness / 
cause of failure. In PMMA cements, including non-organic fillers, polymer/filler 
interface is a weakness as filler particles can act as crack initiation sites (5). 
Composite strength is raised through improved filler dispersion/impregnation 
(wetting).  This reduces voids, which may act as crack initiation sites at particle 
surfaces.  Moreover, it could enhance physical micromechanical interlocking 
between the particles and matrix.  Chemical bonds between filler and matrix can 
further increase mechanical properties by enabling better stress transfer 
between phases (62,80,81). In PFCs and Cortoss, silane treatment increases 
filler hydrophobicity and thereby monomer wetting. The silane methacrylate 
group also enables chemical bonding between the monomer and filler during 
polymerization (84). PMMA bead dissolution prior to cure may have the same 
effect. 
With high levels of PPGDMA, increasing filler content raised strength.  In this 
case the monomer is very fluid which may enable good particle wetting.  After 
cure, load may then be more effectively transferred to stronger filler particles. 
With low PPGDMA, strength declined with raising powder content. This may be 
due to the polymer phase being stronger than the glass.  Alternatively, the more 
viscous monomer may less effectively wet the filler particles.  Particle 
agglomerates may then form particularly at high powder content.  Agglomerates 
reduce strength by introducing flaws (81). They may also trap oxygen locally 
reducing chemical and physical bonding between the filler and organic phase 
(142).  
Modulus 
Increasing the powder content results in an increase in modulus of PFCs, 
independent of the level of PPGDMA.  
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It is clear that modulus of the PFC materials depends on the stiffnesses of the 
constituent phases as the measured values lie within the envelope of the Voight-
Reuss models. Increasing the powder content results in an increase in modulus 
of all PFCs, due to higher volume of high modulus filler. There is good 
agreement between the measured PFC stiffness values and those predicted by 
the Hashin-Strikman lower bound. The deformation and hence the stiffness of 
the polymer can be thought of as being totally governed by the more compliant 
PPGDMA phase, implying that the structure of the polymer phase corresponds 
to the ‘springs in parallel’ iso-strain composite model; The flexible propylene 
backbone of the PPGDMA creates regions of the polymer that attract a large 
proportion of the overall deformation. The stiffness of the polymer is governed 
by how much the polymer chains can deform in between crosslinks. The 
crosslinking increases the amount of recoverable strain. 
When PPGDMA is high and filler is low, good stress transfer between filler and 
polymer ensures increasing volume of the higher modulus phase increases the 
composite modulus. When the PPGDMA is low and the filler is low, the filler is 
still fully wetted, and this same dependency of the stiffness on the respective 
phase stiffnesses and volume fractions applies. 
The low Tg of PPGDMA gives a more flexible, lower stiffness, 
polymer/composite material than PFCs with high UDMA content. Likewise 
BisGMA/BisEMA/TEGDMA polymer in Cortoss is stiffer than that found in PFCs 
with high PPGDMA content and so the modulus of Cortoss is similar to PFC 3 
and 4.  
In this study modulus and strength of PFCs are linked; the higher the strength of 
formulations PFC 1 - 4 corresponds to a higher modulus. With PFCs 5 - 8 both 
the strength and the modulus are reduced. As mentioned above, the 
deformation of the PFCs and hence the modulus is governed by the deformation 
of the polymer. When the polymer phase contains high levels of PPGDMA, the 
Kirsty Main  PhD Thesis 
 180 
polymer will attract large deformations. Incorporation of any particulate 
reinforcement will result in a small number of voids and imperfections although 
the silane treatment may provide a strong interfacial bond, it will never be 
perfect. These large polymer deformations will result in cracking, initiated at 
these imperfections at the filler/matrix interface, at lower loads than for a higher 
modulus material with lower deflections. The crosslinking does, however, 
prevent polymer chain disentanglement and so it is likely that the failure of the 
PFC materials will be due to cracking at the polymer/filler interface.  
Crosslinking (due to bi-functional monomers) in the PFC materials increase their 
extension at failure.  
For traditional engineering materials, e.g. titanium, strength is usually of the 
order of 2% of Young’s modulus (143). Composite bone cements, such as 
Cortoss and Comp06 have strength of around 4 – 5 % of the modulus. For 
Simplex P and Palacos cements this value is higher, strength is around 8 – 9 % 
of stiffness. For PFCs with high PPGDMA, the extension at failure is larger still 
and the strength can reach up to 12 % of the stiffness. Reducing the modulus 
relative to the strength is particularly important in applications such as 
vertebroplasty and screw augmentation when stabilizing osteoporotic hip 
fractures. More flexible cement materials may prevent damage to adjacent 
vertebrae, as over stiffening of cement treated vertebrae can be a major cause 
of adjacent vertebral fracture (144–146). Treatment with Simplex P cement has 
been shown to lower the stiffness of the vertebral body obviating a stress-riser 
effect in adjacent vertebrae and so a similar stiffness to PMMA cement would 
seem desirable (19). Additionally cement augmentation could make screw 
fixation of hip fractures more suitable for osteoporotic bone. The flexible cement 
material could prevent screw pull out and damage to surrounding weak bone by 
enhancing the stress transfer between bone and screw. For screw-free hip 
fracture fixation, however, a stiffer material would be more suitable. PFCs in this 
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study have moduli that more closely match that of trabecular bone (< 3 GPa, 
(143)) compared to Cortoss. 
Effect of Fibre Reinforcement on BFS and Young’s Modulus 
As discussed in the introduction (chapter 1) the effects of fibre incorporation 
reported in literature are varied but most authors explain the importance of 
having a good interfacial bond between fibres and polymer matrix for the 
reinforcement to enhance the mechanical properties. Examining the effect of 
fibre reinforcement in this study it is clear that the fibres did not affect either the 
strength or stiffness of the PFCs. It is possible for fibre incorporation to have no 
effect if the negative effect (increased crack initiation) is balanced out by the 
reinforcing effects (strong interfacial bond with chosen monomer system, length 
sufficient for fibre bridging, and decreased crack propagation). 
5.7.3.2 Fracture Behaviour 
Brittle fracture of the PFC with low fibre content was typical of that observed with 
conventional dental composites and Cortoss (99).  With high fibre content 
cracks that opened in the material at first failure were bridged (see Figure 5-9). 
The load was carried, with increasing deflection up until the fibres failed. The 
behavior seen with Simplex was comparable with PFCs with high fibre content. 
  
Kirsty Main  PhD Thesis 
 182 
5.8 Conclusions 
PPGDMA can be used as a diluent to produce dual paste PFC bone cement 
with rheological characteristics suitable for use in a commercial double barrelled 
syringe with a smaller bore mixing tip than Cortoss.  PFC reaction rate 
decreased with raising PPGDMA level and was inversely proportional to the 
inhibition time. Use of the syringe gave a short mixing time enabling use of 
pastes with a short inhibition time and fast subsequent cure.  Potentially 
problematic BisGMA and TEG DMA can be replaced by UDMA and PPGDMA 
monomers resulting in lower shrinkage and better conversion which could mean 
PFCs exhibit better biocompatibility than Cortoss. 
The Lower the PLR and fibre content, the less viscous the material but this had 
to be balanced with the effects of reducing strength and heat generation and 
shrinkage associated with a higher proportion of monomer. All formulations were 
compatible with delivery via a syringe and mixing tip. 
Increasing PPGDMA reduced modulus but also strength. Furthermore, 
formulations with low PPGDMA had strength and modulus comparable to 
Simplex P PMMA but much faster cure, lower calculated shrinkage / heat 
generation and potentially lower residual monomer.   PFCs could therefore be a 
PMMA alternative.   The strengths of PFCs were similar to Cortoss but those 
with high levels of PPGDMA had lower modulus, which better matches that of 
bone.  Finally high fibre content PFC had fracture profiles similar to Simplex P, 
whilst low fibre content formulations exhibited brittle fracture similar to Cortoss. 
Incorporation of fibres could overcome the problem of brittle fracture of Cortoss. 
Based on the results of this chapter, a formulation with intermediate values of 
PPGDMA and PLR, with a high level of fibres was made as a prototype product. 
The curing and mechanical properties of this prototype product, along with  
further in-vivo investigations, are presented in the next chapter.
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6 Prototype PFC In-vitro Characterization and In-vivo 
Implantation 
6.1 Abstract 
The aim of this chapter was to characterize the in-vitro and in-vivo performance of a 
single PFC formulation to evaluate its viability as an alternative to existing bone cement 
materials. 
The levels of PPGDMA, powder (P) and fibre (F) were set in an attempt to produce a 
PFC material with optimal properties compared to those measured in chapter 5. The 
curing and mechanical properties of this optimized formulation (referred to as Prototype 
formulation) were obtained as described in chapter 2. The biaxial flexural strength and 
the elastic modulus of the material were comparable to current bone repair materials. 
Particularly considering the long term BFS, the PFC material performed better than 
Cortoss and fracture behaviour of this formulation was non-brittle unlike Cortoss. The 
levels of PPGDMA and PLR have been balanced to obtain these mechanical 
properties whilst enabling good conversion and favourable cure kinetics. From these 
results the PFC prototype was shown to be an improvement in several areas compared 
to existing bone repair materials. 
The Prototype formulation and a high viscosity PMMA cement were implanted in lapine 
models and the in-vivo responses were investigated and compared. The sterile 
manufacture and implantation procedures are as per chapter 2. The implant sites were 
examined after one week and four weeks in-vivo.  
Micro CT analysis showed that the injectable PPGDMA cement was more radiopaque 
than the PMMA cement. Bleeding at the implant site was thought to prevent 
interdigitation of both types of cement into the surrounding bone.  
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Preliminary investigation suggested that the in-vivo response of the prototype PFC was 
excellent; histological examination showed no instances of infection or inflammation 
due to the implanted material. Some PMMA implantation sites showed infection and 
inflammatory response. From this, the PFC prototype was shown to be a viable 
alternative to PMMA cements in-vivo. 
6.2 Introduction 
In chapter 5 systematic investigation of PFC materials was carried out to ascertain the 
effect of varying the levels of PPGDMA, glass filler G4S and glass fibre FGS on the 
properties of so called PFC composites. It was thought that intermediate values of 
these components could produce a PFC that was a viable alternative to PMMA and 
composite bone cements.  
For PFC materials to be regarded as viable they must have favourable handling, curing 
and mechanical properties and an improved biological tissue response when implanted 
compared to existing materials.  
The handling, curing and mechanical assessment that has been used throughout this 
project was deemed to be an acceptable way of measuring in-vitro performance, and, 
as mentioned in the materials and methods (chapter 2) a lapine model is thought to be 
an excellent way to assess in-vivo performance. 
6.3 Aims and Objectives 
The aim of this chapter was to characterize the in-vitro and in-vivo performance of a 
single PFC formulation to evaluate its viability as an alternative to Cortoss composite 
bone void filler and Palacos R PMMA bone cement for osteoporotic vertebroplasty and 
fracture fixation applications.  
The levels of PPGDMA, powder (P) and fibre (F) were set in an attempt to produce a 
PFC material with optimised properties compared to those measured in chapter 5. The 
PFC formulation (‘prototype’) contained intermediate levels of monomer, filler and fibre 
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compared to the formulations investigated in chapter 5. That is, the levels of the 
components for the ‘prototype’ formulation were chosen to try and produce a material 
with an acceptable strength/stiffness compared to exisiting bone cement materials 
whilst having comparable or lower shrinkage and heat generation and higher 
conversion. The prototype composition was set with 0.5 wt.% BP and 0.5 wt.% DMPT. 
The cure was controlled with 70 ppm BHT (as in previous chapters, initiator quantities 
given as weight percentages of monomer phase). 
The objectives of the in-vitro testing were to determine the following for the prototype 
PFC: 
1. The handling and mixing. Evaluated by eye. 
2. The shape of the curing profile (FTIR) 
3. The cure times and degree of conversion (FTIR) 
4. Polymerization shrinkage (calculated from FTIR and composition) 
5. Biaxial flexural strength and Young’s modulus  (Biaxial testing) 
6. Fracture behaviour (Biaxial testing). 
Quantitative assessments of parameters 2-4, and qualitative analysis of parameters 1 
and 5, were used to compare the prototype PFC to the PMMA cements, composite 
bone cements and the dental composite characterized in chapter 3. 
The objectives of the preliminary in-vivo implantation experiment were as follows: 
1. Confirm material could be sterilized and injected and set in vivo  
2. Assess the suitability of the material viscosity 
3. Assess the ability of the material to wet and bond bone in presence of blood 
4. Compare the radiopacity of PFC to trabecular and cortical bone 
5. Ensure no toxic reaction by examining organs after extraction 
6. Assess bone integration via microCT and histology 
Kirsty Main  PhD Thesis 
 186 
7. Qualitative assessment of bone formation via appearance of bone and cellular 
presence in histological sections. 
The in-vivo response of the prototype PFC formulation was compared to Palacos R 
PMMA cement. 
6.4 Hypotheses 
It was thought that choosing intermediate values of monomer, filler and fibre, based on 
the results of chapter 5, would produce a formulation with curing and mechanical 
properties that were comparable or better than existing bone cements. 
Nearly equal quantities of PPGDMA and UDMA (with a small amount of HEMA) 
combined with a high level of silanated filler were envisaged to produce a material with 
handling properties that enabled easy delivery and precise application via a double 
barrelled syringe and mixing tip.  
The monomer and initiator levels were chosen to enable a rapid, reliable and complete 
cure compared to existing bone repair materials. 
The inclusion of a high level of the diluent PPGDMA was intended to reduce the 
modulus of the PFC material to better match the stiffness of trabecular bone whilst 
maintaining strength values comparable with Cortoss, Comp06 and PMMA cements. 
The handling, cure, chemical composition and mechanical properties of the prototype 
were intended to allow host tissue to maintain normal metabolic function and have a 
close interface when implanted in-vivo, without any inflammatory response or fibrous 
encapsulation. 
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6.5 Materials and Methods 
Materials 
In the prototype PFC the monomer phase contained 50 wt.% PPGDMA, 45 wt.% 
UDMA, 5 wt.% HEMA. The filler phase consisted of 75 wt.% G4S glass and 25 wt.% FGS 
glass fibres. The composite was 80 wt.% filler; 4:1 PLR. Please see Materials and 
methods (chapter 2), for details of material sources. 
Methods 
The PFC paste was manufactured as per the protocol in chapter 2. The handling of the 
material was assessed by eye. The cure profile, cure times (normalized inhibition time 
and t0.5) and degree of conversion were determined via FTIR analysis. Mechanical 
properties including fracture behaviour, biaxial flexural strength and Young’s modulus 
were found through biaxial testing of disc specimens.  
The PFC material components were sterilized and mixed in a sterile environment prior 
to in-vivo implantation. The PFC and Palacos R implants were removed, when the 
animals were killed, after one and four weeks and the sites examined by microCT. 
Histological sections were made and stained with either Goldner’s trichrome or 
Toluidine blue stains. 
For full details of methods please refer to Materials and methods (chapter 2). 
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6.6 Results 
6.6.1 Prototype Formulation Characterization 
Table 6-1 shows a summary of the properties of the prototype formulation including 
Conversion, t0.5, Shrinkage, BFS and Stiffness compared to the commercial materials 
tested in chapter 3 and PFC 9 from chapter 5. Figure 6-1 shows the normalized cure 
profile for the prototype PFC. With PMMA cements, the inhibition period (Table 6-1) 
was longer but subsequent polymerization reaction sharper than the prototype 
formulation. Furthermore, there was no ‘swelling period’ with the prototype PFC 
materials due to the insoluble silica filler (small changes seen in FTIR spectra of 
Simplex P in the first few minutes were attributed to swelling where dissolution of 
polymer into the monomer phase reduced the double bond density in the solution prior 
to the onset of polymerization).  
The Prototype PFC normalized cure profile is shown in Figure 6-1 superimposed on 
those of composite bone cements, PMMA cements, Z250 dental composite and PFC9. 
The prototype PFC profile has the same shape as the other PFC’s, and, at later times it 
is most similar to PFC 9. The inhibition time of the prototype PFC is shorter than for the 
all the commercial bone cements aside from Cortoss. The normalized inhibition time (ti) 
for the prototype is less than for Cortoss.  
The BFS of the Prototype formulation was of the same order of magnitude as all the 
commercial PMMA and composite bone cements and similar to PFC9. The stiffness 
was between that of the commercial PMMA and composite cements and higher than 
PFC9 due to increased filler content. The biaxial specimen fracture surfaces can be 
seen in Figure 6-4. The rough texture is indicative of a good interfacial bond between 
the particulate and the polymer (147). The filler fibres are protruding – this shows that 
the fibres are ‘pulling out’. 
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The BFS of Cortoss decreased by 39 % after four weeks, and 58 % after 20 weeks, 
whilst the stiffness decreased by 27 % and 43 % respectively (Figure 6-2). The 
prototype formulation exhibited first a BFS decrease of 18 % after four weeks, but the 
strength after 20 weeks was found to be unchanged from the original value. The 
stiffness of the Prototype formulation was unchanged after four weeks, but increased 
by 13 % after 20 weeks.  
Load versus deflection of the Prototype formulation (Figure 6-3), however, was similar 
to the PMMA cements. It did not exhibit brittle fracture behaviour unlike Z250, Cortoss 
or Comp06.  The non-brittle fracture behaviour was maintained after both four and 20 












76 ± 1 276 ± 29 406 ± 28 6.2 ± 0.1 131 ± 12 1.6 ± 0.1 
Palacos 
R 
86 ± 2 170 ± 16 281 ± 19 6.9 ± 0.2 152 ± 18 1.6 ± 0.1 
Cortoss 64 ± 4 130 ± 29 232 ± 21 3.8 ± 0.1 120 ± 9 3.4 ± 0.1 
Comp06 64 ± 0 171 ± 17 416 ± 15 3.7 ± 0.1 146 ± 12 3.1 ± 0.2 
Z250 49 ± 1 light cure 1.8 ± 0.1 224 ± 18 4.5 ± 0.4 
PFC 9 82 ± 4 52 ± 5 163 ± 5 4.0 ± 0.2 87 ± 7 2 ± 0.1 
Prototype 
PFC 
80 ± 1 64 ± 5 207 ± 4 3.2 ± 0.0 93 ± 3 2.2 ± 0.1 
Table 6-1 Summary of properties of prototype formulation, containing 50%PPGDMA, 45% UDMA, 5% 
HEMA; 80% Filler (3:1 Particle: Fibre), compared to commercial materials and PFC 9. Errors are 95% CI, 
n=4 for conversion, cure times and shrinkage. n=8 for BFS and Modulus. 
Kirsty Main  PhD Thesis 
 190 
 
Figure 6-1 Normalized cure profile of prototype formulation (50%PPGDMA, 45% UDMA, 5% HEMA; 80%P 
(3:1 Particles: Fibres) marked in red. This largely overlaps other PFC's. 
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Figure 6-2 Effects of hydration period on biaxial flexural strength and elastic modulus. Cortoss showed a 
significant decline in BFS after 4 weeks storage in water at 37 °C. The elastic modulus of Cortoss also 
dropped after 4 weeks and 20 weeks hydration. The BFS of the prototype product is shown to decrease 
after 4 weeks hydration. BFS of PFC after 20 weeks, however, is not significantly different to its 24-hour 
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Figure 6-3 Load vs. Deflection plot for Prototype formulation. 3:1 ratio of particles to fibres in filler phase 
prevents brittle fracture through fibre bridging as with high fibre content PFC's. 
 
Figure 6-4 Prototype PFC biaxial specimen fracture surface. Reinforcing fibre fillers can be seen 
protruding from the surface where the interfacial bond has failed and the fibre has 'pulled out' 
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6.6.2 In-vivo Implantation of Prototype PFC 
6.6.2.1 Surgical Procedure and Outcomes 
The PFC cement had a markedly lower viscosity than Palacos, with the former being a 
flowable paste and the latter being a putty-like dough. Bleeding occurred at the implant 
site.  This could displace the liquid PFC before cure. The PFC, however, did not mix 
with the blood. The PMMA was not displaced by bleeding during implantation as the 
dough could be packed into the implant defect. 
The PFC cement was pre-mixed meaning that there should be no alteration of 
monomer/powder ratio due to clinician mixing. The PMMA was not pre-mixed and so 
there was scope for accidental change in monomer/powder ratio although to the best 
knowledge of the experimenters no such alteration occurred. 
The PFC was probed 45 s after injection into the site and was found to be hard. PMMA 
was found to be set, by probing, 90 s after application (packing into defect).  
Explant notes can be found in Table 6-2 Inspection of the one-week specimens after 
removal revealed no infections for either material, although one of the PFC defect sites 
was empty and the material found encapsulated in surrounding soft tissue. There were 
three infections observed for the four-week PMMA filled defects. One of the four-week 
PFC sites was again found empty with the material encapsulated in surrounding soft 
tissue.  
  




















669 L V 























Material totally encapsulated out of wound. No inflammation 
661R N 
Table 6-2 extraction notes for implanted materials after one and four weeks.  
N: material not visible in defect. V: Material visible in defect. 
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6.6.2.2 Micro CT  
The Micro CT images of the PFC implants after one-week show empty defects in two 
out of four implant sites (Figure 6-5). This was as expected from the visual inspection 
during extraction. The microCT images of 669L and 670L in the transverse plane show 
that the PFC material does not fill the defect well, the outline of the defect is visible with 
a gap between it and the implanted material. Despite incomplete filling of the defect, 
good contact can be seen at some points. 
The micro CT images of the Palacos implants after one week showed that there were 
three empty defects out of the four implant sites Figure 6-6. The microCT image of 
implant site 665R shows the top edge of the implant having close contact with the host 
bone. 
 
Figure 6-5 PPGDMA Micro CT images after one week in vivo. Material visible in 669L and 670L. Defect 
visible in 668R and 671R. Defect sites marked with red circles. Images marked with T and S are in the 
transverse and sagittal planes respectively. 
PFC:%1%week%
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Figure 6-6 Palacos Micro CT images after one-week in-vivo. Material visible only in 665R. Defect visible in 
all other specimens. Defect sites marked with red circles. Images marked with T, S and C are in the 
transverse, sagittal and coronal planes respectively. 
Micro CT images of the implants after four weeks in-vivo showed three empty defects 
where PFC was implanted (Figure 6-7) and one empty defect where PMMA was 
implanted (Figure 6-8) 
One of the four week PFC implants, 658R, has voids within the material. Two of the 
voids measure less than 1 mm. The large void at the bottom of the implant site 
measures around 3 mm. Aside from around the large void, the material appears to be 
in close contact with the host bone.  
The PMMA implanted into sites 655R and 657R is well packed into these defects with 
good contact at the interfaces seen in the microCT images. The PMMA material is not 
fully packed into the 656R site, the outline of the defect can be seen above and to the 
right of the plug of PMMA material with a gap in between. There is also excess material 
visible outside of this defect.  
Palacos:(1(week(






Kirsty Main  PhD Thesis 
 197 
 
Figure 6-7 PPGDMA Micro CT images after four weeks in-vivo. Material only visible in 658R defect visible 
in 659R and 661R. Defect sites marked with red circles. Neither material nor defect visible in 660L. Images 
marked with T and S are in the transverse and sagittal planes respectively. 
 
Figure 6-8 Palacos Micro CT images after four weeks in-vivo. No explant image available for 657R or 
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Whether or not there is fibrous encapsulation of the implants cannot be seen on the 
micro CT images. 
The PFC cement was more radiopaque than the PMMA (for example site 658R, Figure 
6-7, versus 655R, Figure 6-8). The PMMA cement had a radiopacity more similar to 
cortical bone. 
6.6.2.3 Histology 
Histological evaluation of the heart, lung, kidney, liver and spleen samples showed 
normal healthy organs for all animals, despite the recorded infections and displaced 
materials. 
All images of histological sections are in the transverse plane. Sections were stained 
with Toluidine blue or Goldner’s trichrome stains. When stained with toluidine blue, and 
viewed with polarized light, lamellae that are orientated in one direction, appear blue, 
whereas those at 90° to this appear yellow. Mature bone is highly organized with 
parallel aligned collagen bundles, whereas immature bone has more randomly 
orientated collagen bundles. When sections are viewed under polarized light, with this 
stain, the degree of organization of the tissue can be a sign as to whether the bone is 
mature or immature. Cartilaginous fibrous tissue is shown as wavy pink regions with 
toluidine stain. When using Goldner’s trichrome stain, mineralized / mature and 
unmineralized / immature bone are coloured as green and red/gold respectively. 
Cartilage and fibrous tissue shows as purple. 
PFC After One Week In-vivo 
Figure 6-9 andFigure 6-10 show sections of two of the implant sites treated with PFC 
after 1 week. Figure 6-9 shows a section of implant site 670L stained with toluidine 
blue viewed with polarized light. The blue and yellow regions indicate normal bone 
remodelling behaviour. There are no giant cells (multinucleated macrophages) and no 
other indications of an inflammatory response or thermal necrosis. There is no 
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evidence of new bone growth near to the implant. The gap between the implanted 
material and the bone tissue is due to slide processing due to the shape and 
appearance of the gap.  It is thought, therefore, that whilst in-vivo the bone was in good 
contact with the implant at this point.  
Figure 6-10 is a section of implant site 668R stained with Toluidine Blue. MicroCT 
investigation of this site showed that the defect site was empty; the histological section, 
however, shows that there are fingers of bone within the defect region. It is clear that 
the morphology of the bone is different on the left of the defect (denser with smaller 
holes (osteocyte lacunae) which are further apart, compared with new bone (depicted 
by arrows) where there is much less of a lamellar (layered) pattern and the lacunae are 
large and closer together.  
 
Figure 6-9 670L PFC after one week with toluidine blue stain. Very thick section makes it difficult to see 
cellular detail in bone tissue however, a combination of blue and yellow bone surrounding the implant is 
evidence of normal metabolic remodelling activity. Slide processing caused gap between bone and 
material – but evidence of good apposition between material and bone prior to this. No inflammatory 
response. 
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Figure 6-10 668R PFC after one-week in-vivo. Section showing empty defect site and surrounding tissue – 
material dislodged in-vivo. Blue/Yellow coloured ‘fingers’ (two such fingers shown by arrows). 
Palacos After One Week In-vivo 
Figure 6-11 and Figure 6-12 show sections of Palacos implant sites after one-week in-
vivo. In Figure 6-11 there is no evidence of material or tissue in the defect site.  This is 
in agreement with the MicroCT image for this site. In both Figure 6-11 and Figure 6-12 
the surrounding bone tissue cell distribution and tissue colouring is indicative of normal 
bone remodelling in healthy tissue and there is no evidence of inflammatory response 
or thermal necrosis.  
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Figure 6-11 666R Palacos one-week in-vivo with toluidine stain. Section showing empty defect site and 
surrounding bone tissue. No tissue visible inside defect. Bone colouring and cell density around defect 
indicate no inflammatory response. 
 
Figure 6-12 665R Palacos after one-week in-vivo with toluidine blue stain.  The slide is too thick to see 
cellular detail in bone tissue but interface between bone and PMMA shows good apposition, with 
blue/yellow bone tissue indicative of normal bone metabolic behaviour. 
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PFC After Four Weeks In-vivo 
The histological images for PFC implants after four weeks in-vivo Figure 6-13 to Figure 
6-16 show close contact between the implant material and the surrounding normal 
viable bone.  There appears to be new bone growth up to the implant in Figure 6-17 
indicated by a higher density of lacunae and less organized tissue structure. There is 
no evidence of any inflammatory response and the colouring and texture of bone 
further from the implants is indicative of normal remodelling behaviour and shows no 
thermal damage.  
 
Figure 6-13 658R PFC after four weeks. Goldner’s Trichrome stain. See Figures 6-13, 6-14 and 6-15 for 
details of regions of interest in boxes 1, 2 and 3. 
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Figure 6-14 658R box 1: Good contact between host bone and material: Arrow 1: presence of blue 
coloured lamellar bone close to material. Arrow 2: Dots are lacunae containing osteocytes. Arrow 3: 
bubble in resin. 
 
Figure 6-15 658R box 2: Air bubble in material. Can clearly see fibres in material too – aspect ratio well 
defined 
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Figure 6-16 658R box 3: Gap here thought to be due to slide processing as other regions show good 
contact between lamellar bone and composite. Arrow depicts region of blue and yellow indicative of normal 
viable bone. 
 
Figure 6-17 658R PFC after four weeks. Toluidine Blue stain. Interface between material and bone is 
yellow in colour indicating deposition of new woven bone next to implant. Density of lacunae in blue and 
yellow ‘old bone’ further away from material indicative of normal bone metabolic activity. No inflammatory 
response. Fibres ‘in’ bone (depicted by arrows). 
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Palacos After Four Weeks In-vivo 
The histological sections for PMMA implanted for four weeks (Figure 6-18 to Figure 
6-21) also show good apposition of surrounding tissue to the material surface. 
However there is no evidence of new bone formation unlike the PFC sections. Similar 
to the PFC implant sections, there is no cellular inflammatory response and no giant 
cells are present around the implants and again there is no evidence of thermal 
necrosis. 
 
Figure 6-18 656R Palacos after four weeks with Toluidine blue stain. Good bone apposition next to 
material, no inflammatory response. 
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Figure 6-19 656R Box 1 intimate contact between Palacos material and Bone. Blue and yellow bone 
regions indicative of normal bone metabolic activity. Normal osteocyte abundance with no evidence of 
inflammatory response. 
 
Figure 6-20 656R Box 2 PMMA cement with adjacent cartilaginous tissue of growth plate. Once again, 
issue shows no signs of inflammatory response to PMMA cement. 
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Figure 6-21 656R deeper section, Palacos after 4 weeks with toluidine blue stain; As with Figure 6-18, 
shows good apposition between bone and Palacos material with no inflammatory response. No new bone 
formation, but blue/yellow pattern and osteocyte distribution indicative of normal bone metabolic activity. 
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6.7 Discussion 
6.7.1 Prototype Formulation Characterization 
The conversion of the prototype Formulation is not significantly different to PFC 9 as 
the levels of the three monomers are very similar; in the prototype PFC, compared to 
PFC9, 1.5 wt.% of UDMA and 2 wt.% of HEMA are replaced by PPGDMA, the filler 
level is increased by 5% and the proportion of fibres is increased. Palacos conversion 
is slightly higher, whilst that of Simplex P, Z250, Cortoss and Comp06 (Table 6-1) is 
significantly lower than the PFC. 
The time to 50% reaction for the prototype formulation is significantly shorter than 
those times measured for all the commercial materials, excluding the light cured Z250 
(Table 6-1). 
The calculated shrinkage for the prototype formulation (Table 6-1) was lower than for 
PFC9 and the commercial composite bone cements due to the high filler content. 
The conversion and time to cure have profound implications on the amount of residual 
monomer that the patient is exposed to both during the implantation procedure before 
cure and afterwards. The benefits of a high level of conversion have been discussed 
previously (chapter 3 chapter 5) and so it is very encouraging that this prototype 
exhibits such favourable curing characteristics, compared to PMMA cements, Cortoss 
and Comp06 (Chapter 3), when considering it for bone repair applications. 
The shrinkage of the material during cure can affect the interdigitation of the cement 
into the surrounding host bone as discussed in the introduction (chapter 1) and chapter 
3. The prototype PFC combines the effects of high molecular weight monomers, with 
high conversion, and high filler content leading to a lower calculated shrinkage than 
that calculated for PMMA and Cortoss (chapter 3) and lower than PMMA shrinkage 
values from literature. Indeed the prototype formulation shrinkage is approaching the 
value quoted for dental composites. The low shrinkage value calculated for the 
Kirsty Main  PhD Thesis 
 209 
prototype PFC compared to the other commercial materials, combined with fluid 
rheological properties, suggests that the PFC could create a mechanically sound 
interface with host bone. An excellent interface is necessary for the longevity of the 
implant. 
The benefits of a shorter induction time, prior to the onset of cure, and time taken for 
the material to cure were discussed with an orthopaedic surgeon8. Low viscosity 
cement materials that are slow curing carry a risk of migrating into the patient’s 
circulation and, in the case of vertebroplasty, putting pressure on the spinal cord 
(31,32). For this reason high viscosity Palacos is recommended for vertebroplasty. 
Cement infiltration of surrounding bone, however, could be compromised when using 
packable cement. Manipulation of the injection site is done prior to injection. Swift cure 
of cement subsequent to injection is beneficial to the surgeon as it facilitates fast fixing 
of the fracture site with minimal opportunity for the material to migrate. A flowable 
material will still be fluid enough to intermingle with surrounding bone, and create a 
mechanically sound bone/material interface at low injection pressures. 
The strength of the Cortoss declined when stored for extended periods in water at  
37 °C. This strength decline after 4 weeks was the same magnitude as that observed 
by Boyd et al. (10). Boyd suggested that the reason for this strength decrease is 
related to BisGMA encouraging water sorption, which plasticizes the cement. It is also 
thought that the strength decline could be in part due to the dissolution of the combeite 
phase (Combeite degrades, releasing sodium and calcium ions and soluble silica, 
(148) as this is also a problem reported with MCPM/bTCP containing composites (64). 
The strength decline, after 4 weeks, observed for the prototype product is smaller than 
for Cortoss. The prototype product contains UDMA and PPGDMA, both without 
hydroxyl groups. The prototype product does, however, contain a small quantity of 
                                                8	  The	  curing	  time	  of	  orthopaedic	  cements	  was	  discussed	  with	  Auvo	  Kaikonnen,	  in	  September	  2010,	  during	  the	  2010	  European	  Society	  for	  Biomaterials	  conference	  in	  Tampere,	  Finland.	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HEMA, which does contain hydroxyl groups that will encourage water sorption and 
therefore lead to plasticizing of the material and ultimate strength loss. The level of 
HEMA is small and therefore the plasticizing effect is smaller than for BisGMA 
containing Cortoss.  
Silane coupling provides a chemical bond between the filler and the polymer phases in 
methacrylate composites that can prevent hydrolytic degradation of the filler phase 
preventing strength decline when stored in wet conditions (149). Both the prototype 
PFC and Cortoss contain silane coupled glass filler. In Cortoss, however, the combeite 
phase is not silane coupled and so it is thought that the lack of interfacial bonding 
between the polymer and combeite is also responsible for hydrolytic degradation and 
subsequent poor long term strength of this material. It is hypothesized water sorption 
has a more detrimental effect on the polymer phase than the filler phase when the filler 
is silane coupled (147). It is difficult to quantify the efficacy of silane treatment other 
than by indirect methods such as strength of composites and handling of material prior 
to cure. The fracture surface in Figure 6-4 could be considered as evidence of a good 
interfacial silane bond between the particulate filler and polymer whereas the fibre pull 
out could be indicative of less effective silane coupling of the fibre filler. 
The strength of the prototype product, however, returns to its 24-hour value after 20 
weeks hydration with an associated stiffening. This contradicts what is expected if 
water sorption is plasticizing the material. In materials that contain MCPM and bTCP it 
has been hypothesized that a ‘self healing’ mechanism reverses decreases in strength 
associated with water sorption by reaction of the MCPM and bTCP to form a brushite 
phase (64). It is thought that the FGS fibres (which contained calcium Table 4-3) could 
react with other components in the PFC material, but that this reaction would be 
insufficient to produce a self-healing mechanism in the bulk of the material that results 
in greater stiffness and flexural strength. Ferracane et al. have some data suggesting 
an increase in flexural strength of dental composites after ageing in water. This 
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apparent increase was attributed to large variability in flexural strength results because 
the test method used (three point bend) is sensitive to surface condition of specimen 
(150). A large variability in results due to sensitivity of test method to specimen surface 
condition is thought to be a much more likely cause for the observed increase in BFS 
and stiffness between 4 and 20 weeks of the PFC material. The error expected for a 
mechanical test of this kind is around 10 %; the error observed in the 20 week tests is 
quite low, meaning that a change from 76 MPa to 93 MPa appears significant. It is 
thought that surface condition of the specimens after 20weeks and only a small sample 
size is responsible for a smaller than expected error. The observed increase in BFS 
from 4 weeks to 20 weeks is thought therefore to be insignificant. It is thought that 
there is probably a small decrease in BFS over the storage period and a larger number 
of specimens at each time period are therefore required to give a better estimate of 
this. Furthermore, the observed increase in stiffness of the PFC material is thought to 
be insignificant for the same reason.  
The decline in BFS of the PFC material was less than for Cortoss after 4weeks, which 
is encouraging. Boyd et al. (10) showed that PMMA cements did not have a decline in 
strength following extended periods of hydration; the PFC cement performs better than 
Cortoss in terms of long term strength and modulus and comparably to PMMA cements 
in terms of mechanical properties after 24hours. Despite the changes in BFS and 
Modulus, the fracture behaviour of the PFC material remained unaltered for all the 
storage periods. A decrease in strength is expected; usually decreases in fracture 
toughness/ strength are attributed to water plasticizing the polymer and polymer 
hydrolysis (150). 
As discussed in chapter 5, the strength, for current composite bone cements (Cortoss 
and Comp06), was around 4 – 5 % of the stiffness. For the prototype PFC, the strength 
is also around 4 % of the stiffness. The flexural strength of the PFC is above the 
required 50 MPa and the modulus is above the 1.8 GPa required by BS 5833. The 
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compressive strength required by both ASTM 451F and BS 5833 is 70 MPa. Although 
this has not been determined for the prototype PFC, it must be considered in further 
development of the material. 
6.7.2 In-vivo Implantation of Prototype PFC  
6.7.2.1 Surgical Procedure 
The animals used received implants in both hind legs. First and foremost this was to 
maximize the number of implantation sites, whilst reducing the number of animals 
required in line with animal testing ethical framework ‘the 3 R’s’ (Replacement, 
Refinement, Reduction (151)). Secondly, bones need to be loaded to heal effectively 
(152), implantation in both hind legs prevented the animals from ‘favouring’ the 
implanted limb and affecting the host healing response. Finally, allocation of implant 
materials was random. 
The PMMA was not pre-mixed and so there was scope for accidental change in 
monomer/powder ratio, due to spillage and evaporation, and therefore change in 
properties. In this respect the PPGDMA cement was more reliable as there was no 
possibility for changing the composition due to hand mixing. Some pre-mixed cements 
phase separate during storage. The PFC materials were stored in the syringes for 24 
hours before implantation; no phase separation was noted in this time. Phase 
separation after longer periods of storage is something to be considered in 
development of PFCs for bone repair. 
Three cases of infection were observed following excision of PMMA material. This is 
much higher than the rate of infection recorded for human vertebroplasty (153). The 
higher infection rate is attributed to a less clean operating environment than is used 
with human procedures and hand mixing of the PMMA material in the open 
environment of the operating room. 
Kirsty Main  PhD Thesis 
 213 
The PFC material cured faster than at the lower in-vitro temperatures, setting solid 
within 45 seconds of injection. It has been reported that thermal necrosis occurs in a 
rabbit model when tissue temperatures are above 50 °C for more than one minute 
(154). This is at odds with findings for humans, however, where nociceptive nerve 
endings are reported to be ablated at 42 – 45 °C. Furthermore, the amount of material 
injected in rabbits is considerably lower than into humans so temperature rise will be 
much reduced.  The rabbit femur model is therefore not expected to be good at 
predicting the thermal response of human trabecular bone to cement placement.  
In this study, neither Palacos nor PFC mixed with blood preventing which might cause 
decreases in cement mechanical properties associated with blood entrapment (155). 
The fact that many of the defect sites were found to be empty when recovered is 
considered to be a major problem with the surgical procedure. Bleeding has been 
reported to reduce the strength of the material/bone interface significantly (156). It is 
therefore thought that bleeding prevented the material from infiltrating the trabecular 
bone surrounding the implant sites. Without good mechanical interaction, the implants 
came loose.  The PMMA cement had a lower incidence of displacement; the higher 
viscosity material could be packed into the defect halting bleeding more effectively than 
the PFC cement, enabling a mechanically superior interface. If more effective methods 
of stopping bleeding had been used the lower viscosity PFC material may not have 
been at a disadvantage. In human vertebroplasty, there is not as much bleeding as the 
cement is injected into an existing fracture, rather than a defect that has been freshly 
made. Displacement of implanted material due to bleeding in vertebroplasty is, 
therefore, not envisaged to be a significant problem. In joint replacements, cement 
material is implanted when there is active bleeding (157). In this procedure 
bone/cement interface can be improved by lavage and pressure on the curing cement 
(158). The latter, however, is incompatible with low viscosity materials.  
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6.7.2.2 Micro CT 
The Micro CT instrument manufacturer recommends a minimum of 15% transmission 
to get a good/clear reconstructed image, but because of the thickness of specimens, 
the minimum transmission in this study was 4.3 %. This means that the image contrast 
is not as strong as desired. 
The large and small voids in the four-week PFC implanted material (658R) are thought 
to be due to air bubbles in the pre-mixed material that were not removed by mixing.  
Small voids such as those measuring less than 1mm have been reported in human 
vertebral augmentation (159) and are thought to be air bubbles introduced from the 
injection syringe. 
The PFC was more radiopaque than PMMA and so could be considered as better for 
surgeons. The silica glass component of the PFC cement, however, contains barium. 
Barium sulphate, also an additive in some PMMA cements, has been associated with 
causing bone resorbtion, as discussed in the introduction (chapter 1). Further to this, 
Togawa et al reported that macrophages surrounding PMMA implants in humans 
contained particles of barium sulphate (159). Barium sulphate can also affect the 
mechanical properties of PMMA cement.  The opacifying component found in Palacos, 
ZrO2, has fewer adverse effects on mechanical properties compared to BaSO4 (3). 
6.7.2.3 Histology 
In a histologic evaluation of human vertebroplasty, Togawa et al has reported cement 
in venous tissues (159). Neither the PFC cement nor Palacos, however, exhibited 
problems with cement leakage/migration into venous tissue or organs. The serious 
complications associated with this cement migration were, therefore, avoided. 
Regions of blue and yellow bone with normal lacunae density and size next to the 
implant in histological sections were taken as evidence of bone remodelling and normal 
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metabolic activities. Cartilaginous fibrous tissue at the material/bone interface would 
suggest fibrous encapsulation. 
In general the histological sections in this study have been used to give a qualitative 
sense of the host response to the implant materials. A good response was deemed 
one where there was a good snug interface between the host bone and the implanted 
material; poor apposition would be evidence of fibrous encapsulation and a poor 
response. As well as the physical look of the implant/material interface, the lacunae 
concentration at the interface was compared to bone further from the implant. If the cell 
concentration at the interface were higher than surrounding tissue it would suggest 
immature bone. The presence of macrophages or other multinucleated giant cells 
would suggest an inflammatory response. For both PFC and PMMA cements after one-
week in-vivo, there was one implant site where the material had stayed in place and 
was sectioned effectively. Intimate contact between material and healthy host bone 
was seen, implying a good early response to both materials.  
It is not known at what point the implants came loose from the empty defect sites 668R 
and 666R (shown in Figure 6-10 and Figure 6-11 respectively). It is difficult, therefore, 
to get a fair idea of the biological response of the host to the implant as the duration of 
implantation is not known. In Figure 6-10 (668R; PFC after 1week) the structure and 
lacunae size/concentration of the bone ‘fingers’ within the defect indicates that they 
both consist of woven bone. Piattelli et al. observed that it took up to 9 weeks for 
mineralized bone to be found in PTFE membrane lined 8mm defects in rabbit tibia 
metaphyses (160). One week is therefore not considered sufficient time for mature 
bone to form in a defect. It is thought that the PFC material did not fully fill the defect 
and became dislodged during the implantation procedure or shortly afterwards allowing 
formation of new, immature tissue in the defect. In site 666R the totally empty defect in 
Figure 10 implies that either immature tissue or the material that was in the defect was 
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removed during slide processing or that the PMMA material was dislodged just prior to 
extraction, or during extraction.  This is another negative of the implant procedure. 
In Figure 6-15 the large void is thought to be an air bubble due to delivery method 
rather than a void created by bleeding, as there is no evidence of blood cells within the 
void. 
In Figure 6-17 the fibres ‘in’ bone surrounding implant could be migration of fibres due 
to bioactivity, but are more likely to be due to processing of slides. 
No thermal necrosis was evident in the histological images for either material at either 
implant duration. Erbe et al. and Verlaan et al. found that thermal necrosis was not a 
problem in rabbit and goat models respectively (161,162). It is postulated that it is 
blood flow in-vivo that helps to dissipate heat on cure and prevent the high 
temperatures that are reported in-vitro (163). 
Togawa et al, also found that foreign body giant cells and mononuclear macrophages 
were identified in the thin membrane surrounding implanted PMMA (159). In the 
present study, however no cellular inflammatory response was seen. Despite the lack 
of evidence for a cellular response it is thought that foreign body reaction could be 
more important than thermal necrosis (sheep model) (164).  
Neither the PFC cement nor the PMMA cement exhibit any fibrous encapsulation of the 
implant. Conversely, Togawa et al. have shown that for PMMA cement, there was no 
direct bone apposition to the cement; there was instead a thin fibrous membrane 
separating tissue from PMMA (159). Revell et al. also report fibrous encapsulation of 
PMMA cements after 6 weeks implantation (36). 
Erbe showed Endosteal/periosteal bone surrounding both PMMA and a composite 
containing bioactive glass filler (Cortoss) after four weeks in-vivo (161). More bone 
contact, however, was seen with Cortoss. Cortoss showed apposition of new bone in 
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Rabbits at 24 weeks. This is similar to the response to the PPGDMA cement at four 
weeks, which shows new bone growth up to the implant and possible integration of 
fibres with bone tissue. This could be due to the bioactive nature of glass, but could 
also be due to histology processing.  
Revell et al. report that some quantitative assessment of histological sections can be 
made; a percentage of viable bone in contact with implanted bone cement can be 
found by examining the perimeter of implanted cement in a section (36). However, this 
will only give a useful estimate of biocompatibility when a number of implant sites can 
be examined. In the present study this was not possible as too many implants came 
loose.  
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6.8 Conclusions 
The handling and mixing of the prototype PFC were suitable for syringe and mixing tip 
delivery, however, the viscosity was too low for an in-vivo situation in which bleeding 
was not completely stemmed. The PFC materials were found to cure faster at 37 °C 
than at room temperature. 
The shape of the curing profile of the prototype PFC formulation was most similar to 
PFC9, with a more gradual cure than Cortoss, Comp06 and PMMA materials. The 
polymerization shrinkage was calculated to be lower than for the commercial 
composite and PMMA bone cements despite the level of conversion being higher. The 
BFS of the PFC prototype was comparable to commercial materials but the stiffness 
was lower than for Cortoss and Comp06 – the benefits of lower stiffness are discussed 
in chapter 5. The long term strength and stiffness of the PFC material is variable, 
although initial results indicate that the PFC material does not decline in strength after 
ageing in water as much as Cortoss. Addition of fibres enabled a non-brittle fracture 
pattern as demonstrated in chapters 4 and 5.  
In-vivo implantation of the PFC material confirmed that the material could be sterilized, 
injected and cured in-vivo. There were no recorded infections for PFC implant sites. As 
mentioned above, the viscosity of material did cause some problems and the material 
did not bond to bone in the presence of blood. There were regions in which good 
apposition between PFC and bone was observed – it is thought that bleeding was 
more successfully stemmed in these areas. Furthermore the close contact of host bone 
to the implanted PFC, normal metabolic activity of surrounding bone tissue and regions 
of osteoid growth adjacent to PFC are all evidence that the material induced a 
biological response superior to PMMA cement. The PFC was found to be more 
radiopaque than Palacos R PMMA cement and cortical bone. Despite evidence in the 
literature to the contrary (mentioned in chapter 1) barium present in glass did not 
appear to cause a negative bone response. 
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PFC is an implant material with good biocompatibility and radiopacity that may be 
suitable for use in humans for fixation of osteoporotic fractures via percutaneous 
vertebroplasty. 
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7 Effects of Initiator and Inhibitor System Concentrations on 
Curing and Shelf Life of Prototype PFC. 
7.1 Abstract 
In the previous chapter an in-vivo and in-vitro characterization of a prototype PFC 
formulation was performed. Although this formulation performed well when cured 
immediately after mixing or after 24 hours refrigerated storage, it is necessary to have 
an appreciation of how long the material can be stored for before spontaneously 
polymerizing and what the effects of changing the levels of initiators are on the curing. 
The aim of this chapter was to perform a factorial design (using the Prototype PFC 
monomer and filler systems) to investigate the effects on the curing times and degree 
of conversion of DMPT, BP and BHT levels. Accelerated ageing of 1 and 2 % BP PFC 
pastes was performed to predict the shelf life of these pastes at room temperature and 
4 °C.  
Increasing BP will significantly increase the conversion of PFC formulations when low 
amounts of BHT are present. The level of DMPT had the largest effect on the lead in 
time/time to 50% of the three variables investigated. This suggests that the effect on 
cure time and rate of lower BP and higher BHT can be balanced by addition of DMPT. 
The effects of initiators and inhibitors are highly specific to the monomer system used.  
Decreasing the level of BP relative to BHT increases the shelf life of PFC formulations. 
BP will be consumed during the shelf life period and so it is clinically relevant that the 
PFC pastes still have high levels of conversion even at very low levels of BP (0.125 %). 
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7.2 Introduction 
In chapter 5 it was found that increasing the level of diluent monomer (PPG) slowed 
down the rate of polymerization and resulted in higher levels of conversion. Cure times 
and rates were compared with kinetic theory and an equation was derived that implies 
a linear relationship between cure time and inhibitor, monomer and initiator 
concentrations. 
In the previous chapter the monomer and filler systems were chosen to create a 
prototype PFC formulation that was characterized in terms of strength, modulus, cure 
and in-vivo response – the initiator system was kept constant throughout. 
Many authors report how the initiator system can affect material properties. In this 
chapter the cure times and levels of conversion will be examined. Previous work at the 
Eastman has suggested that doubling the level of BP and DMPT will decrease the time 
to half reaction by factors of 1.2 and 2 respectively for UDMA/TEGDMA/HEMA 
composites (165). Hasenwinkel et al. have reported a power law relationship (exponent 
of -0.5) between BP and DMPT concentration and setting time when used to initiate a 
two solution PMMA cement (34). 
Inhibitors are substances that neutralize the action of polymer and initiator free radicals 
and therefore slow down or stop the polymerization reaction depending on how 
efficient the action of the inhibitor is (16). An amount of initiator to overcome the level of 
inhibitor is required for polymerization to begin / reach a desired level. In this study 
Butylated Hydroxytoluene is the inhibitor being investigated. It is a common inhibitor for 
use in methacrylate based composites and PMMA bone cements (both Cortoss and 
Comp06 contain BHT). A study by Rosentritt suggests that BHT will have a linear effect 
on the inhibition time and reaction rate in TEG DMA/BisGMA composites when used 
with a light cure initiator system (138).   
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The in-vitro and in-vivo characterization of the prototype PFC formulation that formed 
the subject of the last chapter focused on the immediate curing profile following a 24 
hour storage period between mixing and implantation. Ensuring a reproducible cure 
after a period of storage as well as favourable cured cement properties is central to 
developing a viable bone repair product.  
The BP paste of each formulation will spontaneously cure over time and it has been 
shown that this spontaneous cure follows Arrhenius type temperature dependence 
(16,166). Once the Arrhenius equation is determined the effect of temperature on the 
spontaneous cure will be known and the shelf life of the material for a range of storage 
temperatures can be predicted. 
7.3 Aims and Objectives 
This chapter aims to investigate the effects of changing the initiator system on the 
curing profile of the prototype. The relative levels of initiator Benzoyl Peroxide (BP), 
acceleratoractivator Dimethyl Para-toluidine (DMPT) and inhibitor Butylated 
Hydroxytoluene (BHT) were to be altered to establish their effects on the following: 
• The shape of curing profile and level of cure. 
• Quantification of inhibition time (tinh) and time to 50% cure (t0.5). 
• Comparison of kinetic theory equations from Chapter 5 with experimental 
conversion and cure profile results. 
• Determination of inhibition mechanism of BHT 
It is also the aim of this chapter to make preliminary investigations into how the level of 
BP affects the time that PFC materials can be stored before spontaneously curing 
(shelf life) and discuss areas in which greater depth of investigation is still required for 
development of this prototype PFC. 
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7.4 Hypotheses 
Previous work at the Eastman (discussed in the introduction to this chapter) has 
suggested that doubling the concentration of both BP and DMPT decreases the time to 
50% reaction of UDMA/TEGDMA/HEMA composites by factors of 1.2 and 2 
respectively. It is thought, therefore, that increasing the level of BP and DMPT, whilst 
keeping the monomer levels constant, will reduce the inhibition time and the time to 50 
% whilst increasing the level of BHT will increase the inhibition time and t0.5. 
In terms of the shelf life, an Arrhenius type equation is assumed. It is thought that 
increasing the level of BP/DMPT will reduce the shelf life whilst increasing the level of 
BHT will increase the shelf life. 
7.5 Materials and Methods 
A three variable factorial design experiment was performed varying the initiator system 
of the prototype formulation, from the previous chapter (Table 7-1). The nine initiator 
factorial design (IFD) formulations listed below were investigated to establish the effect 





























IFD8 70 71 
IFD9 0.25 0.75 35 71 
Table 7-1 Variable 1 (VAR 1) is level of DMPT, variable 2 (VAR 2) is level of BP and variable 3 (VAR 3) is 
ratio of mass of BP to mass of BHT. BP and DMPT given as wt.% of total monomer mass. BHT in ppm of 
monomer mass. 
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The variables were chosen to allow the effects of large changes in BP, DMPT and BHT 
to be observed. In preliminary studies, using a factorial design with low and high levels 
of BHT fixed (either 18 or 294 ppm) then a formulation containing 0.125 % BP and 0.25 
% DMPT and 294 ppm BHT did not polymerize sufficiently.  Conversely a formulation 
containing 0.5% BP, 1.0% DMPT and 18ppm BHT set within the mixing tip of the 
double barrelled syringe. Changing BP and DMPT by a factor of four and BHT by a 
factor of 16 will result in composites with curing levels and times that are practical for 
measurement whilst also allowing the effects over large ranges of initiator, activator 
and inhibitor to be observed. 
The formulation contained equal quantities of PPGDMA and UDMA (both at 47.5 wt.% 
of total monomer mass) and a small amount of HEMA (5 wt.% of total monomer mass) 
combined with silanated barium silica glass (G4S) and glass fibres (FGS) at a total PLR 
of 4:1 (glass content 75 wt.% of total filler mass, fibres at 25 wt.% of total filler mass).  
Formulations were manufactured and the level of conversion and normalized cure 
profiles were found for each formulation as per the methods detailed in chapter 2. 
The stability of the material with time (shelf life) can be tested by doing accelerated 
ageing tests as detailed in ASTM F1980 (167). This protocol was modified as 
explained in chapter 2; the Arrhenius dependence of the PFC material was determined 
by placing formulations containing either 1 or 2 % BP (with 140 ppm BHT) in incubators 
maintained at 60 °C, 45 °C and 37 °C and monitored periodically to see at what time 
point they begin to cure.  
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7.6 Results 
7.6.1  Effect of Initiators 
The normalized cure profiles for the 9 IFD formulations are shown in Figure 7-1. From 
inspection of this figure it can be seen that the normalized inhibition times, ti, are longer 
for those formulations containing low levels of DMPT (IFDs 1-4). The subsequent 
reaction is sharper for these IFDs and for ti < t/t0.5 < 1 the reaction rates are steeper. 
The intermediate formulation (IFD9) is similar in shape to IFDs 1-4. 
 
Figure 7-1 Normalized cure profiles of BHT factorial design formulations. DMPT has major greatest effect 
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The factorial analysis a-values of the conversion, t0.5 and ti results are shown in Figure 
7-2. The level of DMPT is the major factor that affects the time to 50 % reaction extent, 
with BP and BP/BHT having smaller yet still significant effects.  
There are small interaction effects on t0.5 between the levels of DMPT and BP and the 
level of DMPT and the BP to BHT ratio however, these interactions, however, are small 
in comparison to the size of the effects of DMPT, BP and BP/BHT and so it is difficult to 
tell if they are significant or not. The a-values for normalized inhibition time and 
conversion are small in comparison to experimental errors and so it is difficult to 
interpret the effects of the variables on these properties from factorial analysis; further 
analysis is required and outlined next.  
 
Figure 7-2 Factorial analysis giving effect of variables on time to 50% reaction extent, t0.5; normalized 
inhibition time, ti; and conversion. The level of DMPT has the largest effect on the time to 50% reaction, 
followed by BP and then the ratio of BP to BHT. The effect of interactions are considered experimentally 
insignificant as they are comparatively small or the 95% confidence interval error bars cross zero. DMPT 
also has an effect on ti. The effects of the other variables/interactions on ti and the effect of all variables on 
conversion are relatively small and so the above factorial analysis method is not useful for interpreting how 
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To ascertain the effects of each variable on the levels of conversion the formulation 
composition with absolute level of BHT and final conversion is tabulated (Table 7-2). 
Increasing the level of BP results in an increase in conversion, although this increase is 














17.5 71 76 ± 4 
IFD2 70 18 85 ± 2 
IFD3 
0.5 
17.5 286 85 ± 1 




17.5 71 79 ± 2 
IFD6 70 18 80 ± 1 
IFD7 
0.5 
17.5 286 86 ± 1 
IFD8 70 71 85 ± 2 
IFD9 0.25 0.75 35 71 78 ± 4 
Table 7-2 IFD formulation composition including absolute level of BHT. Formulation degree of conversion. 
To investigate effects of the variables and interactions on t0.5 and ti these data have 
been plotted against the IFD composition in Figure 7-3 and Figure 7-4 below. IFDs 1-4 
have smaller t0.5 and ti than IFDs 5-8. Both IFDs 1-4 and 5-8 show a reduction in t0.5 as 
BP and BP/BHT increase.  
From Figure 7-3 the ratio of t0.5 values on comparing IDF samples 1/2,3/4,5/6 and 7/8 
were 1.5, 1.7, 1.3 and 1.4 respectively. The change in BHT from IFD2 to IFD1, IFD4 to 
IFD3, IFD6 to IFD5 and IFD8 to IFD7 is a factor of four in each case. Thus a four-fold 
increase in BHT increases t0.5, on average, by a factor of 1.5. Though as reaction rate 
increases (increase DMPT and BP), increasing BHT has less effect. This suggests that 
the inhibitor has only a minor effect on t0.5 largely at low initiator concentrations.  
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Comparing analysis from Figure 7-3 to factorial analysis results (Figure 7-2) for t0.5 
suggests that the interaction terms with DMPT are insignificant as the trends in 
behaviour for IFDs 1-4 are the same as for IFD’sIFDs 5-8. 
 
Figure 7-3 Time to 50% reaction vs. IFD formulation composition. Levels of DMPT and BP shown as wt.% 
of total monomer mass, BHT given as ppm (again of total monomer mass). 
ti is around 0.5 for all samples with DMPT of 0.25 wt.% and tends to 0.3 with high 
DMPT (Figure 7-4). This reflects the increased t0.5 for low DMPT compared to high 
DMPT. With low DMPT ti is also slightly lower with higher BHT.  As well as increasing 
time for half reaction, high BHT therefore increases inhibition period but to a slightly 
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Figure 7-4 Normalized inhibition time, ti, vs. IFD formulation composition. Levels of DMPT and BP shown 
as wt.% of total monomer mass, BHT given as ppm (again of total monomer mass). 
The results for IFD9 (conversion = 78±4 %, t0.5 = 496±17 s and ti = 0.48±0.02) are not 
similar to the average of the other specimens. Instead IFD9 lies in between IFD4 and 
IFD5. 
7.6.2 Accelerated Ageing Studies 
The time of set for 1 % BP paste and 2 % BP paste (each with 140ppm BHT) range 
from just over 1.5 hours (2% BP at 60 °C) to nearly 28 hours (1 % BP at 37 °C) (Table 
7-3) below.  The times to set are plotted in Figure 7-5; the activation energy (Ea) and 
frequency factor (A) can be found from the line of best fit of the plotted cure times. The 
activation energy for the two formulations is similar whereas the frequency factor of the 
2% BP formulation is 24 times higher than that for the 1% BP formulation (Table 7-3). 
The predicted shelf lives of the two formulations, at 23 °C, range from 4.1 to  
5.7 hours for the 2% and 1% BP pastes respectively. At 4 °C these predicted setting 
times increase to just under 57 days and just over 65 days (Table 7-3). 
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94 7.9E+12 98 1367 45 335 
60 95 
Table 7-3 The setting times of the two formulations, with activation energies and frequency factors from 
the plotted data. Predicted shelf lives of each formulation – 1 % BP paste has smaller frequency factor and 
hence an increased predicted shelf life at both 23 °C and 4 °C compared to 2 % BP paste.  
 
Figure 7-5 Plot of ln(1/ts) (y-axis) vs. 1/T (x-axis). The Activation energy (Ea) and frequency factor (A) for 
the 2 formulations can be found from the gradient and the intercept, respectively, of the line of best fit of 
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7.7 Discussion 
7.7.1 Effect of Initiators 
An increase in level of DMPT will result in a decrease in t0.5.  This is due to the 
decreased inhibition time, and also a faster reaction. It is thought that DMPT could acts 
to stabilize the free radicals that BP produces. Increasing the level of DMPT would 
therefore ill result in more stable free radicals reducing the time taken to ‘use up’ the 
BHT inhibitor prior to polymerization and increasing the reaction rate whilst 
polymerization has begun.  
The factorial analysis results provided useful insight into the size of effects of variables 
on measured material parameters in previous chapters. In this chapter, however, the 
factorial analysis is difficult to interpret the effect of the BP, BP/BHT or the interactions 
on ti as the a-values are very small.  
An increase in BP means an increase in conversion. A low level of BP, interestingly, 
does still result in a level of conversion that is similar to Cortoss, Comp06, Simplex P 
and Palacos bone cements (Table 7-2). This is important as it suggests that if the level 
of BP is depleted (by up to 75 %) following storage then the formulation will still cure 
satisfactorily. A study by Hasenwinkel et al showed that level of DMPT had a significant 
effect on conversion/residual monomer of a two solution injectable MMA bone cement 
but that BP did not have a significant affect over the ranges investigated (35). The 
range of DMPT was similar to that used in this chapter, however the range of BP was 
higher, the lowest amount being coincident with the high amount used in this chapter. 
The level of inhibitor used by Hansenwinkel is not known and methyl methacrylate was 
used rather than the dimethacrylate monomer system used here. As seen in chapter 5, 
the monomers have a significant effect on conversion and curing times and this, in 
part, will explain the discrepancy between Hasenwinkel’s study and this one. It is clear 
that the effects of DMPT and BP are dependent on the level used, with both 
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Hasenwinkel’s study and this chapter showing different behavior for different levels of 
these chemicals. Furthermore, the type and level of inhibitor relative to the amount of 
BP is shown here to affect the action of the initiator and its effect on conversion. The 
difference in findings between Hasenwinkel’s study and this one can therefore be 
attributed to the differences in levels of initiators and level and type of inhibitors. 
Increasing the level of BP also decreases t0.5 as Equation 7-1 below would suggest. 
     Equation 7-1 
If concentration of DMPT ([A]) and BP ([B]) and monomer system are constant, then f 
(initiator efficiency) should be constant for a given formulation in which initiator and 
monomer/filler systems are kept constant. It is clear that the effect of changing initiator 
levels is highly dependent on what monomer system is being used; chapter 5 and 
Rosentritt and Hasenwinkel have all shown different effects of increasing levels of BP 
and DMPT on cure time (34,138). 
Equation 7-1 implies that changing the concentration of inhibitor should have a linear 
effect on the inhibition time but this was not the case; changing BHT by a factor of 4 
changed the inhibition time, on average, by a factor of only 1.4. This discrepancy can 
be attributed to the level of inhibitor already present in the monomer when received 
from the manufacturer. The PPG from the manufacturer contains 100ppm BHT and 
100ppm MEHQ, the UDMA contains between 100 and 200ppm MEHQ and the HEMA 
contains between 40 and 60ppm MEHQ. This means that when changing the amount 
of BHT from 18 – 71ppm, the actual factor change in total inhibitor amount could range 
from 1.25 to 1.3, whilst increasing BHT from 71 -– 286 ppm will result in a factor 
change of between 1.3 and 2.0. From this it is clear to see a more linear agreement in 
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of this experiment reflects the unknown quantity of inhibitor in the monomer when 
received from the manufacturer as well as errors in measurement of the added BHT. 
It is important to discuss here whether the manufacturer added inhibitor should be 
removed from the monomers prior to use. The aim of this project ultimately is to enable 
the production of a commercial composite bone cement. It was felt that it would be 
more useful to determine the effects of initiators and inhibitors over practical ranges on 
monomers in the state that they were received from the manufacturer to better simulate 
how a potential product would be manufactured. 
There are interaction effects between the BP and DMPT; the BHT has a different effect 
at low levels of BP/DMPT compared to at high levels. Polymerization rate constants 
cannot, therefore, be determined from this factorial design experiment. For this reason 
overall trends in behaviour are thought to be more important and interesting than 
finding quantitative effects of the initiator system. 
It has been shown that BHT has a linear effect on inhibition time when in high enough 
ratio with Camphorquinone light activated initiator [Rosentritt/Palin, 2010]. Similarly, 
Cook et al. found that BHT increased inhibition time effectively at low reaction rates 
only making it a good stabilizer (168).  
Hasenwinkel et al. have reported how the level of BP and DMPT and inhibitors affect 
the mechanical properties of PMMA bone cements (34). It would be necessary to 
check the BFS and modulus and fracture behavior of the IFD formulations to fully 
understand the effects of altering the initiator system. 
7.7.2 Accelerated Ageing Studies 
Only one repeat for each formulation was performed; this was only designed to be a 
very preliminary study into the shelf lives for the materials at ranges of BP and BHT 
that have been used in previous chapters. The discussion that follows compares the 
Arrhenius coefficients found from this study to those in literature. In order to find the 
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statistical relevance of these results it is necessary to perform more repeats. 
Furthermore only two levels of BP have been investigated – to design a bone repair 
material with an adequate shelf life, an understanding of the effects of storing the 
DMPT paste and both BP and DMPT pastes with higher levels of inhibitor is required. 
Increasing the level of BP is thought to increase the concentration of free radicals, 
increasing the number of molecular collisions that are successful and hence 
decreasing the time to set. It is expected that changing the level of BP should therefore 
only affect the frequency factor and the activation energy should be unaffected. The 
activation energy for the two formulations was similar, whilst the frequency factor 
differed by a factor of 24. This seems to fit with expected behavior although, as 
mentioned above, the 95% confidence interval cannot be found as only one repeat was 
performed. In a previous study by Shim et al. the activation energy for methyl 
methacrylate with BP were 129 kJmol-1 whilst the frequency factor was found to be 
between 2.1 and 3.8 x 1018 (166). The activation energy for thermal decomposition of 
BP is quoted as being 124 kJmol-1 by Odian (16). Both the activation energy and the 
frequency factor are dependent on how the BP interacts with the monomer system and 
so it is expected that they should be very different from the values found in this study. 
Furthermore neither Shim nor Odian have an inhibitor present; the efficiency of the BP 
and hence the kinetics of spontaneous polymerization will be affected by the presence 
of BHT. 
The time to cure was predicted at 25 °C (room temperature) and 4 °C (refrigerated). It 
is envisaged that the level of BHT will have to be increased substantially to achieve 
similar shelf life values at 4 °C to Comp06 and Cortoss. From the BP/DMPT/BHT 
factorial design, it was seen that BHT is a more effective inhibitor when at large 
concentrations in comparison to BP. Furthermore it is thought that levels of BP will be 
consumed during the shelf life period and so it is clinically relevant that the PFC pastes 
still have high levels of conversion even at very low levels of BP (0.125 %). 
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7.8 Conclusions 
The factorial analysis shows that the level of BP affects the conversion of the 
formulations when low amounts of BHT are present; increasing BP will significantly 
increase the conversion when a large quantity of BP relative to BHT is present. For the 
ranges of initiator that have been tested the BP level can be depleted by around 75 % 
and the formulation will still cure to a satisfactory level. There are interactions between 
all three variables with respect to conversion and so it is not possible to evaluate 
kinetic equation coefficients. 
Neither the level of BP nor the level of DMPT, have a linear effect on the cure 
rate/time; the results of this factorial analysis contradict the previous work at the 
Eastman. The level of DMPT has the largest effect on the lead in time/time to 50% of 
the three variables investigated. This suggests that the effect on cure time and rate of 
lower BP and higher BHT can be balanced by addition of DMPT.  
BHT has a more significant inhibiting action when the level of BP used is low. 
It is clear that the effects of initiators and inhibitors are highly specific to the monomer 
system used. It is therefore necessary to determine the behavior of the initiator system 
over a suitable range to ensure reliable cure. 
Decreasing the level of BP relative to BHT has been shown to increase the time to set 
(via spontaneous polymerization) and hence the shelf life of the BP paste of a PFC 
formulation. It is thought that changing the level of BP affects the frequency factor only, 
although more repeats are required to ascertain statistical relevance. Similar shelf life 
experiments should be performed for the DMPT paste and both pastes for a range of 
BHT levels. 
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8 Conclusions and Further Work. 
This chapter summarises the main conclusions of each chapter of this project followed 
by a description of the further work necessary to further develop the prototype PFC 
formulation together with some preliminary data in some of these areas.  
8.1 Conclusions 
As mentioned in the introduction to this thesis, the ultimate goal of this project was to 
develop a composite material that is a viable alternative to PMMA and composite 
cements for bone repair – particularly in osteoporotic vertebral and femoral neck 
fracture fixation applications. The previous chapters have dealt with selection and 
tuning of components resulting in the production of a prototype PFC formulation that 
was then characterized in-vitro and implanted in-vivo to assess its curing and 
mechanical properties and its biological response. The initiator system of the prototype 
PFC was then investigated to establish its effects on the curing and shelf life of the 
material.  
Inspection of the literature surrounding bone cements, in the introduction chapter, 
suggested that current PMMA bone cements had levels of residual monomer and 
polymerisation shrinkage that were too high. Conversely, composite bone cements 
were too stiff and without sufficient strength for load bearing applications. 
In chapter 3, two composite bone cements, two PMMA bone cements and a dental 
composite material were investigated and characterized in terms of their chemistry/ 
microstructure, curing, shrinkage and mechanical properties. A novel Raman technique 
for characterizing the chemistry and structure of fracture surfaces together with SEM 
and EDX methods, visual inspection, FTIR cure analysis and biaxial mechanical testing 
enabled a comparison of the materials in terms of the properties that were deemed to 
be critical to bone cement success; namely, handling, residual monomer, curing time, 
strength, stiffness and fracture behaviour. The Raman mapping technique in particular 
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could be very useful for characterizing materials recovered from in-vivo to compare the 
chemistry of materials prepared in the operating room with subsequent contact to body 
tissues to those prepared in the laboratory and tested in vitro. The results of chapter 3 
confirmed the reported problems with the materials investigated and the analysis 
methods used suggested that high molecular weight and flexible monomers combined 
with a silane treated filler would result in a material with high conversion and low 
shrinkage, good interfacial bond strengths enabling high strength, but with relatively 
high modulus. 
In chapter 4, a selection of fillers and monomers were screened to ascertain their effect 
on composite properties. The silane treated glass (G4S) enabled the best handling, PLR 
and composite strength compared to the other particulate fillers, whilst inclusion of 
barium proved to make the glass highly radiopaque. Silane treated glass fibres (FGS), 
included at high levels, were found to prevent brittle fracture. Including HEMA 
increased conversion and strength of composites whilst incorporation of PPGDMA 
improved conversion and lowered composite modulus but did slightly reduce strength. 
PPGDMA, G4S glass and FGS fibres were selected as the subject of a systematic study 
in chapter 5. 
Within the range investigated, composites containing PPGDMA, G4S filler and FGS 
fibres were found to be syringeable and capable of achieving flexural strength 
comparable to current cement materials whilst having a lower modulus than Cortoss 
and Comp06. Potentially problematic BisGMA and TEGDMA can be replaced by 
UDMA and PPGDMA.  The latter has not been used before in composites for bone 
repair but results in lower shrinkage and better conversion which could mean PFCs 
exhibit better biocompatibility than Cortoss. The effects of each variable on the curing 
kinetics were investigated. PFC curing profiles were compared to classical 
polymerisation reaction kinetics, and equations characterising each stage of the 
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reaction process were established. As PPGDMA has not been used before, this 
investigation was thought to give crucial insight into the potential of UDMA and 
PPGDMA to replace TEGDMA and BisGMA. The levels of filler and PPGDMA 
monomer had to be balanced to ensure good filler wetting for strength whilst 
maintaining low shrinkage. Incorporation of fibres could overcome the problem of brittle 
fracture of Cortoss.  
A formulation with intermediate values of PPGDMA and PLR, with a high level of fibres 
was made as a prototype PFC formulation. The curing and mechanical properties of 
this prototype product, along with further in-vivo investigations, were presented in 
chapter six. Although easily syringeable, the viscosity of the prototype PFC formulation 
was too low for an in-vivo situation in which bleeding was not completely stemmed. 
The PFC materials were found to cure faster at 37 °C than at room temperature. The 
levels of PPGDMA and filler selected were found to produce a material with 
mechanical and fracture properties that compared favourably with current cement 
materials; strength was comparable whilst modulus was reduced compared to 
composite bone cements and brittle fracture was prevented. PFC is an implant material 
with good biocompatibility and radiopacity that may be suitable for use in humans for 
fixation of osteoporotic fractures via percutaneous vertebroplasty. 
The monomer and filler systems of PFC materials were investigated but the initiator 
system was not optimized. In chapter 7, the effect of varying initiator and activator 
levels, of the prototype PFC formulaaltion, on the composite curing properties was 
investigated. It is clear from comparison of the results of this chapter and literature that 
the effects of initiators and inhibitors is highly specific to the monomer system used. It 
is therefore necessary to determine the behaviour of the initiator system over a suitable 
range to ensure reliable cure. 
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The relative levels of initiator and inhibitor are central to controlling spontaneous 
polymerization and hence the shelf life of the BP paste of a PFC formulation. It is 
thought that changing the level of BP affects the frequency factor only, although more 
repeats are required to ascertain statistical relevance.  
In summary it is felt that the investigations described and discussed in this thesis show 
that the prototype PFC formulation could be an excellent alternative to PMMA and 
composite cements for osteoporotic vertebral fracture fixation and hip fracture screw 
augmentation. It is hoped that the Raman mapping of commercial materials and the 
investigations around the curing kinetics of the PPGDMA containing composites add 
something new to the extensive literature surrounding materials for bone repair. 
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8.2 Further Work 
Whilst the handling, cure, flexural strength and modulus and fracture behaviour of PFC 
materials and commercial PMMA and composite bone cements have been 
characterized, there are some areas that could be investigated to further characterize 
these materials to better understand the effects of material composition on 
performance. This section will introduce these topics. 
In the introduction chapter, porosity was discussed as having a major effect on the 
curing and mechanical properties of PMMA and composite bone cements (25,146) and 
vacuum mixing was shown to control the number and size of voids in PMMA materials 
(23,26). The porosity of PFCs and commercial materials was not measured in this 
project but an idea of the porosity was ascertained from inspection of the SEM images 
of the fracture surfaces of PFCs. It is hypothesised that evacuation of a PFC material 
could be used as part of a novel sterilisation technique. Some very preliminary studies 
into the feasibility of this technique have been conducted; PFC materials were mixed 
with chloroform and then evacuated to remove the chloroform. It is hoped that the 
chloroform could render the pastes sterile and evacuation would reduce porosity of the 
material. It is thought that evacuation was sufficient to remove the chloroform, as it was 
not detected in FTIR curing analysis and syringe delivery was unaffected, but did not 
affect the porosity, as it was found that neither the strength or modulus of PFC 
materials nor the curing were affected.  
Generally composite bone cements are sterilized via aseptic mixing of monomers and 
conventional methods of sterilising filler materials. Chapter 6 showed that monomer 
toxicity and UV sterilisation of fillers was sufficient to prevent infection in a lapine 
implantation procedure. However, for human applications a more rigorous sterilisation 
procedure is required by ISO 5833 and ASTM F451. The ability of the chloroform-
evacuation technique to sterilise the paste was not investigated. This is an essential 
next step in development of PFC materials for clinical use. 
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Polymerization shrinkage was calculated in this project but was not measured. 
Shrinkage has been found via a density bottle method by Buruiana (46) and computer 
controlled mercury dilatometer method by Skrtic (47). Measurement of shrinkage by 
one of these methods should be performed to fully evaluate the shrinkage calculation 
method. 
In the chapter 7, very preliminary data was found regarding the shelf life of the BP 
containing paste of PFC materials. As mentioned in the conclusions section above, 
more repeats are required to assess the statistical relevance of the findings whilst 
similar shelf life experiments should be performed for the DMPT paste and both pastes 
for a range of BHT levels. Sideridou et al. found the Arrhenius coefficients of 
experimental bone cement formulations via DSC (169). Comparison with this technique 
is suggested as a method of evaluating the trends found via the varying incubator 
storage method of this project. 
As the literature review demonstrated poor fatigue life is one of the major shortfalls of 
current bone repair materials. The addition of fibres has been shown to improve the 
fatigue response. In this project fibre addition was shown to prevent brittle fracture of 
PFC materials. The fatigue behaviour and fracture toughness of PFCs should be 
evaluated to give a complete picture of the effects of fibre addition.  Methods for 
characterizing fatigue and fracture toughness are set out in ISO16402 and ISO13586 
respectively. In ISO13586 the method for quantifying fracture toughness involves 
calculating the KIC for mode 1 crack opening under plane strain. Hasenwinkel et al. 
used a similar single edge notched test from ASTM E399-83 to evaluate KIC (also 
under plane strain), as a measure of the fracture toughness of PMMA materials (35). In 
ISO 16402 two methods of determining the fatigue response of materials are 
described. The first looks at a range of stress methods (defining standard S-N curves) 
the second looks only at low stress levels, and it is thought because the stresses on 
bone cements in vivo are mainly low levels stresses (particularly in the case of elderly 
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osteporotic patients) that the second method is critical for evaluating the fatigue of 
bone cement materials. 
Water sorbtion & solubility 
The water sorption and solubility of bone cements post cure would be interesting to 
investigate as bone cement materials must perform in a hydrated environment and 
water sorption could give give valuable information about possible degradation/wear 
mechanisms. The water sorption would be found by measuring mass and volume 
changes; ISO4049 provides tests for dental materials for these things, to date there is 
no equivalent standard for orthopaedic materials. 
Viscosity 
The viscosity of PMMA changes throughout mixing due to swelling of polymer beads in 
the MMA liquid. Composites containing non-organic fillers, however, exhibit constant 
viscosity until onset of cure. Rheology of composites was qualified by whether the 
material was syringeable. This property could be quantified by determining how it can 
flow through capilliary tubes or by using cone and plate viscometer prior to cure. This 
aparatus would enable both oscilliatory and continuous shear to be measured. It is 
suggested that continuous shear would be more relevant due to the continuous way in 
which the materials are sheared when used with a double barreled syringe and mixing 
tip. Also as mentioned in the introduction chapter, ISO5833 stipulates that viscosity 
should not change by more than 10% on storing, stability of viscosity, therefore, is also 
important. Qualitative handling properties are important too and surgeon feedback on 
how easy new materials are to work with is central to ensuring their success as 
products. Some of feedback has been determined following the in-vivo testing of the 
prototype PFC although implant site and volume were not the same as human 
arthroplasty/vertebroplasty. 
 
Kirsty Main  PhD Thesis 
 243 
Creep  
All polymers exhibit viscoelastic behaviour, particularly this is important as in-vivo, 
strain rates experienced by the materials will vary significantly.  Loading is often 
flexural and so as with strength, flexural stresses are common and hence tensile creep 
behaviour is therefore of particular interest for bone cement materials. ASTM D2990 
has details of measuring both the compressive and tensile modulus of creep. The 
loading conditions in-vivo should be examined so that the predominant mode of stress 
on a material is determined so that meaningful data can be gleaned from creep tests of 
different sorts. 
Impact  
Impact strength testing is covered by ISO179/180. It is thought that bone cement 
materials should perform in a similar way to host bone in impact tests so that should 
traumatic overloading occur, the material will not act as a ‘weak link’. 
Biocompatibility 
The possible levels of leachable agents from bone cement materials have been 
inferred, in this project, from degree of conversion data and molecular size. Leachable 
agents e.g. monomers could be measured by High Performance Liquid 
Chromatography (HPLC) analysis of fluid in which bone cements have been immersed 
during cure to simulate in-vivo curing conditions. This would give some idea of the 
species leached during and following cure. 
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8.3 Final Remarks 
In conclusion, the author feels that this thesis has been a successful start to the 
development of an injectable composite bone repair material that would be well suited 
to fixation of osteoporotic bone in vertebroplasty and screw augmentation of hip 
fracture fixation procedures. The effects of incorporating a range of fillers and 
monomers on composite properties has been established and compared with literature. 
In particular this project has given insight into the effects on cure and mechanical 
composite properties of the novel diluent monomer PPGDMA. PPGDMA has the 
potential to produce materials that have superior properties to current materials.  
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